Synthesis of enantiomerically enriched B-branched amino acids via Erlenmeyer oxazolones by Bell, Sharon
Synthesis of Enantiomerically 
Enriched 13-Branched Amino Acids via 
Erlenmeyer Oxazolones 
Sharon Bell 
A thesis submitted for the degree of 
Doctor of Philosophy 
The University of Edinburgh 
October 2000 
Li 
This thesis is submitted in part fulfilment of the requirement for the degree of Doctor 
of Philosophy at the University of Edinburgh. Unless otherwise stated, the work is 
original, is my own work and has not been previously submitted, in whole or in part, 
for any degree at this or any other university. 
Sharon Bell 
The University of Edinburgh 
October 2000 
Acknowledgements 
I would like to thank Prof. Nick Turner for his support and advice throughout this 
research. Thanks also to Dr James Dowden for his encouragement and advice in the 
early stages of the project. 
There are a number of people at Chirotech who I would like to thank - firstly my 
supervisors, Dr Ray McCague and Dr Steve Taylor. I am especially indebted to Dr 
Mark Smith, both for proof reading my thesis and for all his ideas and advice during 
and after my placement. Sincere thanks go to Catherine Rippé, Will Spearing and 
David Baldwin, who developed and ran analysis for me. 
Thanks to Dr Simon Parsons at Edinburgh for obtaining crystal structures on two of 
my compounds. 
I would also like to thank all the technical staff at the University of Edinburgh, but in 
particular John Millar and Donald Robertson, Alan Taylor and Harry McKenzie. 
I would also like to thank all the members of the Turner-Flitsch group at Edinburgh 
and everyone in labs 1 and 2 at Chirotech, for all their help and advice over the last 
three years. 
Finally, thanks to Phil, and to my mum and dad, for all their love and support. 
IM 
Abstract 
There is much interest in the synthesis of unnatural, enantiomerically pure amino 
acids, including dehydroamino acids and ,-disubstituted amino acids. Described 
here is a method involving a novel, acid-free oxazolone synthesis which utilises 
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Rh-DuPHOS and Rh-BPE hydrogenation of these dehydroamino acids led to the 
discovery of a dynamic kinetic separation occurring during hydrogenation, leading to 
single products in high d.e. and e.e. from mixtures of E and Z geometric isomers. 
Synthesis of such oxazolones on solid phase would provide a method for on-resin 
amino acid modification, allowing for greater flexibility in the combinatorial 
synthesis of peptides. Linkage via a silyl linker would allow mild and selective 
cleavage, while use of an acid functionalised linker would allow inverse (N-*C) 
peptide synthesis. Attempts to synthesise I are described, along with a method of 
oxazolone formation which avoids the use of acid, and is therefore compatible with 
silyl linkers. 
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ACE angiotensin converting enzyme 
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DAST (diethylarnino)sulfur trifluoride 
DABCO. 1 ,4-diazabicyclo[2 .2.2] octane 
DBU 1 ,8-diazabicyclo[5.4.O]undec-7-ene 
DCC dicyclohexylcarbodiimide 
DCM dichioromethane 
DDQ 2,3 -dichJoro-5 ,6-dicyano- 1 ,4-benzoquinone 
d.e. diastereomeric excess 
DIBAL diisobutylaluminium hydride 
DMAP 4-dimethylaminopyridine 
DMF dimethylformamide 
EDCI 1 -(3-dimethylaminopropyl)-3 -ethylcarbodiimide hydrochloride 
e.e. enantiomeric excess 
El electron impact 
FAB fast atom bombardment 




MTBE methyl tert-butyl ether 
NBS N-bromosuccinimide 
V 
NMP 1 -methyl-2-pyrrolidinone 
NMR nuclear magnetic resonance 
PAMP phenyl(o-methoxyphenyl)methylphosphine 
PEGA polyethylene glycol-dimethylacrylamide co-polymer 
PPA polyphosphoric acid 
q quartet 
RT room temperature 
5 singlet 
SFC supercritical fluid chromatography 
SPE solid phase extraction 
t triplet 
TBAF tetrabutylammonium fluoride 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
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Solid phase synthesis 
Overview 
Since 1963, when Merrifield' reported the first example of solid-phase organic 
synthesis, the scope and number of syntheses carried out on solid phase has grown 
steadily. Access to new linkers and resins has facilitated transfer of known chemistry 
to solid phase, while the demand for compound libraries for high throughput 
screening of drug candidates has provided a push to further develop the technology. 
A technique that was first developed for synthesis of peptides has now been extended 
to more diverse syntheses of oligonucleotides, 2 ' 3 oligosaccharides 4 and small 
molecule libraries. 1.6  Inverse peptide synthesis, in which the amino, rather than the 
carboxy, terminus is attached to the solid phase, has also been investigated. 7 ' 8 
Solid phase synthesis has become popular because it is a simple way to make a large 
number of molecules in a short time. Long purification techniques are not required: 
filtration and washing of the resin will remove most impurities. Due to this ease of 
purification, a large excess of reagents may be used to drive reactions to completion. 
Lastly, resins are physically easy to handle and solid phase synthesis may therefore 
be automated. 
There are disadvantages to solid phase synthesis, however. While soluble impurities 
may easily be removed from the resin, polymer-bound impurities are extremely 
difficult to remove. Therefore, reactions on solid phase must go to completion with 
no side reactions. Linker and resin choice present a problem, as not all reagents and 
conditions will be tolerated: the resin may not swell in the desired solvent, or the 
linker may be cleaved under the reaction conditions. Extra steps are required for 
attachment and cleavage of the product from the solid phase, and on-resin analysis is 
difficult although advances are being made: JR and NMR are routine techniques on 
polystyrene resin, and a wide variety of chemical tests have been developed for use 
on solid phase." 
Introduction 
In summary, solid-phase synthesis works well with large numbers of similar 
compounds. An initial investment of time must be made to develop conditions and to 
ensure that reactions go to completion, and then solid phase synthesis is a very fast 
and powerful method. 
Linkers and resins 
Synthesis on solid phase involves attachment of a substrate to a resin via a 
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Scheme 1. Attachment, reaction and cleavage of substrate on solid phase. 
Resins 
Although more thought tends to be given to linkers, the resin backbone is also an 
important factor in the success or failure of a synthesis. Handling properties, porosity 
of resin and affinity for solvents must all be considered. 
By far the most popular resin is polystyrene crosslinked with divinylbenzene. The 
amount of crosslinking determines the ability of solvents and reagents to penetrate 
the resin - more crosslinking decreases the porosity and prevents penetration. 
Crosslinking also affects the handling properties of the resin so that too little 
crosslinking will produce a resin which is not firm enough to be filtered. Generally a 
compromise - 1-2% crosslinking - is used. The most common polystyrene resins are 
chioromethyl-, aminomethyl- and hydroxymethylpolystyrene. 
Polystyrene resins are not well penetrated by polar solvents. For reactions in water, 
TentaGel, ArgoGel and PEGA are used. TentaGel and ArgoGel are both 
polystyrene/divinylbenzene-poly(ethylene glycol) graft colpolymers, used when a 
reaction requires solvents too polar for polystyrene/divinylbenzene. PEGA on the 
other hand is a poly(ethylene glycol)/dimethylacrylamide copolymer, and is much 
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more easily penetrated by polar solvents and large molecules, and is often used in 
reactions involving enzymes. Its mechanical stability is lower than that of the 
polystyrene resins and so its use is limited. 
Finally, the last few years has seen a rise in popularity of pins/crowns. These are 
much larger than the conventional resins, and they do not swell: reaction takes place 
on the surface only. Inevitably, they have lower levels of functionalisation than 
conventional resins, but they potentially facilitate synthesis of bulky molecules, and 
offer a greater chance of reaction completion, since reagent penetration is not an 
issue. 
Linkers 
Linkers are used in solid phase synthesis for two reasons. Firstly, they act as a 
spacer, allowing solvent and reagents to come into better contact with the polymer-
bound substrate. Secondly, they are used to attach the substrate to the resin through a 
linkage whose reactivity has been designed to be stable to the reaction conditions and 
to be orthogonally cleavable. In this way the design of linkers closely resembles that 
of protecting groups, and many common linkers have been modelled on solution-
phase protecting groups.' 2 
Linkers may be considered as two types: those obtained by direct derivatisation, and 
those formed in solution and attached to the resin, usually via an ether, amide or C-C 
bond (Figure 1). The former were popular in the early days of solid phase synthesis 
but the small range of derivatives obtainable from direct reaction, coupled with the 
fact that direct derivatisation means being closer to the backbone, has meant that 
loaded resins (formed in solution and attached to the resin) are becoming more 
popular. 
As research on linkers continues, the number of reactions and possible products that 
can be synthesised on solid phase grows. 
Introduction 
Figure 1 Direct derivatisation vs. attachment via linker 
Combinatorial and Parallel Synthesis 
In recent years, improvements in biological screening of drug candidates" have 
meant that the rate-limiting step in the development of a new drug is the generation 
of compounds to be tested. Traditionally organic synthesis has concentrated on 
highly organised selective combination of reagents to give one product. Now, with 
the need to generate a large number of compounds in a short time, combinatorial 
chemistry is increasingly popular. Combinatorial chemistry uses reagents to generate 
as many compounds as possible. There are two methods of combinatorial chemistry: 
the "split and mix" method and the parallel synthesis method. 
In split and mix, the polymer beads are split into a number of pools, each containing 
a different reaction mixture or different building block. The reaction is carried out 
and the beads are washed, mixed and redivided for the next reaction (Scheme 2). 
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Scheme 2 Combinatorial library synthesis 
With a large enough number of beads it is likely that all the possible combinations 
will be synthesised. 
In parallel synthesis, a matrix containing all the possible combinations of products is 
formed. This matrix can be in the form of a polymeric sheet with a different space 
for each compound," a set of "teabags" which contain resin and allow reagents to 
diffuse in and out,' 5 a set of sintered syringes," or a matrix of pins or crowns.' 7 
Parallel synthesis has advantages over split and mix in that it is guaranteed that some 
of every possible compound will be present, and that all the compounds are obtained 
separately. Parallel synthesis requires more material per compound synthesised (i.e. 
at least one pinlcrowniteabag etc.) and so is more suitable for smaller libraries. 
Both of these techniques were developed with the linear synthesis of peptides in 
mind. However it is possible to use them for small-molecule synthesis where instead 
of adding each new amino acid on at the end of the peptide chain, new building 
blocks are incorporated into the molecule at various sites of diversity, where 





Since much of the use of solid phase synthesis is in the generation of compound 
libraries for biological screening, it is important that a full range of properties may 
be accessed via solid phase synthesis, i.e. there should be no more restriction on size, 
shape, polarity or functionality than for solution phase synthesis. This poses a 
problem in that the method of attachment of a molecule to a linker is usually via a 
heteroatom bond. Cleavage of the product leaves a "polar handle" which may 
adversely affect the molecule's physicochemical properties. 
Traceless linkers are designed to avoid this problem. The basic strategy is to cleave 
the molecule in such a way that no polar handle is evident; this may be achieved in a 
number of ways. 
Arylsilanes 
The arylsilanes have received a great deal of interest in recent years and are 
considered with the other silicon linkers, below. 
Sulfur - thioethers, sulfones, sulfonates and sulfonium salts 
The earliest example of a traceless linker was published in 1983.18  Aldehydes and 
ketones were condensed with poly(p-vinylsulfonylhydrazine) to form a polymer-
bound sulfonyihydrazone which was reduced with sodium borohydride or 
hydrolysed with sodium 2-hydroxyethoxide to give the alkane and alkene 
respectively (Scheme 3). Yields were moderate, and more hindered ketones such as 
camphor resulted in lower yields of product. Whether this was due to difficulties in 
the loading or the cleavage step is not clear. 
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Scheme 3 Traceless cleavage from hydrazone linker 
Thioethers have been used in a number of traceless linker strategies. The first was in 
1994, when Sucholeiki synthesised the linker system 1 (Scheme 4) which could be 
cleaved photochemically.' 9 The linker 2 was synthesised in 20% overall yield from 
2-methoxyphenylacetic acid, and its attachment to aminomethyl TentaGel was 
achieved under standard conditions. After coupling of the substrate, irradiation at 
350nm gave the desired product 3 and the aldehyde 4 in a 20:1 ratio. Such a non-
specific cleavage was undesirable and other thioether linkers which give single 
products have since been developed. 
PhSS 
DIC,DCM 	 o 
0. Ph 
OH (D-NH  
1. PhCHSH, 
('Pr) 2NEt, DMF 
2. 4-phenylbenzyl 
Ph—__- 	 Ph 	
-bromide, (iPr) 2NEt, 
+ 	3 	hv(350nm) 	
DMF 
Ph 
4 	 _aEA H 
Scheme 4 Synthesis and cleavage of a photocleavable linker 
An alternative cleavage method for thioether linkers was developed  21  involving 
cleavage of the linker 5 (Scheme 5) using Raney nickel. The soluble polymer, 
poly(ethylene glycol)monomethyl ether was used, and recovered after cleavage by 
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trituration with ether. Cleavage resulted in release of 6 in 94% yield, which after 
concentration of solvent was spectroscopically pure. 
However, the group later reported problems with the linker - dimerisation due to air 
oxidation, and formation of the thioester rather than the amide during synthesis. 
Therefore the modified linker 7 (Scheme 5), which does not have these problems, 
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Scheme 5 Cleavage of Zhao 's thioether linkers with Raney nickel 
This linker was then used in development of different conditions for thioether 
cleavage. 22 A method was desired which could selectively cleave the thioether 
without reducing any other reduction-sensitive functional groups in the substrate. It 
was found that oxidation to the sulfone using potassium hydrogen persulfate and 
reductive cleavage with 5% sodium-mercury amalgam selectively released the 
desired product. It was hoped that since these are known to be selective 
oxidising/reducing agents, the method would be suitable for cleavage of sensitive 
substrates. 
Sulfonates as well as sulfones have been used for the mild traceless cleavage of 
products from solid phase . 2' The arylsulfonate 8 (Figure 2) was prepared from 2% 
cross-linked benzenesulfonic acid resin and a number of alcohols and amines were 
coupled to it. Palladium-mediated cleavage released the benzyl esters and 
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benzamides in moderate yields: yields were better for the esters, supporting the 
authors' hypothesis that more electron-poor arylsulfonates would be more easily 
cleaved. Since no reactions were carried out on the polymer-bound substrates, the 
stability of the linker is not known. 
11 
Figure 2 Arylsulfonate linker for esters and amides 
Palladium-mediated cleavage was also used in the strategy of Vanier et al. •24  Their 
thioether linker was cleaved by activation to the sulfonium salt followed by 
treatment with a Pd(0) complex and an arylboronic acid (Scheme 6). Thus, the 
Suzuki-coupled product 9 was obtained. The reaction was carried out using a variety 
of polymer-bound thioethers and arylboronic acids, giving a small library of biaryl 
compounds. 
R 1 , R2 = H, Me, Ph, 
NO2, F, OMe, CO 2 , 
CO2NH, CN, -OCH 20-. 
- R 1 
Et3OBF4 	
BF 
Ar 	 R - 	 1 Pd catalyst 
ArB(OH)2 
K2CO3 
24-99% R 2 
9 
Scheme 6 Cleavage of a thioether linker via activation to the sulfonium salt 
Ring-closing metathesis 
Much of the work on traceless linkers has concentrated on replacing the C-
heteroatom bond to the solid phase with a CH bond on cleavage. Another strategy 
however, is cleavage by ring closure. Nicolaou and co-workers have developed 
strategies based on ring-closing metathesis and cyclisation via an intramolecular 
Heck reaction. The ring-closing metathesis was used in the synthesis of the 
(S)-zearalone 
Bu\ 	QI. 




microtubule inhibitor epothilone A (Scheme 7), where the intermediate 11 was 
obtained by action of Grubbs' catalyst on 10.25  Similarly, the natural product (5)- 












11 Epothilone A 
12 
Scheme 7 Ring-closing strategies for synthesis of natural polyketides 
Selenium linkers 
Selenoethers may be cleaved in a number of ways to give traceless products; they 
may also be easily formed in a number of ways. Nicolaou and co-workers 
investigated some of these methods 2' and demonstrated reversible addition and 
elimination of polymer-bound selenium bromide on an alkene (Scheme 8). A 
selenoether was also formed from the alkyl iodide 13 which could then undergo 
cleavage to the alkene using hydrogen peroxide, or reduction to the alkane with 
tributyltin hydride (Scheme 8). Ruhland et al. 28 used a different method of 
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Scheme 8 Nicolaou 's traceless selenoether linkers 
Triazene linkers 
Bräse et al. investigated the use of the triazene functionality as a traceless linker. The 
linker29 was formed by coupling of aryl diazonium salts to a polymer-bound amine 
(Scheme 9). A number of transformations were carried out, including Heck coupling, 
DIBAL reduction and lithium-halogen exchange. Cleavage was effected by 
hydrochloric acidJTHF and ultrasound. Although this method of cleavage gave clean 
products in good yields, polymeric material was also obtained due to ring-opening of 
THF. A milder cleavage using trichlorosilane was therefore developed. 30 
N THF rtJ 1 OtBu 	IN 
16c 
THE, HCI (conc), ))) 
p N 
Further reaction 
R= p-NO 2 , o-Br-p-Me, p-C 6 H 9 p-CONH 21  
p-0O2 Et, p-CH=CH-0O2tBu, p-CH 2000C7 H 15 , 
p-I, p-CHCH-C6H 13 




Another linker which is cleaved with release of N 2 is the hydrazide linker developed 
by Stieber et al. The linker 14 (Scheme 10) was prepared from 
aminomethylpolystyrene and subjected to palladium cross-couplings with a number 
of substrates. Cleavage was via copper (II) acetate or NBS oxidation. 
0 
H 11 __~ H-0— 
0 	 o 
14 
Oxidation, Nu 	 Nu N, N 
—a  R 0-Y H 	 R 
+ 
R = aryl, alkenyl, alkynyl 	 N2 
Scheme 10 Stieber 'S hydrazide linker 
Schiemann and Showalter have recently used a benzotriazole linker in the synthesis 
of tertiary amines. 32 They also investigated the effect on reactivity of adding a spacer 
into the linker - it was found that a longer spacer resulted in better swelling 
properties and higher reactivity. 
The intermediate 15 (Scheme 11)" was obtained from polystyrene-
diphenyiphosphine and underwent Wittig olefination with methyl-4-formylbenzoate 
in the presence of sodium methoxide, giving 16. With only one product prepared 






15 	 OMe 
Scheme 11 Traceless cleavage via Wittig reaction 
H. 
CO2Me 
16 	 OMe 
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Finally, a new method of attachment to solid phase has been developed in which an 
aromatic is tethered to chromium in a "piano stool" complex (Scheme 12). 
Chromium hexacarbonyl is first complexed to the aromatic of interest, and then CO 
is substituted with polymer-bound triphenyphosphine. LiA1H 4 reduction and 
acetylation were performed on solid phase, and cleavage was performed once by air 
oxidation and once by heating in pyridine. The "non-invasive" nature of the 
attachment to the solid phase makes this an attractive linker but it requires more trial 
reactions and development of standard cleavage conditions before its utility can be 
judged. 
R1 	*—PPh 
R 1 Cr(CO) 6 
_ R-t 	
R1 




Scheme 12 Polymer-bound aryl chromium carbonyl complex 
In conclusion, the last ten years have seen the development of many strategies for 
traceless synthesis. Although most work at the moment concentrates on development 
of new linkers and reaction conditions, the diversity of systems already developed 
makes it likely that in the next ten years synthetic applications will be found for 
these linkers, most likely in the synthesis of small-molecule libraries. 
Silyl linkers 
Overview 
Among the traceless linkers, arylsilane linkers are some of the most studied. 
However, arylsilanes are some of the more recent examples of silyl linkers - many 
more examples exist, some of which have been applied to complex synthetic 
targets. 35 
Silicon linkers have two interesting properties. Because of the high affinity of 
fluoride for silicon, silicon linkers can be cleaved under conditions orthogonal to 
most other reaction conditions. In addition, arylsilanes can undergo electrophile- 
13 
Introduction 
induced desilylation so that an electrophile (e.g. halogen or proton) is substituted for 
silicon. These properties account for most of the uses of silyl linkers. 
Silyl linkers for alcohols 
A number of silyl linkers have been designed which immobilise alcohols (Figure 3). 
These take advantage of the specificity of cleavage conditions for silyl ethers, and 
are cleaved by fluoride salts. Three strategies have been used in the synthesis of 
these linkers. 
— OR1 
Figure 3 Silyl linkers for alcohols - general structure 
The first of these strategies 36 was the direct lithiation of polystyrene followed by 
addition of diphenyldichiorosilane (Scheme 13). Base catalysed silylation of an 
alcohol then gave the polymer-bound silyl ether. This method has also been used in 
the synthesis of an oligosaccharide; 35 it was found that the diisopropyl linker 
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Scheme 13 Chan's silyl linker 
Two groups have produced linkers which are synthesised by hydrosilylation of a 
polymer-bound alkene. Stranix et al. 37 synthesised a silyl chloride which may be 
recycled after cleavage, while the linker of Hu et al.38 may be stored as the stable 
silane and activated to the silyl chloride on treatment with 1 ,3-dichloro-5,5- 
dimethylhydantoin. However neither of these linkers has yet found practical 
application. 
Finally, Nakamura et al. 39' 4° have developed a silyl chloride linker for the synthesis 
14 
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of glycopeptides. Using a preformed handle approach, the glycopeptide is linked to 
solid phase via a silyl ether linkage with serine. 
Silyl linkers for acids 
Silyl linkers have also been used to link acids to solid phase - again, the specificity 
of cleavage is the motivation for the silyl linker and cleavage is achieved by 
treatment with a fluoride salt. The methods of synthesis are different, but the 
cleavage mechanisms are similar: fluoride ion attack followed by direct" or 
indirect42 ' 43 cleavage (Figure 4). The two earlier linkers 41 ' 42 were used to synthesise 
small peptide chains, while the more recently developed linker 43 was reacted with a 





spacer 	Si 0 	R 
RSi 
Figure 4 Mechanisms of release ofpolymer-bound acids: i. Direct release ii. 
Indirect release 
Arylsilanes as traceless linkers 
However, the largest area of research by far has been on arylsilanes as traceless 
linkers. The ability of arylsilanes to undergo electrophile-induced desilylation 
(Scheme 14) means that treatment with acid gives an aryl compound with no 
"memory" of attachment to the solid phase. As discussed earlier, this has 
implications for library synthesis. 
15 
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R 2 	 R 2 	 R 2 
Scheme 14 Electrophile-induced desilylation 
Broadly speaking there are two types of arylsilane linker - alkylarylsilanes 17 and 
alkoxyarylsilanes 18 (Figure 5). The alkylarylsilanes can be further divided by their 
method of attachment to the solid phase: via C-C or C-heteroatom bond formation. 
_er O ooi{3- 
17 	 18 
Figure 5 Alkylarylsilanes and alkoxyarylsilanes 
AlkyI(aryl)silanes with C-C bonds to solid phase 
Two syntheses have been carried out using alkylarylsilanes. In both cases, 
allylsilanes were hydroborated and attached to bromopolystyrene by a Suzuki 
coupling (Scheme 15). Further reaction and cleavage with TFA gave a 
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Scheme 15 Synthesis of alkylarylsilanes bound to solid phase via Suzuki coupling 
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Alkyl(aryl)silanes with C-heteroatom bonds to solid phase 
Other alkylarylsilanes are attached to solid phase through a heteroatom bond. In one 
example this is an amide" but in the rest an ether is formed (Figure 6). In all these 
examples a preformed handle is synthesised and attached to the solid phase via the 
heteroatom bond. 
—e1-- 0 S1 
'  ':::;R 2 
Figure 6 General structure of alkylarylsilanes attached to solid phase through C-O 
bonds 
These linkers are cleaved by TFA, with one exception" - a benzodiazepine (Figure 
7), which is extremely electron-poor when protonated, and requires HF to cleave the 
Si-C bond. Some uses have been found for these alkyarylsilane linkers. A small 
library of halogenated biphenyls 48 was prepared via Suzuki coupling, and a 100 
member library of biaryl amides46 was also synthesised using a Suzuki coupling. 
Suzuki coupling was also used in the synthesis of a number of tamoxifen 
derivatives.49 However, some of the linkers developed have simply had their stability 






R1 = 3-MeOC6H4, 1-adamantyl, 
Ph, 4-MeOC 6H4 
R2 = CH2CH(CH 3 )
21 
 CH2C6H40H, CH3 
R3 = CH2CH3, CH2C6H 5 , H 
Figure 7 Plunkett electron-poor benzodiazepines 
Alkoxy(aryl)silanes 
There are fewer examples of alkoxyarylsilanes than alkylarylsilanes. This is probably 
because of the decreased stability of these linkers. Cleavage of the Si-O bond results 
from action of TFA. Therefore, the linker must be cleaved by action of the basic 
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fluoride salts CsF or TBAF, not TFA or HF, and in the case of electron-rich 
arylsilanes, fluoride ion cleavage can be very slow. 52 
Nevertheless there are examples of its use, in the synthesis of benzofurans in a 
preliminary study for library synthesis" , in the synthesis of a benzopyranone 
library" and in the controlled synthesis of a thiophene polymer. 55 In all cases a 
preformed handle approach is taken, so the most challenging chemistry needed to 
make the linker is performed in solution (Scheme 16). This linker is now 
commercially available. 
R 
BuLl  Br-Ar 	 Cl—Si–Ar 0 	Ar R2SiCl2 	I 	imidazole R 
Scheme 16 Synthesis of alkoxyarylsilanes 
Allylsilanes as traceless linkers 
Allylsilanes as well as arylsilanes undergo electrophile-induced cleavage. The 
allylsilane linker 19 (Scheme 17)56  was synthesised by direct lithiation of 
polystyrene/divinylbenzene, and olefin metathesis gave polymer-bound substrates 
20. Cleavage with TFA yielded products 21 in 0.4-0.6mmolg' loading; substrates 
used included a sugar and a protected valine residue. 
_R 
19 	
C12(PCy3)2RuCPh 	 20 
R = PhCH 21  protected sugars, 
amino acids and amino alcohols 	
RFA, DCM 
21 
Scheme 17 Attachment and cleavage of allylsilane linker 
In summary, the silyl linkers have already shown their utility as linkers for acids and 
alcohols, and there has been promising work on their use as traceless linkers. In 
choice of a traceless silyl linker, the choice must be made between stability 
(alkyl(aryl)silanes) and ease of synthesis (alkoxy(aryl)silanes). 
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Solid phase reactions of amino acids 
Overview 
Solid phase synthesis involving amino acids is not a new field: the first reported solid 
phase synthesis produced a tetrapeptide. Although synthesis of C to N peptides is the 
largest field in solid phase chemistry, synthesis in the other direction has also been 
investigated. N to C peptide synthesis (inverse peptide synthesis) and unnatural amino 
acid synthesis are developing fields which will offer a route into a variety of peptides 
and peptide-like structures. 
Inverse peptide synthesis 
Conventionally, peptides were synthesised on solid phase by initial attachment to 
amine resin. Thus the C terminal of the peptide is attached to solid phase and is 
unavailable for reaction. Many natural peptides and biologically active peptides have 
modified C termini - C-terminal amides, alcohols and esters, among others. 57 
Therefore, methods of attachment that leave the C-terminus free for elaboration are 
desirable. Inverse peptide synthesis is one such method. The first amino acid is 
coupled to resin capable of anchoring via the amine - generally carboxylic acid resin is 
used to form an amide - and the peptide is grown by stepwise addition as in 
conventional peptide synthesis. However, there are two complications. First, since the 
amino acids are coupled through N not C, a new protecting group strategy is 
required. Second, activation of the resin-bound amino acid can result in oxazolone 




Q_f ptide]7 4JsJ 
o 	L - leaving group 	0 
Acidic proton,  susceptible to epimerisation 
Scheme 18 Side reaction of oxazolone formation in inverse peptide synthesis 
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Oxazolone formation is suppressed by optimisation of reaction conditions, while the 
most common protecting group strategy for inverse peptide synthesis is the 
fluorenylmethyl (Fm) ester (Figure 8). As with the closely related Fmoc protecting 
group, cleavage is with piperidine. The dibenzofulvene product is UV active, and 
loading may be measured by measuring its concentration in cleavage mixtures. 
H2  1'~K ,~, 
U2 
Figure 8 Fm protected amino acid 
Modification of amino acids 
Unnatural amino acids and related structures are in demand for synthesis of peptide-
like drugs and as probes for peptide conformation. They are also useful intermediates 
for other small molecules. While synthesis of unnatural amino acids can be achieved 
in solution, there are advantages to solid phase synthesis. Combinatorial methods 
may be used to access a wide range of compounds, and modification of peptides on 
solid phase allows simple preparation and comparison of analogues. For example, 
the antibacterial peptide MP was modified on solid phase to investigate stability and 
potency of its analogues. 58 
Modification of amino acids on solid phase is becoming easier due to the number of 
methods currently being developed. Recently Salvino and coworkers" synthesised a 
number of a-amino aldehydes (Scheme 19). Synthesis involved attachment of a 
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R = Me, 'Pr, PhCH2, 	 H 	( 
 NHBoc
CH 2CO2tBu, (CH 2 )4NHCO2tBu 
R 
Scheme 19 Synthesis of amino alcohols on solid phase 
The target for Hall et. al.,6° in contrast, was the amino functionality: they devised a 
mild method of monoalkylation of amino acids in which amides are reduced to 
alkylamines through borane reduction. Although amide formation and borane 
reduction is known, most procedures require acid or base to dissociate the borane-
amine adduct product. Hall's titration with iodine in buffered solution allows 
dissociation at neutral pH. 
Borane reduction was also used in the synthesis of a library of diethylenetriamines 6 ' 
(Scheme 20). After synthesising the dipeptide and capping with an acid, reduction 
was carried out using borane at 65°C. Treatment with HF liberated the product. 
R 1 	R 2 0 
N --Iy H Y 
0 	R 3 0 
R 1 	R 2 









Y N '1~  R 
Scheme 20 Synthesis of a diethylenetriamine library 
Several new strategies for synthesis have also recently been published. The work of 
O'Donnell et al. on alkylation of Schiff bases is particularly interesting. Initial work 
delivered racemic amino acids through alkylation of a glycine Schiff base anion 
(Scheme 21).62  An asymmetric variant was then developed using pseudoenantiomeric 
cinchonidine and cinchonine derivatives as catalysts. 63 The synthesis strategy was 
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R = alkyl, benzyl, 
alkenyl, alkynyl 
RX 
BEMP 	 0 
NMP 
C ILN=CPh 2 
R 
Ii. iN HCI 
2. iPr2NEt 
0 
O NH 2 
R 
Scheme 21 Alkylation of a glycine Schff's base 
Radical alkylation has also been explored. Yim et al.65 synthesised some sterically 
hindered alanine derivatives by radical addition of organomercury chloride 
compounds to polymer-bound dehydroalanine. Yields were moderate, and racemates 
were obtained. The work of Miyabe et al. 66 is more general, since addition is at the a 
position; triethylborane-assisted addition of alkyl iodides proceeded in moderate 
yields except in the case of the more unstable 'butyl and adamantyl radicals. 
Conclusion 
Although the most popular use of amino acids on solid phase is in the synthesis of 
peptides, increasingly, small molecule transformations are being carried out with 
amino acids as starting materials or products. Many recent examples of amino acid 
syntheses are by asymmetric methods, with stereoselectivity comparable to solution 
phase syntheses in some examples. 
Oxazolones 
History 
Since the first synthesis of an unsaturated oxazolone by P16chl 67 in 1883, there have 
been two periods of concentrated research on oxazolones. The first was around 1940 
after the thiazolidine-oxazolone structure was wrongly assigned to penicillin. In the 
1970s and 80s another burst of activity was produced by the increasing interest in 
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oxazolones as precursors to dehydroamino acids and other conformationally 
restrained amino acids . 68 ' 69 
This discussion will deal mainly with the unsaturated oxazolone 22 (Figure 9), but 
the saturated oxazolones 23 should also be mentioned. Both types of oxazolone can 
be considered to be the dehydration product of an N-acyl amino acid. Oxazolones of 
the general structure 23 have been obtained by dehydration of amino acids with 
acetic anhydride, DCC 7° and EDCI, 7 ' chloroformates 72 and thionyl chloride." 
R2 R3 
R 2  R 3 
N 	0 	N Nr 
0 
R 	 R 22 	 23 
Figure 9 Oxazolone general structures 
Oxazolones of the general structure 22 can also be synthesised by dehydration of the 
corresponding dehydroamino acid: the most common cyclising agent is acetic 
anhydride. 13  However, the value of this reaction is limited due to the small numbers 
of dehydroamino acids available. Indeed most dehydroamino acids are prepared from 
the corresponding oxazolone. 
In the synthesis of 22, stereochemistry of the C=C double bond is an important 
consideration. With monosubstituted oxazolones, most methods give the Z isomer 
since this is the thermodynamically more stable form. However, there are exceptions 
to this rule, and, Z/E isomerisation of oxazolones has been the subject of much 
research. In the disubstituted oxazolones the situation is less clear, with many 
methods giving rise to mixtures of Z and E products. 
Methods of synthesis of oxazolones 
As mentioned earlier, the first synthesis of a dehydrooxazolone was carried out by 
Plöchl in 1883. Erlenmeyer then expanded the work by proposing the oxazolone 
structure and synthesising a number of oxazolones. Their method - condensing N-
benzoyl or N-acetyl glycine with an aldehyde in glacial acetic anhydride - continues 
to be the most commonly used method of preparation for monosubstituted 
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dehydrooxazolones 68 (22, R3=H). Modifications of this method include addition of 
sodium acetate, 74 ' 75 potassium carbonate" and lead (IV) acetate . 73 ' 77 The lead acetate 
method in addition allows the synthesis of a number of acetophenone derivatives (22, 
R2=Ar, R3=Me). 77 In the case of aldehyde derivatives the products are exclusively Z 
but the stereochemistry of the acetophenone derivatives is more complicated 
(Scheme 22). The more electron-withdrawing substituents give rise to Z/E mixtures, 
while the electron-releasing substituents give exclusively Z. 
IV 	 ,LCI UL,l ICI 11101! ' 	
R 
1 
C6H 5 70:30 Z:E 
p-02NC6H5 	70:30 Z:E 	 0 
m-02NC6H 5 70:30 Z:E OH >=
DO 	
N p-H 3CC6H5 	70:30 Z:E 
II >=O m-H3CC6H5 70:30 Z:E 
p-H3COC6H5 	70:30 Z:E 
p-CIC6H 5 	Pure Z 
2-furyl Pure 	 Ac20, Pb(OAc)4 , reflux 
2-thienyl 	Pure Z 
Scheme 22 Synthesis of acetophenone-derived oxazolones 
There are a number of problems with the acetic anhydride method. The primary 
disadvantage is the harshness of the conditions used. Reactions are carried out in 
refluxing acetic anhydride, so low-boiling aldehydes and ketones cannot be used. In 
addition, the use of acetic anhydride rules out synthesis of acid sensitive products. 
Therefore, solid phase synthesis using the acetic anhydride method is almost 
impossible due to the effect of neat acetic anhydride on resin. The synthesis also 
seems limited to less hindered alkenes (22, R 3=H, Me). 
The acetic anhydride method is by far the most popular but there are others that 
avoid some of its limitations. The use of ethyl chloroformate has allowed the 
synthesis of a number of more challenging targets including 2478  (Figure 10). 
NTh 
24 
Figure 10 Highly hindered benzophenone-derived oxazolone 
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In this synthesis an N-acylglycine is treated with ethyl chloroformate and 
triethylamine to form the dihydro intermediate 25 (Scheme 23). Heating with a 
carbonyl or imine results in condensation and the formation of the desired oxazolone. 
0 
OH C2 H5000CI, (C2H5)3N N"7° 
R 	
-HCI 	 ,)L0 
0 	 R125 







R 1 = CH31 CA, C6 H 5CH=CH, R2 = Ar, (cis) CH=CHC6 H 5, -(CH 2 )5-
R3= H, -(CH 2 )5-
1 
 CH3 X = 0, N-C6 H 5 
and R 1 = R2 = R3 = C6 H5, X = NCH3 
Scheme 23 Synthesis of oxazolones using ethyl chloroformate 
In reactions with aldehydes this reaction gives (with one exception) the Z product: 
with trans-cinnamaldehyde the E product is formed, presumably because of the 
extended conjugation through the oxazolone ring in the E form. In the one reported 
synthesis using an unsymmetrical carbonyl compound (R'=R 2= CA,  R3=CH3) a 
mixture of Z and E isomers was obtained. 
Since the active species 25 is formed before the carbonyl compound is added, milder 
conditions can be employed. The condensation step requires only gentle heating and 
triethylamine reacts with the acid formed in the cyclisation reaction. The method 
also potentially allows use of volatile carbonyl compounds since they can be 
converted to their higher-boiling imines. However the use of imines in this reaction 
creates its own problem: the amine which is generated can then attack the oxazolone, 




RNH 2 	3 
A N NX1(R 4 
IV 	R4NH 2 
Scheme 24 Nucleophilic ring-opening of an oxazolone 
This ring opening occurs with retention of configuration at the C=C double bond. 
There are a number of other methods which involve condensation of a carbonyl or 
imine with intermediate 25: these include the use of perchioric acid, 79 
phenyldichlorophosphate 8° and 2-chioro- 1,3 -dimethylimidazolinium chloride." 
Polyphosphoric acid (PPA) 82 has also been used to condense N-acyl amino acids with 
carbonyl compounds. The paper suggests that the reaction occurs via the Perkin 
mechanism (Scheme 25) but no evidence is given for this. 
jOH 




R 3 	R 






Scheme 25 Perkin mechanism of oxazolone formation 
The PPA and perchiorate methods are both interesting in that they give the more 
labile E oxazolones. The perchiorate method was only performed on one example 
(22, R 1 =R3=C6H5 , R2=H) but the PPA method has been successfully used with a 
number of aromatic and aliphatic aldehydes and ketones. It suffers from one main 
drawback however: PPA is extremely viscous and the difficulty in mixing and 
handling the reaction mixture would prevent its use on large scale. 
Phosgene has been used to synthesise a number of oxazolones from a-substituted 
amino acids; the phosgene acts first as a cyclising agent andthen as a dehydrating 
agent. While the reaction proceeds in good yield, its applicability is limited to the 
range of amino acids with a 3 hydrogen. In addition, the toxicity of phosgene gas 
precludes its use on large scale. 
As well as triphosgene, dichlorodicyanobenzoquinone (DDQ) may be used to 
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dehydrogenate a 5(411)oxazolone. 83 A key step in the synthesis of L-aspartyl-Z-
dehydrophenylalanine methyl ester was dehydrogenation of the phenylalanine 
residue of Boc-3-benzyl-L-aspartyl-L-phenylalanine. This was achieved by DCC 
cyclisation to the oxazolone followed without purification by dehydrogenation using 
DDQ and collidine (see below). This method avoids the use of acidic reagents, 
presumably to avoid Boc deprotection, and could be suitable for other syntheses 
where acid sensitivity is an issue. 
Ph 
Boc-/jsp-Phe-OH DCC1 	I N Ir 0 
OBzI 	 PhCH2O T 
NHB0c 
Ph 	-' DDQ 





The methods outlined above give simple access to monosubstituted Z-oxazolones. 
However, access to the E isomers and to pure samples of Z and E isomers of 
disubstituted oxazolones is less simple. PPA allows access to the mono- and 
disubstituted E isomers, but this method is not useful on large scale due to the 
viscosity of the reagent. A number of attempts have been made to isomerise Z and E 
isomers and these have been outlined here. 
Ullman and Baumann" investigated the effect of various wavelengths of light on 4-
(Z)-benzylidene-2-phenyloxazol-5(411)-one. On irradiation with 3650A light a 
photostationary mixture of 1:1 Z:E isomers was produced, along with a small amount 
(11%) of unisolable side products. While this reaction is a relatively high-yielding 
and simple process, it is impractical for the preparation for large amounts of 
material. The low concentration of the reaction (1 g of oxazolone per litre of solvent) 
and the need to separate the isomers by column chromatography and discard the 
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unwanted isomer make it a difficult and expensive process to scale up. 
An alternative is chemical isomerisation. Cativiela et al.75'77' 85-87  have made use of a 
method developed by Rao" in which isomerisation between Z and E forms is 
achieved by pyridine and saturated HBr solution respectively (Scheme 26) 
NIO 
R 2 
sat. HBr solution 
N \ 
pyridine, heat 	I cjvL0 
R1 = aryl, heteroaryl, R2 = Me, H 
Scheme 26 Isomerisation of oxazolones 
Unfortunately, while the E to Z isomerisation with pyridine is practical on large 
scale, the Z to E isomerisation is unsuitable because of the use of HBr gas. It remains 
to find a scaleable route to E oxazolones. 
Reactions of Oxazolones 
Ring opening of oxazolones with nucleophiles - basic hydrolysis, amines, alcohols 
and amino acids - leads to a,3- dehydroamino acids, amides, esters and peptides 
respectively. This area is dealt with in greater detail below. The dehydrated 
oxazolone also offers a route to saturated amino acids, either through ring opening 
followed by reduction, or by reducing the oxazolone and hydrolysing the resulting 
saturated oxazolone. In this case, since saturated oxazolones can easily racemise, 
ring opening with resolution is necessary to obtain an enantiomerically pure amino 
acid. This resolution can be performed using metal complexes 89 ' 90 or by enzyme-
assisted ring opening. 9 ' 
A number of groups" -9 ' have used oxazolones as intermediates to c3-cyclopropyl 
amino acids, which are interesting conformationally restrained amino acids, and have 
been found in nature. 96 Recently, oxazolones have also been used as dienophiles in 
Diels-Alder reactions. Again the aim was to produce an unnatural amino acid: Gelmi 
et al. 97 synthesised the serine analogue 26 (Figure 11), while Avenosa et al. 98 
synthesised 27 which was used as a model for 28 in ab initio calculations to aid 
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calculation and prediction of protein structures containing 28. 










Figure 11 Conform ationally restricted amino acids from oxazolones 
As well as insertion into the C=C, substitution is also possible. The intermediate 29 
has been used in a Stille coupling" and in substitution with thiols 94(Scheme 27). 
While the Stille reaction proceeded with retention of stereochemistry, the thiol 
substitution caused isomerisation, and mixtures of E and Z isomers were obtained. 
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Scheme 27 Substitution reactions on oxazolone C=C 
Oxazolones have also been used to synthesise a variety of heterocycles. Recent 
examples include the synthesis of the marine alkaloid Leucettamine B,' °° and the 
synthesis of some macrocyclic analogues of a natural ACE inhibitor."' 
Conclusion 
Oxazolones have been known for over a hundred years and over that time many uses 
have been found for them, mainly as intermediates for other compounds. In 
particular the Erlenmeyer oxazolones provide a simple route into dehydroamino 
acids through hydrolysis. 
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a, -Dehydroamino acids 
Overview 
a, 3-Dehydroamino acids, of general structure 30 (Figure 12) are an interesting class 
of compounds, both as precursors to saturated amino acids and as targets in 
themselves. A significant number of natural products derived from small peptide 
chains contain dehydroamino acids. The lantibiotics' °2 are a class of such peptides. 
These peptide antibiotics, which contain a large number of post-translationally 
modified amino acids, include the food preservative nisin.' °3 Azinomycins are 
another such class of peptide derived products, which show potent in vivo antitumour 
activity. Total synthesis of the azinomycins has not yet been achieved; however, 
synthetic studies have resulted in an interesting method of stereospecific bromination 
which will be discussed later. 
R)IIO2 
300 
Figure 12 a,,&Dehydroamino acid general structure 
a, 3-Dehydroamino acids are not only interesting because of their appearance in 
natural products. The rigidity imparted by the dehydro backbone has led to much 
work on the effect of dehydroamino acids as peptide modifiers.' °4 In small molecules 
also, the presence of a dehydroamino acid may have a crucial effect on activity. The 
depsipeptide phomalid& °5 (Scheme 28) is a fungal toxin which causes blackleg 
disease in certain cereals, but the closely related structures (shown below) and are 
inactive. 
Ph 
0 0 0 
R
R/,,, O) 
NH 	H  
phomalide R 1 , R2 = (E)-CH3CH 
isophomalide R 1 , R2 = (Z)-CH 3CH 
R-dihydrophomalide R 1 = CH 3CH2, R2 = H 
S-dihydrophomalide R 1 = H, R2 = CH3CH2 
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Scheme 28 Phomalide and related structures 
Considered on their own, dehydroamino acids have interesting reactivity. The olefin 
may be polarised as nucleophilic or electrophilic (Figure 13), due to the amino and 
acid functionalities, and as a result their reactivity to a wide range of nucleophiles 
and electrophiles has been studied. Dehydroamino acids have also been used in many 
traditional olefin reactions, such as pericyclic reactions and most notably 
hydrogenation. The asymmetric hydrogenation of dehydroamino acids has been 
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Figure 13 Alternative polarisations of cz,/3-dehydroamino acids 
Methods of synthesis 
Before considering the many methods available to synthesise dehydroamino acids, 
two issues should be mentioned. Firstly, unsymmetrically substituted olefins (30, 
R3#R4) exist as Z and E isomers, and most synthesis methods give the 
thermodynamically more stable Z. However there are a number of methods which 
result in E geometry and these will be highlighted. Secondly, dehydroamino acids 
are difficult to incorporate into peptides. Therefore methods which allow 
incorporation of a "masked" dehydroamino acid - for example in the form of a 
protected alcohol which is subsequently dehydrated - are of greater synthetic utility. 
Indeed, dehydration of -hydroxy-a-amino acids is one of the most common 
methods of synthesis. The dehydration may be achieved by leaving group formation 
followed by elimination, for example by tosylate' °6 or mesylate' °7 formation. 
The leaving group may also be generated by action of a carbodiimid&°2' 108  in the 
presence of CuC1. In the first example the preparation of dehydrothreonine from 




Methods now exist to stereospecifically dehydrate f3-hydroxy-a-amino acids. The 
earlier method' °9 uses (diethylamino)sulfur trifluoride (DAST) to dehydrate the 
alcohol, while the later method uses thionyl chloride (Scheme 29)" 0. Both reactions 
proceed via antiperiplanar elimination, so that threo and erythro reactants result in Z 
and E products respectively. In the first example DAST makes such a good leaving 
group that the elimination proceeds via a concerted E2 elimination process, and in 
the second example thionyl chloride reacts with the OH and N, forcing an 
antiperiplanar transition state. 
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SOC 1 2-  
'
". " Me 
III HO Et 
R 1 	 H 
COBn 	1NCO2 Bn 
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o=s" 1'H DBU 	II 
\ -k'Me DCM EtMe 
0 Et 
R 1 = Ac, Boc, other protecting groups 
Scheme 29 Stereospecflc dehydration with thionyl chloride 
In contrast, an a-hydroxy a-amino acid is the intermediate in the condensation of an 
amide or amino acid with an a keto acid followed by dehydration." 112  This method 
has been used to synthesise dehydroalanines, monosubstituted and disubstituted 
dehydroamino acids. 
Elimination of N-hydroxy cc-amino acids is also known.' 3 Treatment with tosyl 
chloride results in the O-tosyl derivative which is not isolated but spontaneously 
undergoes elimination, favouring the Z isomer (ratios ranged from 3:1 to 12:1). In a 
similar method,' 4 treatment of an amino acid with 'butyl hypochlorite gives the N-
chlorinated compound which loses HC1 in the presence of base. A mixture of 
geometric isomers is obtained from this method. 
One final elimination method '5 of interest is the addition-elimination of 
benzylselenol to dehydroamino acids. The E isomer of the dehydroamino acid may 
obtained in this way, and the selenoether intermediate may be suitable for 
incorporation into peptides as a masked dehydroamino acid. 
Most other dehydroamino acid syntheses involve in some form, condensation with 
an aldehyde or ketone and a glycine equivalent (Scheme 30). 
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Scheme 30 Synthesis of ct,fldehydroamino acids by condensation 
There are a variety of procedures for activation of the fragments to give 
condensation. One of the most important is the formation of oxazolones from N-acyl 
amino acids (Scheme 31), which was dealt with in detail above. Base hydrolysis 
results in the N-acyl amino acid. Similarly, hydrolysis with alcohols and amino 
acids "6' " give amino acid esters and peptides respectively. Conditions exist to 
perform the ring opening reaction with retention of alkene geometry. In the 
oxazolone formation itself, aldehydes tend to give rise to Z products, while ketones 
generally result in a mixture of geometric isomers. 
0 






X=NH2,OH, 	 0 
Scheme 31 Oxazolone formation and hydrolysis 
Although the oxazolone method is widely used, it is often not suitable for synthesis 
of acid-sensitive amino acids or for dehydroamino acid formation in a peptide 
sequence. 
Schmidt et al."' developed a method whereby an aldehyde is condensed with an 
elaborated phosphoryl glycine (Scheme 32). The reaction is carried out in base, 
complementing the acid conditions required for oxazolone formation. A number of 
tripeptides were used in the reaction, and racemisation of the other amino acids was 
not observed. Alkyl and aryl aldehydes were condensed, and a set of conditions was 
found in which only the Z isomer was formed. Yields of dehydroamino acids were 
good, and later developments have enabled the use of ketones in this reaction," 9 
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leading to mixtures of Z and E isomers. It has found application in, for example, the 
synthesis of some dehydrated natural amino acids' 2° and in the synthesis of substrates 
for experiments with asymmetric hydrogenation catalysts ."2' 121  The primary 
disadvantage of this method is that preparation of the phosphoryl glycines is a multi-
step synthesis. 
R 4 	R 3 
2P 
ROl 
R N X + 	 NaH RNX 
H 	II H 
0 
X = OH, OR, NHCH 2CO2CH3 
Scheme 32 Phosphoryiglycine condensation 
The Heck reaction (Scheme 33) has also been used to synthesise some disubstituted 
dehydroamino acids, albeit in modest yields. 122  It has also been used in the synthesis 
of bis-"armed" amino acids, 121  which are found in a number of cyclic peptide 
antibiotics. The Heck reaction has an advantage in that the starting material is 
dehydroalanine. Dehydroalanine is easily obtained, and the substitution of an R 
group after dehydration opens up possibilities for combinatorial synthesis. 
RO2 Ar-X 
R3 = H, CH 3 
Scheme 33 Heck Reaction 
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The Suzuki reaction (Scheme 34), coming from the bromine- or iodine-substituted 
dehydroamino acid, is a little more complicated but halogenation can be achieved 
simply and stereospecifically.'24' 125  Disubstituted dehydroamino acids can be made 
this way, with retention of double bond stereochemistry." 2 As with the Heck 
reaction, palladium catalysis precludes the use of halides with P hydrogens. 
Monosubstituted dehydroamino acids synthesised by the Heck and Suzuki reactions 











R3 = H, alkyl 
R4 = aryl, alkenyl 
X= Br, I 
Scheme 34 Suzuki Reaction 
Reactions of dehydroamino acids 
Because c3-dehydroamino acids can be polarised in two ways (Figure 13) reactions 
with nucleophiles and electrophiles are possible. Reactions with sulfur,"' nitrogen 121 
and carbon 12'  nucleophiles have been observed. 
Reaction with electrophiles is also known, and the bromination of dehydroamino 
acids provides the intermediates for the Suzuki reactions discussed earlier. Treatment 
with NBS affords the a-bromoimine intermediate 31 (Scheme 35), following which, 
treatment with a hindered base gives the brominated dehydroamino acid. In the case 
of unsubstituted dehydroamino acids the Z isomer is formed; with substitution, a 
mixture of Z and E is obtained. 12 ' The ratio of Z isomer in the mixture may be 
increased by treatment with DABCO.'25' 130 
	
3 	 3 	 3Br R..H NBS 	 DABCO 	R..Br 
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Scheme 35 NBS bromination of a dehydroamino acid 
Dehydroamino acids can also undergo pericyclic reactions and this has been used in 
a number of syntheses. A Diels-Alder reaction between 32 and 1,3-butadiene 
(Scheme 36) gave the constrained amino acid 33 in 91% yield and 98% e.e.' 3 ' 
35 
Introduction 







R 1 = * j< 7-__ Ph—---\ * 
Scheme 36 Diels-Alder reaction on a dehydroamino acid 
1,3-dipolar reactions have also been reported. The reaction of diazomethane with 
dehydroamino acids gives an intermediate 34 (Scheme 37) which on pyrolysis in a 
polar solvent gives the disubstituted dehydroamino acid 35:132  synthetically, a CH 2 
insertion into the C-H bond of the alkene. Irradiation of 34, on the other hand, leads 
to insertion of CH 2 into the C=C bond. 133, 111 
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Scheme 37 Reaction of a dehydroamino acid with diazomethane 
A dehydroamino acid has also been used in an ene reaction, 13 ' and N-alkylation' 36 
and decarboxylation' 37 are also known. 
Conclusion 
Dehydroamino acids are useful targets in themselves as unnatural amino acids, but 
their versatility - undergoing nucleophilic and electrophilic attack, pericyclic 
reactions and hydrogenation - means that they are also important synthetic 
intermediates. In particular they are important intermediates for the synthesis of 
branched amino acids through asymmetric hydrogenation. 
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13- Branched amino acids 
Overview 
13- Branched amino acids, of the general structure 36 (Figure 14), are useful synthetic 
targets. The extra substituent at the 13 position confers some extra bulk to the amino 
acid, and substitution of a 13- branched amino acid for a natural amino acid can 
therefore have an effect on the tertiary structure of the protein. 13- Branched amino 
acids have been found in natural products such as the peptide antibiotic 
bottromycin.' 38 They have also been used to probe protein conformation.139' 140 
RO 4 
36 
Figure 14 General structure of ,8-branched amino acids 
Stereochemistry is a consideration in the synthesis of 13- branched amino acids. The 
13 substituent means that C3 can be a chiral centre, and so there are 4 isomers: (2R, 
35) and (2S, 3R), and (2R, 3R) and (2S, 35). The pairs are sometimes referred to as 
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Synthesis of 0- branched amino acids has been achieved in a number of different 
ways. Earlier methods tended to proceed through nucleophilic attack by an activated 
glycine synthon, as in the synthesis of Pratorius et al.,'4 ' where nucleophilic attack of 
a ketone by 'butyl isocyanoacetate resulted in formation of 37 (Scheme 38). A series 
of reductions resulted in the amino acids 38. High voltage paper electrophoresis 
separated the diastereoisomers, and the pairs of enantiomers were separated by 
enzymatic methods. 
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Scheme 38 Synthesis of fl-branched amino acids via 'butyl isocyanoacetate 
A similar method was published a year later 131  in which 1- methylphenylalanine was 
synthesised (Scheme 39). The reaction proceeds in 64% overall yield, but again a 
mixture of the 4 possible isomers is formed. 
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Scheme 39 Synthesis of/3-methylphenylalanine from acetaminomalonate 
An asymmetric synthesis of all 4 isomers of (3-methyl tyrosine was carried out in 
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39 (Scheme 40), attachment of chiral auxiliaries 40 and 41 and subsequent reaction 
with 4-methoxyphenylmagnesium bromide gave the intermediates 42 and 43. 
Cleavage of the auxiliary and attachment of its enantiomer produced 44 and 45. 
Further reactions gave the 4 isomers required in 100% e.e. and 58% (2S, 3S and 2R, 
3R) and 68% (2S, 3R and 2R, 35) yield from 44 etc. This is a method which may be 
applicable to other 1- branched amino acids: it is limited only by the acid chlorides 
and Grignard reagents available. Yields are moderate, but the long synthesis makes 
simpler alternatives desirable. 
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Recently an alternative has been developed specifically for the synthesis of P-
methyltyrosine.' 44 The enzyme tyrosine phenol-lyase catalyses the synthesis of 
tyrosine from phenol, pyruvate and ammonia. By substituting a-ketobutyrate for 
pyruvate, a 1:1 mixture of (2S, 3R) and (2S, 3S) 3-methyltyrosine was produced. 
The diastereoisomers were separated by crystallisation from water. 
A more general synthesis using an N-protected glycine anion and a chromium 
carbene as electrophile (Scheme 41) to synthesise glutamic acid derivatives has also 
recently been published. 14' After hydrolysis and reduction to remove protecting 
groups, the product 46 was obtained in yields ranging from 21% to 36% (from 47) 
depending on the chiral auxiliary and protecting groups. Attack of the carbene 
occurred with good facial selectivity but attack occurred from both faces of the 
glycine anion, so that a mixture of diastereoisomers was produced in each case. 
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Scheme 41 Asymmetric synthesis of,8-substituted glutamic acids 
An asymmetric synthesis of 13-methyiphenylalanine was recently effected"' by the 
action of methymagnesium bromide on 48 (Scheme 42). Addition occurred on the 
opposite face to the carboxylic acid giving 49 in 60-65% yield. Hydrogenolysis 
proceeded with some selectivity (72% d.e., R=Me, 92% d.e., R='Bu) to give 13-
methyphenylalanine methyl- or 'butyl ester. While the synthesis is short and simple, 
the reaction is limited by availability of the azirine starting material. 
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Scheme 42 Synthesis of /3-methylphenylalanine via azirines 
In contrast, the recent paper"' describing the synthesis of 13-branched amino acids 
via the Ugi reaction uses mostly commercially available starting materials. The one 
component which must be prepared is 50 (Scheme 43) but with 50 in hand the 
reaction proceeds to 51 in yields of 80-90%. Although only valine derivatives have 
been prepared, the reaction has scope for synthesis of many other 13-branched amino 
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Scheme 43 Ugi reaction to produce valine derivatives 
Finally, consideration should be given to synthesis via the hydrogenation of 
disubstituted dehydroamino acids. The methods used to prepare these and 
hydrogenate them enantioselectively have been reviewed in this thesis, and these 
well established methods were brought together by Burk et al. 112  to produce a large 
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number of 13-  branched amino acids of all configurations. This particular method, 
using Rh-DuPHOS catalysts, would not be suitable for large scale synthesis of 
erythro products. Hydrogenation is a syn process so erythro amino acids come from 
E dehydroamino acids, and while there are methods for obtaining these, no method is 
suitable for large scale synthesis. However it is still a highly versatile and general 
method, and both the dehydroamino acid synthesis and the hydrogenation are 
suitable for synthesis on a large scale. 
Conclusion 
In conclusion, a number of methods have been proposed for the synthesis of 
branched aminoi  acids. However, the only general method is through the 
hydrogenation of dehydroamino acids. Current synthesis methods result in a mixture 
of Z and E isomers, which are difficult to separate. Therefore it remains to find a 
general method of 13- branched amino acid synthesis which can be applied to large 
scale synthesis of single isomers. 
Asymmetric hydrogenation of dehydroamino acids 
Overview 
In the 1960's, after the thalidomide scandal, the need for enantioselective synthesis of 
drugs was recognised. Since amino acids are present in many drugs - L-DOPA for 
example"' - their enantioselective synthesis became important. 
A wide variety of dehydroamino acids may be synthesised, in a number of different 
ways, so hydrogenation of prochiral dehydroamino acids has become an important 
challenge for chemists. 
Over the last 30 years the area of asymmetric hydrogenation of dehydroamino acids 
has grown from first examples to the point where almost any dehydroamino acid, 
including E and disubstituted amino acids, may be hydrogenated with high e.e.. Most 
of the work carried out has focused on rhodium-phosphine complexes, although 
iridium and cobalt have also been studied. Throughout this short review, catalysts 
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have been compared by examining the e.e. of their hydrogenation of Z-
acetamidocinnamic acid 52 or Z-methylacetamidocinnamate 53 (Figure 16). This 
dehydroamino acid has been used in almost every study, probably because of its 
simple synthesis and increasingly, because it has become the benchmark for 
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Figure 16 Z-Acetamidocinnamic acid and its methyl ester 
Rhodium-phosphine complexes: development 
The discovery of the efficacy of rhodium diphosphines as hydrogenation catalysts 
predates their use on amino acids. It was in the hydrogenation of E- 13-
methylcinnamic acid using a Rh complex of 54 (Figure 17) that these diphosphine 
complexes first proved themselves as hydrogenation catalysts."' In addition, it was 
noted in this paper that a,13-unsaturated  carboxylates hydrogenated with higher 
enantioselectivity than simple alkenes. This observation anticipated the later studies 
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Figure 17 Structures of the earlier phosphine ligands for hydrogenation 
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Before long there was speculation that the use of a chelating bisphosphine bidentate 
ligand would impart greater stability to the rhodium complex and increase 
enantioselectivity. DIOP 55 (Figure 17) was synthesised from tartaric acid and was 
found initially to hydrogenate 52 with 72% e.e.' 5° Optimisation - mainly increasing 
the catalyst/substrate ratio - increased that to 89% e.e..' 5 ' It was found that using 
DIOP, Z isomers reacted faster and with greater e.e. than E isomers. 
Another ligand first synthesised around the same time is DIPAMP 56 (Figure 17). 152 ,  
"' Another bidentate ligand, it differs from DIOP in that the chirality is at the 
phosphorus atom and not the carbon backbone. While this may have helped to 
improve the enantioselectivity - hydrogenation of 52 with Rh-DIOP in 4 atm H 2 
resulted in over 95% e.e. - it complicated the synthesis of the ligand. Hydrogenation 
of 53 was also performed, resulting in 96% e.e., while hydrogenation of the  isomer 
of 53 gave only 23% e.e. The increased selectivity may also be due to the fact that 
DIPAMP gives a 5-membered chelate ring with Rh as opposed to the 7-membered 
ring of DIOP (Figure 18). 
x 
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Figure 18 Seven-membered and five-membered chelate rings 
The next three significant ligands to be developed also have 5-membered chelate 
rings. CHIRAPHOS 57 (Figure 17) was synthesised from commercially available 
(2R,3R)-butanediol, and hydrogenated 52 with 89% e.e.' 54 While its 
enantioselectivity may not be as high as that of DIPAMP, its synthesis is easier. 
CYCPHOS 58 (Figure 17) was also synthesised from a commercially available 
starting material, in this case mandelic acid.' 55 Hydrogenation of 52 proceeded to 
give 91% e.e. NORPHOS 59 (Figure 17) hydrogenated 52 with 96% e.e. - an 
improvement over even DIPAMP.' 56 The synthesis of NORPHOS is also simpler, 
starting from a cyclopentadiene. The synthesis results in a racemate which is 
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resolved by crystallisation. 
The drive for increased enantioselectivity then led to the investigation of axial 
chirality as a tool for asymmetric induction. The ligand NAPHOS 60 (Figure 19) was 
used to hydrogenate 52 (50atm H 2 , rt, 15h, [(1,5-hexadiene)RhC1] 2/2 (S)-(-)-
NAPHOS) giving a modest e.e. of 54%. The low enantioselectivity was due to the 
fact that NAPHOS forms a 7-membered chelate ring, because BINAP 61 (Figure 19) 
was found to hydrogenate 52 with 84% e.e. 158 More significantly, it was the first 
ligand to give high enantioselectivity with E dehydroamino acids. Hydrogenation of 
the  isomer of 53 proceeded in 93% yield and 87% e.e. 
Around the same time, Nagel et al.'59 synthesised PYRPHOS 62 (Figure 19) and 
used it to hydrogenate 52 (Figure 16) with 99% e.e. PYRPHOS can be used at 50atm 
H2 without loss of enantioselectivity. 
The latest refinement in the development of phosphine ligands for hydrogenation has 
been in the synthesis of BPE 63 and DuPHOS 64 (Figure 19).160162  These 
peralkylated phosphines are electron rich, and this has two advantages. Firstly, they 
chelate more strongly to Rh, resulting in a more rigid complex. 161  Secondly, one of 
the key stages in hydrogenation is oxidative addition of hydrogen to the rhodium 
complex: with a more electron-rich rhodium, this step is faster because more electron 
density can be donated into the a*  orbital of H21  causing it to dissociate and add to 
the rhodium complex. This speeds up the reaction. 











Figure 19 Structures of the later phosphine ligands for hydrogenation 
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Both BPE and DuPHOS have been used to hydrogenate 52 and they achieved e.e. of 
93% and greater than 99% respectively. 112  They have been used to hydrogenate a 
number of challenging substrates including the highly hindered 65 and 66, often a 
catalyst poison due to the thioether (Figure 20). Considerable success has also been 
achieved in the hydrogenation of E and disubstituted substrates. 
s 
NCH3 




Figure 20 Two difficult  substrates hydrogenated with a DuPHOS catalyst 
DuPHOS and BPE are synthesised in a 2-step sequence from substituted 2,5-
hexanediols. The diols are obtained either by baker's yeast reduction of 2,5-
hexanediones or in a 3-step synthesis from 13-keto esters. The straightforward 
synthesis, along with the versatility and high enantioselectivity of these ligands, 
means that complexes of rhodium with BPE and DuPHOS are now the catalysts of 
choice for hydrogenation of dehydroamino acids 
Rhodium-phosphine complexes: Mechanism 
The mechanism of hydrogenation of 53 using DIPAMP and CHIRAPHOS has been 
studied in depth, 113  and it is believed that most of the rhodium-diphosphine catalysts 
behave in the same way. Reaction takes place through a "minor manifold" and 
"major manifold" (Figure 21); these come from the minor and major substrate-metal 
complexes and they lead to the major and minor products respectively. 
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Figure 21 Mechanism of hydrogenation with Rh-P catalysts 
Hydrogenation of the catalyst precursor: these catalysts contain a diene, usually 
cyclooctadiene or norbornadiene, which is hydrogenated and loses its affinity for 
rhodium, leaving a coordinatively unsaturated species which is coordinated by 
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solvent or substrate. 
Substrate association/dissociation: the association of substrate with catalyst is 
reversible and substrate can associate to Rh in one of two orientations, giving rise to 
the minor and major manifold. These intermediates have also been characterised for 
DuPHOS. 
Oxidative addition of H 2 : this is the first irreversible step, and so determines the 
configuration, R or S, of the product. This intermediate is assumed, since it has never 
been detected - the next step is too fast. 
Addition of C=C into the Rh-H bond: this results in a Rh-C a bond being formed. 
Migration of H onto C leaves Rh coordinatively unsaturated and a solvent molecule 
takes its place. 
Reductive elimination of product: this results in formation of product and 
regeneration of the catalyst. 
Enantioselectivity arises from the difference in rates of hydrogenation of the major 
and minor manifolds. The minor manifold gives rise to the major product, for two 
reasons: the minor intermediate 67 is less stable than the major 68 (Figure 21), and 
the transition state for oxidative addition of H 2 'Slower for 67 than 68. Activation 
energy is reduced for the minor manifold by having a higher ground state and a 
lower transition state. 
Which orientation of substrate to catalyst will be least stable can be predicted using 
the quadrant model. Developed for the diphenyiphosphines, it also applies in the case 
of alkylphosphines such as DuPHOS and BPE: 
As Figure 22 shows, the C 2 symmetric ligand blocks 2 "quadrants" in front of the 
metal centre - the axial hydrogens on the ring are responsible for the steric crowding. 
Figure 22 Sterically crowded quadrants of R-Me-DuPHOS 
Given that the carbonyl will always associate in the one orientation, the C=C can 
then choose 2 orientations (Figure 23). The less stable orientation 69 can be seen to 
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give rise to the R product, and this is indeed the product observed in hydrogenations 
using (R,R)-MeDuPHOS (pictured). 
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Figure 23 Minor and major intermediates in hydrogenation with R-Me-DuPHOS 
Hydrogen pressure and temperature also play a part in enantioselectiVity. 
Enantio selectivity is determined by the competition of interconversion of the minor 
and major complexes 67 and 68 (Figure 21) with oxidative addition of H 2 . Fast 
interconversion leads to a high steady-state concentration of the minor complex 67 
and a high enantioselectivity; slow interconversion leads to a low steady-state 
concentration of 67, and more of 68 therefore is hydrogenated. 
At intermediate pressures, there is competition between association/dissociation, and 
oxidative addition of 112. When the pressure of H 2  is high enough (at, say, pressure P) 
oxidative addition will become independent of H 2  pressure, and increasing pressures 
will not increase oxidative addition. Because the minor complex is more easily 
hydrogenated, P will be lower than for the major complex. So, for pressures above 
P,01 an increase in pressure will bring about an increase in product from the major 
complex, with no increase in product from the minor complex. Simply, increasing 
pressure in this range will result in decreasing enantioselectivity. 
Increasing temperature has the opposite effect. The enthalpy of 
dissociation/association is higher than the enthalpy of oxidative addition, so that 
increasing temperature increases the rate of interconversion of 67 and 68, compared 
to the rate of hydrogenation. This makes it possible to speed up reactions by 
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increasing hydrogen pressure and temperature, without decreasing enantioselectivity. 
Other systems: ruthenium, cobalt and iridium 
Other metals have been used in the asymmetric hydrogenation of dehydroamino 
acids. Ruthenium-BINAP is a more commonly used catalyst than Rh-BINAP, 
although Ru-B1NAP is used more in the hydrogenation of ketones and alkenes. 
Surprisingly S-Ru-BINAP gives the same products as R-Rh-BINAP and vice versa. 
Cobalt complexes have also been studied, but enantioselectivities were much lower 
than for rhodium catalysts. Iridium catalysts have found some use in synthesis of 
dehydroamino acids '65"66 - although they are up to 50 times slower than similar 
reactions with Rh-DuPHOS catalysts, they have been useful in mechanistic studies 
of hydrogenation since the intermediates are so stable. A very significant result was 
also obtained using an iridium catalyst in the hydrogenation of some -disubstituted 
dehydroamino acids. Hydrogenation of 70 (Scheme 44) with an iridium catalyst 
led to an approximately 1:1 mixture of 71 and 72. 71 and 72 are diastereoisomers 
and the only way 72 could have been formed is through hydrogenation of the E 
isomer of 70. This isomerisation was detected during our own studies, and its 
implications will be discussed in the future work section. Furthermore it was 
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In conclusion, the last 30 years have produced a series of hydrogenation catalysts for 
dehydroamino acids which have improved stepwise, resulting in the fast, highly 
enantioselective Rh-BPE and Rh-DuPHOS catalysts. The most challenging targets 
left in this field are in highly enantioselective hydrogenation of E and disubstituted 
substrates, although BPE has proved useful in the latter and iridium catalysts may be 
the key to the former. 
Conclusions and Aims 
Solid phase synthesis of unnatural peptides 
The overall aim of the research was to devise a method of synthesising peptides 
incorporating unnatural amino acids on solid phase in an N to C (inverse) direction. 
The unnatural amino acids would be obtained by oxazolone formation on a glycine 
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It was decided that the Showalter silyl linker" should be the basis of this approach, 
due to its ease of cleavage and the opportunity for traceless cleavage. The linker 
should be modified to the acid to allow N-terminal attachment, and the method 
chosen for amino acid elaboration should be compatible with the linker. 
Development of a mild method of oxazolone synthesis as a route into 
dehydroamino acids 
The traditional method of synthesising Erlenmeyer oxazolones utilises acetic 
anhydride at elevated temperatures. Such harsh conditions are not compatible with 
solid phase, as degradation of the resin occurs. Therefore, an important aim was to 
develop a method of oxazolone synthesis which avoided the use of harsh reagents 
such as strong acid or base (Scheme 46). It was also important that such a method 












Scheme 46 Development of a mild method of oxazolone formation 
It was envisioned that this work could be carried out in parallel with development of 
the linker system, since it would be necessary for any solid phase synthesis of 
oxazolones, regardless of the linker system eventually used. 
Asymmetric hydrogenation of , 3-disu bstituted dehydroamino acids 
With a method of oxazolone synthesis in hand, asymmetric hydrogenation of the 
resulting dehydroamino acids could be attempted (Scheme 47). 
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Scheme 47 Asymmetric hydrogenation of/fi-disubstituted dehydroamino acids 
Rh-DuPHOS and Rh-BPE hydrogenation catalysts would be used in the first 
instance, due to their tolerance of disubstituted dehydroamino acids.' 2 
Hydrogenations would first be attempted in solution, since the 13-branched amino 
acids produced are themselves of interest. 
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Results and Discussion I - Silyl Linker Synthesis 
Choice of Linker 
In choosing a linker for solid phase, a number of factors must be considered. The 
linker must have suitable functionality to anchor the molecule of interest, and 
convenient high-yielding attachment conditions must be found. The linker must be 
stable to the reaction conditions to be used in the synthesis, and cleavage from the 
support must be high yielding with a minimum of side products. In addition, it is 
desirable to use a linker which can be synthesised in the minimum number of 
synthetic steps with high loading. 
The planned solid phase synthesis involved attachment of an amine, possible 
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Scheme 48 Proposed synthesis ofpeptides incorporating unnatural amino acids 
It was envisioned that amino acids would be protected using the 9-fluorenylmethyl 
(Fm) group depicted in Figure 8 (p20).  Deprotection of the Fm group is by action of 






Results and Discussion I 
acids could be achieved using carbodiimides; attachment to the solid phase would 
preferably be through an amide since they are stable and easy to form. The linker 
would need to be stable to hydrolysis and metal-catalysed hydrogenation, and to the 
oxazolone synthesis conditions. 
It was decided to use a silyl ether linker, a modification of a linker originally 
developed by Boehm and Showalter" and now sold by NovaBiochem (Scheme 49). 
The aldehyde linker had previously been synthesised from p-dibromobenzene in two 
steps. Lithium-halogen exchange followed by quenching with 
diisopropyldichlorosilane gave 73, which was coupled directly to 
hydroxymethylpolystyrene without purification. The aldehyde was formed by a 
second lithium-halogen exchange and DMF quench. It was envisioned that a similar 
procedure, using a carboxylating agent, could yield the carboxylic acid. 
Br 	 1. BuLi, THF, -78°C 
2. (iPr)2SiCl2 , THF, 
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Scheme 49 Synthesis of a resin-bound aldehyde from the NovaBiochem linker 
In solution, such silyl ethers are stable to all the reaction conditions mentioned 
above, and cleavage is achieved using tetrabutylammonium fluoride to give the 
benzoyl protected product. It was hoped that treatment with acid would offer 
alternative cleavage conditions, since arylsilanes can undergo protodesilylation. 
However, treatment with TFA results in attack of the silicon-oxygen bond resulting 
in release of the arylsilane from solid support (Scheme 50). 
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Scheme 50 Methods of cleavage of the silyl linker: fluoride and acid 
Hydroxymethylpolystyrene was chosen as the support. Polystyrene is the most 
commonly used polymeric support' since it is easy to handle and swells in organic 
solvents. 
At the outset, a potential problem was identified. As explained above the silyl ethers 
are not stable to acid, undergoing cleavage at the silicon-oxygen bond on treatment 
with TFA. The traditional method of oxazolone synthesis - the Erlenmeyer reaction 
- uses neat acetic anhydride under reflux. It was anticipated that cleavage of the 
linker might occur under these conditions and so use of the silyl linker was 
dependant on finding or developing a milder method of oxazolone synthesis. 
If such a method could be found, the silyl linker would offer several advantages. The 
first amino acid attached would be protected as an N-benzoyl amino acid (Scheme 
51); N-benzoyl amino acids result in more stable oxazolones than N-acetyl 
derivatives because of increased conjugation. In addition, the product eventually 
cleaved from the support would be traceless - there would be no "polar handle" 
evident by which the molecule had been attached to the solid phase. Synthesis 
leaving no polar handle has advantages in library synthesis for drug candidates, but 
more prosaically, handling and purifying an N-benzoyl peptide or amino acid by 
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Scheme 51 Synthesis of oxazolones from resin-bound N-benzoyl amino acids 
Retrosynthesis 
There are two general approaches to the synthesis of resin-bound linkers - one can 
synthesise the linker directly on solid phase, or the linker can be synthesised in 
solution and attached to solid phase (the preformed handle approach). Both strategies 
have advantages; the preformed handle approach allows a convergent synthesis, and 
avoids the situation on solid phase where each reaction introduces more resin-bound 
impurities. However, the preformed handle approach involves a risk: extensive effort 
may have gone into the synthesis of the linker in solution only to find that the linker 
cannot be attached to resin. For example, if the linker is too bulky, it will not 
penetrate the resin and low loading will result. 
The initial strategy proposed for synthesis of the linker involved a combination of 
the two ideas. The brominated intermediate was synthesised by reaction of the 
"handle" 74 with hydroxymethylpolystyrene (Scheme 52), and attempts to form the 
acid were performed on this resin-bound intermediate. 
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Scheme 52 Proposed synthesis of the silyl linker. I: attempted method. II: published 
method 
A second method was also investigated in which the acid functionality was 
incorporated into the linker before attachment to the solid phase (Scheme 53). This 
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Scheme 53 Proposed synthesis of the silyl linker: preformed handle approach 
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On-Resin Approach 
It was decided to closely follow the work of Boehm and Showalter in the first 
approach to the silyl linker. Their strategy made use of a methoxymethyl-protected 
bromophenol as the starting unit: lithium-halogen exchange followed by treatment 
with diisopropyldichlorosilane gave the chlorosilane intermediate, which was 
attached to solid phase by a simple ether formation. Ortholithiation introduced the 
second site of flinctionalisation, and addition of DMF gave the required aldehyde 
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i. BuLi, THF, -78°C. ii. 'Pr 2SiCl 2 , -78°C to rt 
hydroxymethylpolystyrene, imidazole, DMF, rt 
i. BuLl, TMEDA, Et20, 0°C. ii. DMF, 0°C 
Yields/loadings were not reported 
Scheme 54 Boehm and Showalter 's synthesis of the aldehyde linker 
It was anticipated that with the intermediate (4-methoxymethoxyphenyl)-
diisopropylsilyloxymethyl polystyrene (75) in hand, conversion to the carboxylic 
acid could be achieved through addition of electrophiles (for example CO 2), or 
oxidation of the aldehyde. Acid formation from metallated aryl compounds is 
known"'. In addition, triphosgene seemed a likely synthetic equivalent for an acid 
chloride since phosgene has been used to synthesise acid chlorides from metal 
phenoxides' 68 (Scheme 55). Coordination of the phosgene is followed by 
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Scheme 55 Synthesis of acid chlorides from lithiated phenols 
A set of model compounds (Figure 24) was prepared to investigate some of the 
chemistry required. 





R = H, 78 
R = D, 79 
Figure 24 Silylated model compounds 
The first reaction to be examined was the lithium-bromine exchange on 4-
bromoanisole. Thus 4-methoxyphenyltrimethylsilane 76 was produced in 63% yield 
by lithiation of 4-bromoanisole with nBuLi followed by quenching with 
trimethylsilyl chloride. New peaks at 0.02 ppm and 1.1 ppm in the 'H and ' 3C NMR 
spectra respectively suggested that silylation had occurred. The identity of the 
compound was confirmed by comparison with previously published data. ' 69 The less 
stable intermediate chloro-(4-methoxyphenyl) diisopropylsilane 77 was synthesised 
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in 39% yield by the same procedure, quenching with diisopropyldichlorosilane. On 
isolation, the silanol was obtained: a broad peak in 'H NMR at 1.8 lppm and a mass 
spectrum molecular ion peak of 239 showed this. The identity of the product was 
confirmed by the appearance of new signals in 'H NMR (methyl signals at 0.89 and 
0.97ppm, and a methine signal atl.l3ppm) and ' 3C NMR (new peaks at 12.3, 16.8 
and 17.0 ppm). An alternative method of synthesis of 77 was also attempted, in 
which diisopropyldichlorosilane was added to the solution before lithiation. This 
resulted in a small decrease in yield (31%). 
With the lithiation-silylation procedure established the model compound 78 was 
synthesised from 77 by treatment with benzyl alcohol. The intermediate 77 was used 
directly without isolation. The yield of 38% from 4-bromoanisole reflects the low 
yield of intermediate 77. A number of ortholithiation-quenching experiments were 
carried out on 78, with little success (Table 1). Only when D 20 was used as 
electrophile was the lithiation-quenching successful, resulting in formation of 79, 
whose identity was confirmed by mass spectrometry. 
Electrophile 78 (g) 
(1.5eq.)  
Time before adding (h) Result 
DMF 0.100 4 Starting material 
(CH3)3 SiC1 0.050 2 Starting material 
Triphosgene 0.050 2 Starting material 
CO2 0.050 7 Starting material 
D20 0.050 7 79 
Table 1 Reactions with electrophiles attempted on 78 
A number of options were considered at this point. The strategy could be abandoned 
in favour of a preformed handle approach, further model studies could have been 
performed to try to find conditions under which the electrophiles react or synthesis 
could have been transferred to the solid phase in the hope that the reactions would 
somehow work better on solid phase. 
None of these options was investigated. Instead, a modified linker was synthesised. 
The target became the simplified linker 80 (Figure 25). 
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Figure 25 Simplified silyl linker 
The linker 80 was first produced by NovaBiochem, and it was used to synthesise the 
simplified aldehyde linker 81. It was reasoned that NovaBiochem had already shown 
that this linker could undergo lithium-bromine exchange and quenching with an 
electrophile, and that work on the model compounds had established the ease of 
lithium-bromine exchange. The linker was synthesised in a similar manner to the 
model compound 78. Treatment ofp-dibromobenzene with butyllithium at —78°C 
resulted in formation ofp-lithiobromobenzene, identified (protonated, as 
bromobenzene) in TLC running slightly higher than p-dibromobenzene. Complete 
conversion to the lithiated compound occurred in around 1 hour. Addition of 
diisopropyldichlorosilane afforded the chiorosilane intermediate chloro-(4-
bromophenyl)diisopropylsilane 82 which again was not isolated, but added directly 
to hydroxymethylpolystyrene (Scheme 56). 
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hydroxymethylpolystyrene,. imidazoe, TH F 
Scheme 56 Synthesis of the brominated silyl linker 
Washing and drying yielded the functionalised resin 83. ' 3C NMR agreed with the 
expected structure, with new signals at 12.3 ppm and 17.4 ppm assigned to the 
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methine and methyl groups of the diisopropylsilyl moiety respectively. Bromine 
microanalysis confirmed the presence of the linker, albeit in relatively low loading 
(0.36 mmolg'). Chemical tests gave conflicting results with respect to the extent of 
free OH groups left on the resin. After ester formation with trifluoroacetic anhydride, 
' 917 NMR showed the presence of a signal. However, the chemical test developed by 
Kuisle et al. 9 (Scheme 57) resulted in no colour being formed. It seems likely that the 
free OH groups on resin are buried in the polymer and therefore less accessible. 
Trifluoroacetic anhydride is small enough to penetrate the polymer but the p-
nitrobenzylpyridine used in the test and the chlorosilane may be too bulky to reach 
these inaccessible sites. It may be that more efficient coupling of linker would be 
observed if a spacer was used. 
p-TsCI 








N+ 	OTs - 
violet 	 NO2 	 NO2 
coloured 
Scheme 57 Test for free hydroxyl groups on resin 
To check that only the bulkiness of the linker was responsible for the low loading 
(and that therefore there was no way to improve the loading of the linker by 
changing the reaction conditions), the reaction was attempted under a variety of 
conditions (Table 2). 
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Amount Amount of Time after Time after Resin 
of BuLi* 1Pr2 SiCl2 * 'Pr2 SiC12 resin addition 
addition 
1.1 1.1 3h 16h 83 
1.1 2.2 2h 120h hydroxymethyl 
-polystyrene 
3.3 3.3 2h 16h hydroxymethyl 
-polystyrene 
* Molar equivalents with respect to 4-dibromobenzene 
Table 2 Alternative reaction conditions for the brominated silyl linker 
None of the alternative reaction conditions improved the loading of the linker. 
There was concern that the free hydrcixy groups on resin could interfere in further 
reactions. In the lithiation-triphosgene reaction, there was the possibility that reaction 
with triphosgene would occur. Deprotonation by 11BuLi would give a nucleophile 
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Scheme 58 Chloroformate formation on resin with triphosgene 
To test for this possible side reaction, 83 was treated with triphosgene in the presence 
of triethylamine. If the hydroxy groups reacted with triphosgene to form a 
chloroformate, this should be evident in the IR spectrum of the resin. No difference 
was observed in the spectra of the starting material and product, and it was 
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concluded therefore that chioroformate formation would not be a side reaction. 
83 was then subjected to lithiation followed by electrophile addition. Triphosgene (to 
form the acid chloride) and DMF (to form the aldehyde) were used. The addition of 
CO2  (to form the acid) was abandoned because of the difficulties involved in making 
the gaseous CO 2 come into contact with the solid phase. 
Despite repeated attempts, the acid chloride was never formed. JR of the product 
resins showed a new carbonyl signal at 1771cm' but it was extremely weak, and 
cleavage of the resin (5eq. TBAF in THF, 80°C, 16 h) did not yield the desired 
benzoyl chloride. A ' 3C NMR spectrum of the cleaved resin confirmed that cleavage 
had taken place. The supposed acid chloride resin was also treated with 
phenethylamine and subjected to the cleavage conditions (Scheme 59) - it was hoped 
that this would be easier to detect than benzoyl chloride if it were formed. The 
cleavage mixture was compared with an authentic sample of N-phenethylbenzamide 
by TLC (ethyl acetate/hexane 1:4) and was found to contain none of the desired 
product. It was suspected that N-phenethylbenzamide might be unstable to the 
cleavage conditions but this proved not to be the case. After exposing N-
phenethylbenzamide to TBAF for 16h, passing the reaction mixture down a short 
column of silica gave N-phenethylbenzamide in quantitative recovery. Clearly, the 
desired acid chloride was not being formed. The most likely explanation for this is 
that the treatment of the silyl linker 83 with triphosgene caused acid-mediated 
cleavage. However, the acid chloride was not formed on the model compound either 
so it may be that this is just not a viable route to acid chlorides. 




0 c11 Ph 




Scheme 59 Attempted synthesis of resin-bound N-phenethylbenzamide 
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The aldehyde was formed; IR showed a strong new peak at 1701 cm'. Attempts to 
oxidise the aldehyde to the acid - using suifliryl chloride or tetrabutylammonium 
permanganate - resulted in a blackened, unswellable resin. 
At this point this strategy was abandoned. All the conditions thought or known to 
form the acid on solid phase had proved to be ineffective or incompatible with the 
resin. It was decided instead to attempt synthesis where the acid functionality had 
been incorporated into the linker before attachment to the solid phase. 
Preformed Handle Approach 
It was decided that in incorporating acid functionality into the linker, it would be 
simpler and more convenient also to include the first amino acid (Scheme 60). Using 
an amide would avoid the need for protection and deprotection of the acid, and 
coupling of the first amino acid to the solid phase. Glycine was chosen, as it is the 
substrate for oxazolone synthesis, but in a peptide synthesis, any amino acid could be 



















Scheme 60 Proposed synthesis of silyl linker: the preformed handle approach 
Methyl (4-bromobenzoyl) glycinate 84 was synthesised in 83% yield from p-
bromobenzoyl chloride under Schotten-Baumann conditions - 1 ,4-dioxane was 
added as a cosolvent. Various attempts were made to silylate 84 using different 
bases, cosolvents and silyl chlorides, but in no case was the desired product formed 
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(Table 3). 
Electrophile Additive Time after Time after Result 
BuLi addition electrophule addition 
'Pr2 SiC12 None 15 min 10 min @ -78°C, 16 Recovery of SM 
1.leq h@RT (50%) 
Pr2 SiCl2 None 15 min 64h @ RT Recovery (50%) 
1.leq 
Pr2SiC12 TMEDA 15 min 30 min @ -78°C, 16h Recovery (46%) 
1.leq 2eq @RT 
Me3 SiC1 KH 10 min 5 min @ RT Decomposition 
2.4eq 1.2eq 
Table 3 Attempts to silylate 84 
In the first example, 84 was simply treated with °BuLi followed by 
diisopropyldichlorosilane. After addition of BuLi a dark red precipitate formed. 
Stirring was continued overnight, and TLC (ethyl acetate/hexane 1:2) showed only 
spots for the dichiorosilane and the starting material. Column chromatography gave 
50% recovery of starting material. 
The reaction time was then extended to 64 hours, but a similar result was obtained. It 
was believed that most of the starting material was precipitating due to salt formation 
of the amide with butyllithium, and so TMEDA was added to aid solution. It was 
hoped that this additive, which solvates lithium salts, might also speed up the 
lithium-halogen exchange. However, once again only starting material was 
recovered. 
One final experiment was attempted. Potassium hydride was added to deprotonate 
the amide before adding butyllithium - this strategy worked in the silylation of a 
similar amide (Scheme 61). However, decomposition of the starting material was 
observed. 






I 	 /\ 
Scheme 61 Lithiation and silylation of a 4-bromobenzyl amide 
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It was then decided to transfer efforts to a simpler target - protected 4-bromobenzoic 
acid. Allyl protection was chosen since it can be removed in a mild manner via 
palladium mediated hydrolysis' 70 . The allyl protected bromobenzoic acid 85 (Figure 
26) was synthesised in 67% yield by esterification ofp-bromobenzoic acid with allyl 
alcohol, using pTSA as a catalyst. Its identity was confirmed by comparison of NMR 




Figure 26 Protected acid 85 
Silylation of 85 was attempted in a manner similar to the attempted silylations of 84 
- one equivalent of butyllithium was added to a solution of 85 in THF, and the 
solution was stirred for 15 minutes. During this time a dark orange precipitate 
formed as had occurred during lithiation reactions with 84. 
Diisopropyldichlorosilane was then added. 20 minutes after addition of 
diisopropyldichlorosilane, a new spot was detected by TLC (ethyl acetate/hexane 
1:4). 85 had proved unstable to silica chromatography, and so the reaction mixture 
was purified by distillation. However, only 4-bromobenzoic acid was isolated. It 
seems likely that hydrolysis had taken place: whether this was due to the action of 
butyllithium or due to heating in distillation is not known. 
Conclusion 
The work carried out on the first approach ruled out the use of triphosgene or 
oxidation to form the acid functionalised silyl linker required. Other methods of on-
resin acid formation may be successful, and these are considered below. The 
preformed handle approach was also unsuccessful, but there is evidence that the 
silylation of the preformed handle 85 occurred - purification by distillation, 
however, appeared to break down the silylated product. It may be that direct addition 
to the polymer would result in the desired product: this possibility is considered in 
more detail in the future work section. 
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Future Work 
There are a number of alternative strategies which may yield a silyl linker with the 
desired properties. 
The most promising is the preformed handle approach, which has already been 
investigated. TLC showed evidence that silylation of allyl 4-bromobenzoate occurred 
to give the product 86, but distillation appeared to decompose the product. Direct 
coupling to hydroxymethylpolystyrene without purification may yield the desired 
linker 87, which could then be deprotected to the acid via palladium chemistry. 
Direct loading without purification was successful in the synthesis of the brominated 
linker 83 (Scheme 56), which provides a strong precedent and a methodology for 
synthesis of 87. 







Scheme 62 Proposed synthesis of an allyl-protected acid linker 
Alternatively, with the brominated linker 83 in hand, other methods could be 
attempted to form the acid. One of the most obvious is treatment with magnesium to 
form the Grignard reagent, followed by addition of carbon dioxide. However, this 
method was earlier rejected because of the difficulty of permeating resin with a gas. 
Other methods exist, including metal catalysed carbonylation using methyl formate 
(Scheme 63). Although the reaction only proceeds to 36%, no side products were 
formed, and it may be possible that multiple equivalents of reagents or repeated 
reaction would force the reaction to completion. The chlorine analogue of the linker 
83 would have to be prepared but the same route should be applicable 
Conditions: [PdCl 2(PCy3)2], 
OH 
acl 	
Ru 3(CO) 12 , ammonium formate, 
ly 	cetyltrimethylammonium bromide, methyl formate. 
0 
Scheme 63 Carbonylation of chlorobenzene using methyl form ate 
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Results and Discussion II Synthesis of Dehydroamino Acids 
Overview 
The aims of this part of the project were set out earlier, and included the 
development of a general method of synthesis of dehydroamino acids and 13 -
branched amino acids. It was envisioned that these could be obtained via hydrolysis 
or alcoholysis of Erlenmeyer oxazolones, followed by hydrogenation in the case of 
the saturated amino acids (Scheme 64). 
R 1 	R 2 





H 	 I isomerisation 




NXCO2R4 4 asymmetric 
H H 	hydrogenation 	H 
13-branched 	 dehydroamino 
amino acid acid 
Scheme 64 Synthesis of dehydroamino acids and fl-branched amino acids 
There are a number of advantages to this synthesis route. Firstly, the starting 
materials used in Erlenmeyer oxazolone synthesis are cheap and easily obtainable. 
Secondly, the chemistry is simple and adaptable for large scale synthesis. Finally, in 
the synthesis of dehydroamino acids, it is possible to obtain the Z or E isomer. 
Conversion to pure Z or E isomer is difficult in the case of dehydroamino acids, but 
there exist a number of methods to isomerise Erlenmeyer oxazolones. Therefore a 
number of dehydroamino acids were synthesised via Erlenmeyer oxazolones, and 
hydrogenated. 
While these unnatural amino acids are useful targets in themselves, it was also 
intended that the methods developed to synthesise them should be used on solid 
phase for the synthesis of peptides. Therefore, thought was also given to developing 
70 
Results and Discussion II 
a method of Erlenmeyer oxazolone synthesis which would be compatible with the 
solid phase chemistry. This milder method is presented below, while the synthesis of 
the unnatural amino acids is considered later. 
Development of a Mild Alternative to Erlenmeyer Oxazolone Synthesis 
Overview 
Early on in the planning of the silyl linker synthesis, it became obvious that a mild 
method of oxazolone synthesis was required. Two issues were identified: the acid 
sensitivity of the linker, and the stability of the resin to harsh reagents in general. 
This is important since the Erlenmeyer reaction traditionally uses acetic anhydride at 
reflux as a cyclising agent (Scheme 65).172 
0 	0 
II + 




Scheme 65 Traditional Erlenmeyer oxazolone synthesis conditions 
The stability of the resin was simple to test. Hydroxymethylpolystyrene was 
subjected to the reaction conditions used in the Erlenmeyer oxazolone synthesis 
(acetic anhydride, sodium acetate and benzaldehyde under reflux) and examined over 
the course of 16 hours. A gradual darkening of the resin was observed, and it was 
found to be unswellable after 16 hours of treatment. Even if shorter reaction times 
could be employed, the gradual degradation of the polymer would limit the number 
of times the resin could be used. 
The acid stability of the linker could not be tested, as it had not been synthesised. 
However, information existed from known syntheses. The acid stability of the 
aldehyde linker appeared to be marginal, since 5% TFA in dichloromethane was 
successfully used to deprotect a MOM ether, but neat TFA cleaved the Si-O bond in 
the solution phase model 88 51  (Scheme 66). 
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Scheme 66 TFA cleavage of a silyl linker 
It was decided that in the absence of experience with the acid linker, the mildest 
possible conditions should be developed for oxazolone synthesis. Even if the linker 
were stable to acid, an extremely mild method would extend the range of conditions 
under which an oxazolone may be formed, and could be of synthetic utility for other 
acid sensitive targets. 
The search for a milder method began by considering the mechanism of oxazolone 
formation. Under most conditions it is believed that ring closure occurs first, 














Scheme 67 Mechanism of Erlenmeyer oxazolone formation 
The proposed mechanism was supported by experimental observation. Reaction of 
• hippuric acid with a coupling agent such as EDCI in the absence of a carbonyl 
compound resulted in a new product, observable from its bright yellow colour and 
the appearance of a new, fast-running spot in TLC (ethyl acetate/hexane 1:1). The 
reaction appeared to be complete in less than one hour at room temperature. 
It was reasoned that if the cyclisation occurred under such mild conditions, the acetic 
anhydride used in the Erlenmeyer reaction must also have the purpose of activating 
the carbonyl in some way. Therefore, another method of activating the carbonyl 
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compound would be desirable. 
Kumar et al. 72 reported the activation of carbonyl compounds for oxazolone 
synthesis by converting them to imines. Formation of the oxazolone intermediate 
was achieved with ethyl chioroformate, after which the imine was added. Yields 
were moderate (60-70%) and only gentle heating was required. 
This method is far less harsh than the classic Erlenmeyer synthesis but it still 
produces acid as a by-product. Since carbodiimide reagents can cyclise N-acyl amino 
acids - indeed, this is one of the common side reactions in peptide synthesis - it was 
decided to substitute ethyl chloroformate by EDCI. 
The imines 89, 90 and 91 were prepared from aniline and the corresponding 
aldehyde (Scheme 68). 89, synthesised by mixture of the neat reagents, was obtained 
in 88% yield after recrystallisation. 90 and 91, prepared by refluxing in toluene with 
azeotropic removal of water, were obtained in 35% and 21% yields respectively. 
Clearly the method used to produce 89 is superior, and would first be attempted for 
synthesis of any other aldimines. 
Ph 	R 	imine 
0  
II 	+ Ph—NH 2 	 Ph 89 
RH R 	H 	HOC6 H4  90 
CIC6 H4 91 
Scheme 68 Synthesis of aldimines 
The corresponding oxazolones were produced in a two-step synthesis (Scheme 69). 
Hippuric acid and EDCI were stirred at room temperature in dichioromethane for 1 
hour. When the reagents had fully dissolved, TLC (ethyl acetate/hexane 1:1) showed 
complete reaction of hippuric acid. Imine was then added and the reaction mixture 
stirred at reflux until complete reaction of the imine was observed. Column 
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CIC6 H4 	94 
Scheme 69 Synthesis of oxazolones from hippuric acid 
In the synthesis of 92, another product was isolated: a polar yellow oil. Its identity 
could not be confirmed but 'H NMR suggests that it is the product of aminolysis of 
the oxazolone (Scheme 70). It was decided therefore to attempt synthesis of 92 from 
benzaldehyde; i.e. by cyclisation of hippuric acid with EDCI followed by direct 
condensation with benzaldehyde. While the desired product was obtained, the yield 
(19%) was disappointing. 
PhNH-H 




Ph 	N 	Ph 
950 
Scheme 70 Hypothesised side-product in the synthesis of 92 
This reaction offers a method of oxazolone synthesis under neutral conditions. The 
low yields and presence of the side product 95 make the reaction incompatible with 
solid phase synthesis at present. However, with optimisation to suppress formation of 
95, the method would be appropriate for synthesis of oxazolones on solid phase and 
in other situations where acid cannot be used. 
Conclusion 
A method has been developed to synthesise Erlenmeyer oxazolones via carbodiimide 
cyclisation. Condensation can be achieved using benzaldehyde, although a higher 
yield was observed using N-benzylideneaniline. Synthesis via the imine, however, 
resulted in formation of an unidentified by-product. Therefore, although this method 
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offers an acid-free route to Erlenmeyer oxazolones, it must be optimised before it 
would be applicable to solid phase synthesis. 
Synthesis of Disubstituted Oxazolones and Their Hydrolysis to 
Dehydroamino Acids 
Overview 
One of the aims of this project was to find a method of amino acid elaboration on 
solid phase which would be compatible with the linker, and would deliver 
dehydroamino acids and unnatural saturated amino acids, including 13-branched 
amino acids. Having developed a method that would give monosubstituted 
dehydroamino acids under resin-compatible conditions, it remained to extend the 
reaction to disubstituted dehydroamino acids. 
Disubstituted dehydroamino acids are interesting targets in themselves, since they 
are sterically more demanding than their monosubstituted analogues. In addition they 
are convenient precursors to saturated 13-branched amino acids. Dehydroamino acids 
have been in most cases prepared by three general methods: dehydration of a 
hydroxy amino acid, metal-catalysed coupling with an existing dehydroamino acid or 
through various condensation methods including oxazolone formation (Figure 27). 
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Figure 27 Dehydroamino acid formation: general methods 
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Dehydration and metal-catalysed coupling rely on the availability of elaborate 
starting materials and proceed by linear synthesis. The condensation approach starts 
with simpler starting materials and is a convergent synthesis. Another method of 
condensation, such as the oxazolone synthesis developed herein, could be useful, 
especially since it is the only oxazolone synthesis which completely avoids the use of 
acid. It was decided to investigate the use of this mild oxazolone formation for the 
synthesis of some disubstituted a4-dehydroamino acids. Seven targets were chosen 
(Figure 28). 
dehydroamino 
R1 R2  acid 
	





H p-CIC6 H4 
Figure 28 Dehydroamino acid methyl esters: targets 
These were to be synthesised by methanolysis of the corresponding oxazolones 
(Figure 30). 96 was a logical progression from the benzaldehyde derived oxazolone 
and the difference in sizes of the substituents offered the best chance at synthesis of a 
single isomer. 97 and 98 were also synthesised, but these were obtained through 
hydrolysis and esterification, and their synthesis is considered separately. 99 was 
chosen to compare with 96, the effect of substituent sizes on isomer ratio. 100 is 
derived from 2-butanone, a low-boiling ketone which is difficult to use in 
condensation since elevated temperatures cannot be used. Finally, 101 and 102 were 
chosen to investigate the scope of the oxazolone synthesis i.e. what size of 
substituent is tolerated in the reaction? If the oxazolone synthesis was possible, 
hydrolysis or methanolysis should give the protected amino acids in a 
straightforward fashion. The first step therefore was to synthesise the imines. 
Et 
p-BrC6H4 
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Imine Synthesis 
A group of imines was prepared as shown in Figure 29: the acetophenone derived 
imines 103, 104 and 105, the slightly more hindered 106, an imine based on 2-
butanone (107) and the more challenging targets 108 and 109. Anilines were used in 
the synthesis of all but one - its high boiling point makes it suitable for synthesis by 
azeotropic distillation of water. In addition, an aryl substituent increases the stability 
of the imine' 74 , as in the case of 107. In the case of 108, the N-methyl imine was used 
since the N-methyl imine derivative of benzophenone has been used successfully to 
synthesise an oxazolone 78 . 
R1 1 R2 I R3 	I imine 
Ph Me Ph 103 
R3 
N 	 BrC6 H4 Me CIC6 H4 104 
MeC6H4 
R"R 
Me CIC6H4 105 
CIC6 H4 Et Ph 106 
Et Me Ph 107 
BrC6 H4 Ph Me 108 
Pr 'Pr Ph 109 
Figure 29 Proposed synthesis targets: imines 
The imines were synthesised by refluxing the amine and corresponding ketone in 
toluene with azeotropic removal of water in all cases except 107 and 108. Since 2-
butanone has a low boiling point this method was not suitable, but the condensation 
proceeded smoothly when molecular sieves were used to remove water. 108 in 
contrast was synthesised under more forcing conditions: heptamethyldisilazane was 
heated with the ketone in a sealed vessel for 72 according to the method of Duffaut 
and Dupin.' 75 Yields of the imines were generally low (Table 4), due to the difficulty 
of purification. Purity was confirmed in most cases by melting point. However, 
107176 (oil) and 108' (not isolated) were identified by comparison of 'H NMR 
spectra with published data. In the case of 109, identification was made by 
comparison of JR data with a published example 171 
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* Product was not isolated from starting material 
Table 4 Yields of imines 
Purification of the imines was not trivial. Most of the compounds were obtained as 
oils, contaminated by the starting materials. The main concern was to remove the 
excess amine from the mixtures as it could attack the subsequently formed 
oxazolone. All the imines were found to be unstable on silica, so column 
chromatography was ruled out. 
Aqueous extraction of amine was also impossible, as the imines are unstable in 
water. 
However, replacing water with acetonitrile gave a method that was suitable for 
separation. Reaction mixtures were concentrated, redissolved in hexane and washed 
with acetonitrile. Repeated washings gave the pure imine, although in low yield. 1 H 
NMR of the acetonitrile portions showed that they contained significant amounts of 
imine. The method was useful in obtaining small samples of pure material, but on a 
larger scale a more efficient purification method would have to be found. 
Three of the imines were not purified in this way. 108 was obtained as a mixture 
with the ketone after solution in dichloromethane and filtration. Since no amine was 
present, the mixture was used directly. 107, a liquid, was purified by distillation. 
Only 105 was obtained as a crystalline compound, and trituration with MTBE was 
sufficient to obtain the compound in satisfactory purity. 
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Oxazolone Synthesis 
With the ketone-derived imines in hand, synthesis of the oxazolones (Figure 30) was 
attempted according to the procedure developed previously using the aldimines 89, 
90 and 91. 
R1  R2  loxazolone 
Ph Me 110 
BrC6 H4 Me 111 
MeC6 H4 Me 112 
CIC6 H4 Et 113 
Pr 'Pr 114 
BrC6 H4 Ph 115 
Et Me 116 
Figure 30 Proposed synthesis targets: oxazolones 
The results are summarised in Table 5. 
Oxazolone Yield (%) E/Z ratio 
110 67 3.7:1 
112 * - 
113 52 3.1:1 
114 0 - 
115 75 - 
116 77 1:1 
*Crude product was taken on directly to next step 
Table 5 Yields of disubstituted oxazolones 
The identity of 110 was confirmed by melting point. Oxazolones 111 and 112 were 
not purified, but instead taken on directly to the hydrolysis step. Therefore, yields 
were not obtained. 113 was obtained, albeit in low yield, and characterised fully as a 
new compound. Despite repeated attempts, 114 could not be synthesised. In contrast, 
115 was obtained in good yield. It seems likely that since substituents (aromatic 
rings) of 108 were planar and so able to twist, it was able to offer a less crowded 
centre to the oxazolone and condensation could occur (Figure 31). 
Ph 
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Figure 31 Crowding in the approaches of imines for condensation 
Isomer ratios were determined by 'H NMR in the cases of 110, 113 and 116. 115, 
with only aromatic signals, had no peaks sufficiently separated to assign to one 
isomer or the other. 
In the case of known compounds 110 and 116, assignments of Z or  were made by 
comparing chemical shifts with published results"', I8O The assignment of Z to the 
major isomer of 110 was confirmed when a crystal structure was obtained (Figure 
32) - column chromatography yielded a small amount of the major isomer as large 
yellow crystals. 
OSA 
Figure 32 X-ray crystal structure of 110 
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The major isomer of 113 has been assigned Z stereochemistry for two reasons. 
Firstly, the alkyl signals of the major isomer have higher chemical shift than those of 
the minor isomer, which is the trend most often observed in the other oxazolones for 
which published information was available (Table 6). Secondly, the Z isomer has 
been shown by crystal structure to be the major isomer in the case of 110. 
Oxazolone Chemical shift of alkyl 
substituents in Z isomer 	pm) 
Chemical shift of alkyl 
substituents in E isomer (ppm) 
11o179 2.78 (Me signal) 2.66 (Me signal) 
116180 2.30 (C=CCH3) 2.24 (C=CCH3) 
116 1.11(CH2CH3) 1.07(CH2CH3) 
116 2.68 (CH2CH3) 2.77 (CH2CH3) 
Table 6 Previously published chemical shift data for alkyl groups of Erlenmeyer 
oxazolones 
It is interesting to note the difference in isomer ratios in 110, 113 and 116. The trend 
is towards a greater proportion of the E isomer, as the substituents on the oxazolone 
approach the same size. This would tend to suggest that the Z product has lower 
energy than the E. An interesting question is why any E isomer is produced at all. 
Does the reaction occur under competing thermodynamic and kinetic control, or 
under complete thermodynamic control? Are the energy differences between the Z 
and E isomers sufficient to give only Z at equilibrium, or is a mixture the equilibrium 
position? These questions remain to be answered for the oxazolone synthesis, 
although isomerisation was investigated for the dehydroamino acids. 
Methanolysis 
The amino acid methyl esters were produced by direct methanolysis as shown in 
Scheme 71. 
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Scheme 71 Synthesis targets: dehydroamino acid methyl esters 
Methyl esters rather than acids were required because of their higher solubility in 
methanol, which was to be used as the solvent for hydrogenation. Direct 
methanolysis rather than hydrolysis and esterification was first attempted because it 
resulted in products that could be purified by column chromatography. Methanolysis 
also allowed isomer ratios to be determined for all the products, by comparing the 'H 
NMR integrations of the methyl ester signals. Yields and isomer ratios are 
summarised in Table 7. Yields based on the imine are given for comparison with the 
hydrolysis-esterification method, below. 
Product Starting material 





Yield from imine 
(%) 
96 Pure  50 7.0:1 34 
99 3.1:1 46 3.3:1 24 
100 1:1 71 1.1:1 55 
101 - 57 1:1 43 
Table 7 Yields of dehydroamino acid methyl esters 
In general the overall yields were disappointing. The low yield of 101 can be 
partially explained by the fact that methanolysis also yielded 42% of 4-
bromobenzophenone, the product of the alternative hydrolysis of the oxazolone 
shown in Scheme 72. It may be that exclusion of water would suppress this side 
reaction. There is no evidence that this type of reaction occurred in any of the other 
methanolysis experiments however, and the reaction would not be suitable for solid 
phase synthesis without optimisation. 
An interesting trend in rate of hydrolysis was identified: while 100 took under 5 
minutes to completely methanolyse, 99 took 30 minutes and 101 failed to react 
completely unless the reaction was repeated with double the amount of sodium 
methoxide (0.4eq). 
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Scheme 72 Proposed mechanism of decomposition of 101 
It should also be noted that methanolysis occurred with some degree of isomerisation 
in each case. This isomerisation was further investigated, and the results, along with 
other investigations into isomerisation, are presented below. As with the oxazolones, 
assignment of Z or E configuration was supported by various pieces of evidence. A 
crystal structure of 96 was obtained (Figure 33), and again, the major isomer was 
found to have Z configuration and higher chemical shift of alkene methyl signal in 
'H NMR. The methyl ester signal of the Z isomer also had a higher chemical shift in 
'H NMR. In the cases of 99, 100 and 101, it was assumed that the Z isomer had the 
higher chemical shifts. 
Figure 33 X-ray crystal structure of 96 
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No simple trend could be identified from the changes in isomer ratios observed. In 
the methanolysis of pure Z-110, a small amount of E isomer was produced. 
However, in the methanolyses of 113 and 116, ratios of E:Z isomer were observed to 
decrease slightly. A reasonable explanation would be that the equilibrium position of 
these dehydroamino acids and oxazolones is a mixture of the Z and E isomers. 
Hydrolysis and Esterification 
The amino acid methyl esters produced by hydrolysis followed by esterification are 
shown in Scheme 73. 
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Scheme 73 Synthesis of dehydroamino acid esters by hydrolysis and esterfication 
Hydrolysis and esterification offered advantages over methanolysis from the point of 
view of developing the reaction for large scale synthesis. Instead of purifying at each 
stage by chromatography, the crude oxazolone could be hydrolysed and purified by 
aqueous extraction. After esterification, the mostly polar impurities could again be 
removed by washing with water. 
Three of the oxazolones were hydrolysed and then esterified using thionyl chloride 
in methanol. Yields and isomer ratios are given in Table 8. 
Product Yield*(%) Isomer Ratio (Z:E) 
96 25 1.8:1 
97 17 2.5:1 
98 46 2.5:1 
*yield from imine 
Table 8 Yields of dehydroamino acid methyl esters obtained by hydrolysis and 
esterfication 
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96 was synthesised by both methods for comparison. Clearly, synthesis by 
methanolysis is higher yielding but the yields for these hydrolyses were very variable 
generally. One problem identified was the low solubility of the acid products in 
dichloromethane. A more polar organic phase such as ether or ethyl acetate would 
probably result in greater recovery of product. 
Conclusion 
The carbodiimide method has been used to synthesise a number of dehydroamino 
acids from Erlenmeyer oxazolones. The reaction has been applied to a number of 
difficult substrates, including 107, which is derived from low-boiling 2-butanone and 
is difficult to synthesise by traditional Erlenmeyer conditions. 
In the syntheses of the oxazolones and their hydrolysis to dehydroamino acids, 
mixtures of Z and E isomers were obtained. These ratios were related to the size of 
the substituents on the double bond: i.e. the more similar the substituents were in 
size, the closer to 1:1 was the ratio of Z and E isomers. 
The oxazolones were cleaved by hydrolysis or methanolysis to yield dehydroamino 
acids or their methyl esters respectively. Hydrolysis offers a synthetic route which 
avoids the use of column chromatography, and is suitable for large scale synthesis. 
Isomerisation 
Overview 
As has been discussed above, the method of synthesis of dehydroamino acids used in 
this work gives rise to mixtures of Z and E oxazolones. A useful dehydroamino acid 
synthesis relies on the possibility of obtaining either isomer in high isomeric purity. 
A number of methods have been developed to obtain either the Z or the E isomer 
from ZIE mixtures, from the oxazolone or directly from the dehydroamino acid. 
Initial approaches to isomerisation focused on the oxazolone. Cativiela et al. 
demonstrated methods by which the Z isomer could be obtained from the E and vice 
versa (Scheme 74). 
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HBr: 48% HBr in H 20, HBr gas, 0°C - 8°C, 16h. 
pyridine: pyridine (solvent), rt, 3 mm. 
Scheme 74 Isomerisation of oxazolones 
The method of Z isomerisation - treatment with pyridine - is applicable to large 
scale synthesis although the use of pyridine as a solvent is not ideal. In contrast, the 
E isomerisation method is not applicable to large scale due to the use of HBr gas, 
which is toxic and corrosive. However, the method was useful on small scale and 
samples of a number of disubstituted oxazolones were obtained (Scheme 75). The Z 
isomers were obtained by condensation of hippuric acid and the ketone using acetic 
anhydride and lead acetate. Note that Z isomers were obtained via crystallisation 
from the reaction mixture, and isomerised to E using HBr. The same yields were 
quoted for the Z and E isomers, implying that the Z to E isomerisation was 
quantitative in all cases. 




3-N 02C6 H4 
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0 	
4-CH3C6H4 
Scheme 75 E disubstituted oxazolones obtained by Cativiela et.al . by action of HBr 
With a method to obtain geometrically pure oxazolones discovered, the next step was 
to find a way to hydrolyse to the dehydroamino acid with retention of configuration. 
A later paper by the same group 75  reported the hydrolysis of some thienyl-substituted 
oxazolones with no isomerisation. Although isomerisation had been observed under 
harsher conditions, they found that 1% sodium hydroxide in methanol/water gave the 
desired dehydroamino acid with retention of configuration. Similarly, treatment with 
sodium hydroxide in methanol gave the methyl ester (Scheme 76). This result 
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contrasted with the work reported here, where oxazolones were hydrolysed with 
solutions of 0.1-1% sodium hydroxide or sodium methoxide, and yet isomerisation 
still occurred. This may be because the thienyl compounds are less amenable to 
isomerisation. 
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Scheme 76 Hydrolysis with retention of configuration 
Interestingly, nothing was reported on the hydrolysis of disubstituted oxazolones. 
However, aminolysis of Z-110 and E-110 with aniline resulted in the corresponding 
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Scheme 77 Aminolysis with retention of configuration 
As described earlier, pyridine at room temperature causes the E isomer to convert to 
the Z, but aniline refluxed in benzene results in aminolysis with retention of 
configuration. Presumably the nucleophilicity of aniline results in aminolysis 
occurring more quickly than isomerisation. In fact, since three equivalents of aniline 
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are used, aminolysis must be a much faster reaction than isomerisation. 
In summary, the methods developed by Cativiela and coworkers offer a route into 
diastereoisomerically pure dehydroamino acids, although due to the use of HBr, 
synthesis of the pure E isomer on a large scale is not possible. 
Isomerisation - Results 
Attempts were made to adapt the methods of Cativiela for the purpose of large scale 
synthesis. Since the E to Z isomerisation (with pyridine) was reasonably acceptable 
for large scale synthesis, it was not investigated. Instead, effort was concentrated on 
finding an alternative for Z to E isomerisation. 
It was hoped that substitution of saturated HBr solution with another acid might be 
possible. HBr in acetic acid was chosen for investigation: it was hoped that a solution 
of HBr in an organic acid would have properties similar to a saturated solution of 
HBr in water. The substrate chosen for isomerisation was 110: since the substituents 
have a large difference in size, it was hoped that any isomerisation effect would be 
most pronounced with this substrate. 
Thus, a 3.6:1 mixture ofZ and E 110 was treated with HBr in acetic acid at 5°C for 
16h (Scheme 78). The oxazolone was then isolated by pouring the reaction mixture 
onto ice and extracting with dichioromethane. As anticipated, the ZIE ratio had 
changed from 3.6:1 to 2:1 with 80% yield. The reaction was then carried out with the 
exclusion of moisture, as it was conceivable that water may affect the isomerisation 
process. However, the isomer ratio obtained was 2:1 as before, with a slightly lower 
yield of 76%. Finally, the reaction was repeated at 20°C and a 1.8:1 mixture of Z and 
E isomers was obtained. In each case, the yield was high. Since the final experiment 
proceeded with 100% recovery, the slightly lower yields in the other experiments 
were probably due to mechanical losses. On a larger scale, it should be possible to 
achieve quantitative yields. 
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Scheme 78 Attempts to obtain B 110 
Although this method did increase the proportion of E isomer in the mixture, it is not 
a viable method for synthesising the E isomer for two reasons. Firstly, over half of 
the material is the wrong isomer and would have to be discarded. Secondly, the 
mixture would be difficult to purify by crystallisation since neither of the 
components is present in a large enough proportion to be crystallised. 
Isomerisation can also be performed through photochemical methods. It was found" 
that irradiation of pure Z 92 (Scheme 69) with 3650A light produced a 
photostationary 1:1 mixture of the Z and E isomers which were separated by 
chromatography. While this method does give the E isomer, it is impractical for 
large scale use. The extremely dilute solutions needed for photochemical reactions 
(1.1 g1' in 2-propanol in this case) result in too much solvent waste, and separation 
by chromatography is not possible on a large scale. 
Therefore, it remains to find methods of isomerisation of oxazolones that are 
practical on large scale. 
Isomerisation of dehydroamino acids 
Another approach to obtaining pure geometric isomers of dehydroamino acids is to 
attempt isomerisation of the dehydroamino acid directly. Schmidt et al."' carried out 
some work on monosubstituted dehydroamino acids (Scheme 79), in which a 
mixture of isomers was treated with triethylamine/charcoal or HC1. Treatment 
generally resulted in an increase in the proportion of Z isomer, but in no case was the 
pure Z isomer formed. 
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I 	No 	
I 
CBZNH CO2CH3 CBZNH 	CO2CH3 
Method A: HCl/Et 20 Method B: NEt3/charcoal 
R 
Starting 
EIZ ratio Method 
Resultant 
EIZ ratio 
Et 52:48 A 17:83 
B 79:21 
Ph 37:63 A 10:90 
B Z>99 
a-CH 30C6 H 5 40:60 A 2:98 
B 15:85 
Scheme 79 Schmidt's isomerisation of dehydroamino acids 
Results 
This pattern was repeated with 96, which gave a 4:1 mixture of Z/E isomers when 
treated with triethylamine at room temperature for 16 hours. The reaction was 
repeated at 30°C for 72 hours but the same result was obtained. Finally, this reaction 
was abandoned when heating the mixture to 90°C for 192 hours gave the same 4:1 
mixture of Z and E isomers. 
Clearly there is no advantage in this method over Cativiela's pyridine isomerisation, 
and so it was decided to investigate isomerisation during hydrolysis. 
Stereochemistry of hydrolysis 
The stereochemistry of hydrolysis was examined primarily in the hope that the Z 
dehydroamino acid could be obtained from a mixture of oxazolones. A 5:1 mixture 
of Z and E 110 was hydrolysed with a mixture of 0.25N NaOH and THF (to aid 
dissolution). After 1 hour the isomer ratio was seen to drop to 4.9:1, but after 16h a 
7.2:1 mixture was obtained. Further reaction time resulted in no further change to the 
isomer ratio. Therefore, the reaction was abandoned. 
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Conclusion 
Isomerisation was observed, and eniichment of Z (through hydrolysis) or E (through 
treatment with HBr/acetic acid) was achieved. However, no methods were identified 
that gave in Z or E in ratios high enough to purify by crystallisation, with conditions 
applicable to large scale. It was decided to continue to the hydrogenation step with 
E/Z mixtures. It was hoped that isomers could be separated after hydrogenation, 
perhaps by enzymatic methods. In fact, this proved unnecessary, as asymmetric 
hydrogenation of the mixtures gave rise to isomerically enriched products. 
Future Work 
The carbodiimide-mediated oxazolone synthesis was shown to work for a variety of 
aldehydes and ketones, and offers an extremely mild route into Erlenmeyer 
oxazolones. However, a number of issues remain with this method. Firstly, the 
reaction was shown to work with benzaldehyde, albeit in low yield. This reaction 
should be optimised and its scope investigated. One important question is whether 
ketones will react without being activated by conversion to the imine. 
Even if the carbodiimide method proves to be applicable to ketones, some 
oxazolones derived from low-boiling carbonyl compounds would need to be 
synthesised via the imine. This requirement for imines raises two issues. An 
alternative to aniline should be found, as its use on a large scale is undesirable due to 
toxicity. In addition, the polar side product produced in this reaction should be 
isolated and characterised. Identifying the side product should help in finding ways 
to suppress its formation. If these reactions can be optimised so that the formation of 
side products is suppressed, then they will be suitable for solid phase synthesis. 
The hydrolysis and methanolysis of the oxazolones synthesised proved to be simple 
and rapid. However, yields were moderate to low, and varied widely for different 
oxazolones. In addition, it was shown that the conditions used to hydrolyse the 
oxazolones resulted in isomerisation. Work should be carried out to develop methods 
of hydrolysis and methanolysis, which consistently give high yields with no 
isomerisation. Such a method could be based on Cativiela's hydrolysis procedure, 
which proceeded with retention of configuration. 
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Results and Discussion Ill - Asymmetric Hydrogenation of 
Dehydroamino Acids 
Overview 
In 1988, Cabeza et al. 166  published a paper in which they reported hydrogenation of 
96 with the iridium catalyst 117 (Scheme 80). The yield of expected product (2R,38)-
118 was 41% but a small footnote reported that 46% of the diastereoisomer had also 
been formed. 
Ph) catalyst 	Ph 1 Ph 
	
PhCONH CO2 	PhCONH CO2Me PhCONH CO Me 	 H 	 H 	2 
96 
(2R, 3S)-118 	 (2R, 3R)-118 
41% 	 46% 
catalyst 117 = [lr(cod)(bzn)(pamp)11CI0 41 
Scheme 80 Asymmetric hydrogenation of 96 using an iridium catalyst 
This result was not commented on by the authors and a citation search reveals that no 
other group ever pursued it further. Significantly, this is the only example in which 
N-benzoyl dehydroamino acids have been investigated as substrates for asymmetric 
hydrogenation catalysts: other studies have used N-acetyl dehydroamino acids, and 
such isomerisation has not been reported. 
The same effect has now been observed with the DuPHOS and BPE catalysts. This 
thesis describes the discovery and development of this process by investigation of 
the various factors involved. The aim was to develop a route into diastereomerically 
pure amino acids from E/Z mixtures of dehydroamino acids through dynamic kinetic 
separation. * 
• The term "dynamic kinetic separation" is used here as it is recognised that although this process is 
similar to dynamic kinetic resolution, diastereomers (and not enantiomers) are being separated and so 
the term "resolution" is not appropriate. As far as could be determined, there is no term in the 
literature to describe the separation of diastereoisomers under dynamic conditions. 
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Results 
The first indication that a dynamic kinetic separation was occurring was in an initial 
screen of catalysts for hydrogenation. The alkene 96 (1.6:1 ZIE, 21.8% d-e.) was 
hydrogenated with a series of hydrogenation catalysts and the ratios of the isomers of 
the product (118) were determined by supercritical fluid chromatography analysis. 
Table 9 shows the percentages of each isomer obtained in each hydrogenation, while 
Table 10 shows total Z and E derived products, and diastereomeric and enantiomeric 
excesses in each hydrogenation. 
Catalyst 2R, 3R 
(peak 1) (%) 
2R, 3S 
(peak 2) (%) 
2S, 3S 
(peak 3) (%) 
2S, 3R 
(peak 4) (%) 
PdJC 19.3 30.7 19.7 30.4 
(R,R)-MeDuPHOS 7.5 88.4 3.8 0.3 
(R,R)-MeBPE 5.4 93.0 1.3 0.4 
(S,S)-EtDuPHOS 1.1 1.5 1.0 96.3 
(S,S)-EtBPE 2.1 1.1 3.9 92.9 
Table 9 Asymmetric hydrogenation of 96 with various catalysts 
Catalyst Total Z derived 
products (%) 




e.e. of Z derived 
product (%) 
PdIC 61.1 38.9 22.2 0.3 
(R,R)-MeDuPHOS 88.7 11.3 77.4 88.1 
(R,R)-MeBPE 93.3 6.7 86.6 92.6 
(S,S)-EtDuPHOS 97.9 2.1 95.8 94.7 
(S,S)-EtBPE 94.0 6.0 88.0 91.8 
Table 10 Hydrogenation of 96: diastereomeric and enantiomeric excesses 
With the asymmetric PdIC catalyst, no selectivity is observed, and racemic mixtures 
from both diastereoisomers are produced. From these results it was inferred that peak 
1 and 3 correspond to the hydrogenation products of the E form, and 2 and 4 to the 
products of the Z form (Figure 34). Furthermore, knowing that the (R,R) catalysts 
give R products and the (SS) catalysts give S products, it was possible to determine 
which peak belonged to which enantiomer. Therefore we assigned the four peaks the 
93 
Results and Discussion Ill 
stereochemistries shown in Figure 34. 
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Favoured by R,R-DuPHOS and RR-BPE 
Favoured by S,S-DuPHOS and S,S-BPE 
Figure 34 Hydrogenation products from alkene 96 
With each of the asymmetric catalysts, diastereomeric enrichment of the product 
derived from the Z isomer can be seen: the percentage of product from the 
Z isomer is 
in each case higher than the 61% (21.8% d.e.) of Z isomer in the starting material. In 
each case it can also be seen that the enantiomeric excess of the Z derived products is 
higher than that of the E products. These Rh-DuPHOS and Rh-BPE hydrogenation 
catalysts hydrogenate the Z form faster and with higher selectivity, which is in 
agreement with published 	
12 
For a dynamic kinetic separation to occur, three conditions must be met. The different 
forms of the starting material must be able to interconvert, there must be a selective 
irreversible reaction to transform them and the interconversion step must be faster 
than the selective step (Figure 35). If the selective step is much faster than the 
interconversion then the proportion of disfavoured isomer will increase and a higher 
proportion of it will be transformed to product. If the interconversion step is faster, 
the proportions of favoured and disfavoured isomer will stay constant and selectivity 
will not decrease as the reaction proceeds. 
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Figure 35 Dynamic kinetic separation 
major product 
minor product 
The selective step - hydrogenation - had already been, identified, so it remained to 
determine the method of interconversion and whether the interconversion was faster 
than the hydrogenation. 
To model the reaction conditions, a sample of alkene 96 (96.4% Z, obtained by 
repeated recrystallisation of a mixture of Z and E 96) was dissolved in methanol and 
stirred at room temperature for 96 hours. In this time the percentage of E in the 
mixture increased from 3.6% to 16.2%. The mechanism of this isomerisation is not 
known, but a proposed mechanism involves nucleophilic attack of methanol on the 
enamide (Scheme 81) 
H
0 


















Scheme 81 Nucleophilic attack leading to isomerisation 
If this mechanism is in operation then addition of acid should increase the rate of 
isomerisation. The cationic rhodium catalysts used in these hydrogenations may also 
affect the rate of isomerisation. 
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With reasonable hypotheses proposed for the selective step and the mechanism of 
isomerisation, all that remained was to determine whether the isomerisation was 
faster then the hydrogenation. 
It was decided to attempt some simple kinetic experiments. The substrate 96 was 
hydrogenated as usual, with samples taken at regular intervals. The samples were 
then analysed by SFC and the composition of the mixture determined. If a decrease 
in selectivity were to be seen over time, then it could be concluded that the 
hydrogenation step is faster than the isomerisation. 
It was decided to examine only the isomer ratios (i.e. the enantiomeric and 
diastereomeric ratios) of the products. The mechanism proposed for isomensation 
involves the double bond, so it is likely that the products will not isomerise in 
methanol. Therefore samples could be stored and analysed at any time. 
Unfortunately, it was found that after one sample was taken, the reaction effectively 
stopped. This is probably due to the air sensitivity of the catalysts: while they are 
stable in their crystalline forms, in solution they react rapidly with oxygen. In the 
small hydrogenation vessels that were used, it was impossible to take a sample while 
maintaining H2 pressure: the vessel must be depressurised while the sample is taken 
and repressurised afterwards. During this time N 2 was blown through the vessel to 
avoid air contamination but somehow oxygen must have leaked in. Larger 
hydrogenation vessels exist which can be sampled at pressure, but due to their 
volume the smallest practical amount of material which can be hydrogenated is 
around 100g, and for multiple experiments, preparation of kg quantities of 96 would 
have taken too long. 
Instead, three small scale reactions were run. In each case 96 (1.6:1 ZIE, O.lOg) was 
hydrogenated with (S,5)-EtDuPHOS (1 mol%) in methanol (lOmi). Two reactions 
were run at 150 psi; the other was run at 180 psi. One of the reactions at 150 psi was 
stopped and sampled after 16h, and the others were allowed to run to completion. 
The results are summarised in Table 11 below, and the d.e., e.e. and total percentages 
of Z and E derived products are presented in Table 12. 
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Experiment Peak 1 Peak 2 Peak 3 Peak 4 Remaining starting 
(%) (%) (%) (%) material (%) 
16h @ 150 0.4 0.6 0.5 48.8 49.8% 
psi (0.7) (1.2) (0.9) (97.2) 
Completion 6.0 1.3 7.1 85.7 0 
@150 psi 
Completion 6.0 1.1 7.3 85.7 0 
@180 psi 
Table 11 Proportions of isomers after 1 6h, and at completion. Numbers in brackets 
are normalised percentages of the products 
Experiment Total Z Total E d.e. of product e.e. of Z- 
derived derived (%) derived 
products (%) products (%) product (%) 
16h @ 150 psi 98.4 1.6 96.8 96.0 
Completion @ 87.0 13.0 74.0 84.4 
150 psi 
Completion @ 86.7 13.3 73.5 84.6 
180 psi 
Table 12 Time dependant hydrogenation of 96: diastereomeric and enantiomeric 
excesses 
For comparison, the proportions of the products at 16h have been normalised to 
100%, and these figures are shown in brackets in Table 11. It can be seen from Table 
12 that the proportion of Z-alkene derived products at 16h (98.4%) was higher than 
at completion (87.0%). Selectivity decreases as the reaction proceeds, and it can be 
tentatively concluded therefore that the isomerisation step is slower than the 
hydrogenation. It remains to find ways of increasing the rate of isomerisation in 
order to increase the selectivity. 
In addition it can be seen that at differing pressures, selectivity is little affected. This 
is at first glance a surprising result, since it would seem reasonable that increasing H 2 
concentration would increase the rate of hydrogenation and decrease the selectivity. 
The rates of these reactions were not closely monitored however, and it remains to 
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investigate the effect of H 2  pressure on selectivity and rate. The rate of reaction may 
also be increased by heating - this also remains to be investigated. 
Having investigated the mechanism of selectivity and isomerisation for one 
substrate, the other dehydroamino acids that had been synthesised were also 
hydrogenated. Hydrogenation was performed first with PcIJC to provide a racemic 
mixture for analysis method development, and then with (SS)-EtDuPHOS to 
measure selectivity. (SS)-EtDuPHOS was chosen since it had been used in the 
kinetics experiments above and so provided a basis for comparison. However, the 
substrates were hydrogenated at the lower pressure of 120 psi due to problems 
associated with operating the hydrogenation vessels at higher pressure. The results of 
the experiments are summarised in Table 13, and the products pictured in Figure 36 
below. 
Substrate Product Catalyst Yield Z/E Ratio 
99 119 Pd/C 90% 4.2:1 
99 119 (S,S)-EtDuPHOS unknown - 
100 120 Pd/C 100% 1:1 
100 120 (S,S)-EtDuPHOS 100% 1:1 
101 121 PdJC 100%* - 
101 no reaction (S,S)-EtDuPHOS - - 
*product was the dehalogenated dehydroamino acid 121. 
Table 13 Hydrogenation of other dehydroamino acids 
Ck J 
0 
Ph 'N 	CO2Me 
119 
0 





Figure 36 Products of hydrogenation 
In the case of 99, hydrogenation with Pd/C proceeded smoothly to yield 90% of the 
desired product 119. SFC analysis indicated a 4.2:1 ratio of Z derived products to  
derived products. This ratio is higher than in the starting material (3.3:1) which may 
be explained by isomerisation of the substrate in methanol - the equilibrium position 
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of the mixture is not known. In the asymmetric hydrogenation of 99 an impurity 
appeared which prevented determination of isomer ratios by SFC analysis or 'H 
NMR. In the hydrogenation of 100 to 120, no method was found to separate the 
isomers and so ZIE product ratios were determined by 'H NMR. It was found that in 
both the PdJC and asymmetric hydrogenations of 100 there was no diastereomeric 
selectivity. In the case of 101, treatment with PdJC resulted in the dehalogenated 
compound 121 rather than hydrogenation, and attempted hydrogenation with the 
asymmetric catalyst resulted in recovery of starting material. 
Despite the problems associated with all of these reactions, one conclusion may be 
drawn. In the case of 96 where the alkene substituents are very different (Ph and 
Me), hydrogenation was found to proceed with over 80% d.e. In the case of 100, 
where the substituents (Me and Et) were very similar, d.e. was zero. Clearly 
selectivity depends on having substituents on the alkene which are different from 
each other. An interesting question is whether this difference is steric or electronic. 
Further work is required to determine whether selectivity depends on either or both. 
Conclusion 
It has been shown that in the hydrogenation of mixtures of Z and E 96 with Rh-
DuPHOS or BPE catalysts, enrichment of the Z isomer occurs. The method of 
isomerisation has been identified —the substrate isomerises in methanol - and the 
relative rates of isomerisation and hydrogenation have been probed. Asymmetric 
hydrogenation of 100 has confirmed that the substituents on the alkene affect the ZIE 
selectivity of the hydrogenation, although whether this is due to steric or electronic 
effects, or a combination, is not yet known. 
Future Work 
The work carried out on asymmetric hydrogenation of mixtures of ZIE 
dehydroamino acids is merely a starting point. There are a number of areas in which 
further work is required. 
It was discovered that in the hydrogenation of 96, isomerisation was slower than 
hydrogenation. The difference in rates led to an eventual increase in the proportion 
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of E 96 in the reaction, and in a decrease in selectivity as the reaction proceeded. To 
improve the selectivity, methods should be found to increase the rate of 
isomerisation. If the proposed mechanism is correct then addition of acid may 
increase the isomerisation rate. Since the isomerisation is due to interaction with 
solvent, decreasing the concentration may also result in a rate increase. 
It was noted that this isomerisation effect had only happened when N-benzoyl 
dehydroamino acids were hydrogenated: N-acetyl dehydroamino acids do not show 
this effect. It seems likely that the ability of N-benzoyl dehydroamino acids to 
isomerise is due to the electron-withdrawing effect of the aromatic ring. If 
isomerisation does involve a nucleophilic attack then reducing the electron density 
on the nitrogen atom, making the double bond more electrophilic, should increase 
the rate of isomerisation. It may be possible to increase this effect by choosing a 
more electron withdrawing substituent such as that shown in Figure 37. 
R 1 	R 2 
N CO2  Me 
Ix 
Figure 37 A p-trimethylammoniumbenzamide protected dehydroamino acid 
The kinetics experiments performed on 96 gave a limited amount of information at 
partial reaction and on completion. A more detailed view would be obtained if the 
reaction were repeated using a large scale vessel which would allow sampling at 
pressure. In that way, information about isomer ratios could be obtained for the 
entire reaction profile. 
Finally, the hydrogenation should be investigated using a number of other substrates. 
In this way, the scope of the dynamic kinetic separation can be shown, and the effect 
of different substituents on selectivity could be discovered. In particular, substrates 
such as 122 and 96 (Figure 38) could be compared to determine whether steric or 
electronic effects, or a combination of both, are responsible for selectivity. 
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Figure 38 Dehydroamino acids for comparison of selectivity of hydrogenation 
Finally, it is known that the Rh-DuPHOS and Rh-BPE catalysts are Z-selective. 
There exist a number of iridium catalysts employing ligands such as 123 and 124166 
(Figure 39) which are E-selective. Hydrogenation using these catalysts should be 
attempted, in the hope of obtaining the E-derived products in high selectivity. 
[I r(cod)(bzn)(L)11CI0 41 
L= PAMP phenyl(o-methoxyphenyl)methylphosphine 123 
or NMDPP neomenthyldiphenylphosphine 124 
PPh 
OMe' 
123 	 124 





'H and ' 3C NMR spectra were recorded on Varian Gemini 200, Bruker AC250, 
Bruker WH 360 or Bruker AC400 instruments. Chemical shifts ( 8H,, 6C, 	are 
reported in ppm, and coupling constants (J) in Hertz (Hz). Residual protic solvent 
present in the deuterated solvent was used as an internal standard in NMR spectra. 
When products were obtained as a mixture of diastereoisomers, an asterisk denotes 
signals corresponding to the minor isomer. Signals corresponding to both isomers 
(e.g. aromatic multiplets) are not marked. 
Electron impact (El) nominal mass spectra were recorded on a Kratos Profile mass 
spectrometer. El high resolution and fast atom bombardment (FAB) nominal and 
high resolution spectra were recorded on a Kratos MS50 mass spectrometer. 
JR spectra were obtained using a Perkin-Elmer FT-JR Paragon 1000 
spectrophotometer and a Biorad FTS7 spectrophotometer. Frequencies (v) are 
measured in wavenumbers (cm'). Compounds were measured as thin films or Nujol 
mulls. Resin samples were swollen in DCM and compressed between NaCl plates. 
For resin IR spectra, only those peaks which differ from the base polymer are 
reported. 
Elemental analysis (CHN) was performed on a Perkin Elmer 2400 CHN Elemental 
Analyser. Br elemental analysis was carried out by Medac. 
Unless otherwise indicated, analytical TLC was performed on Merck aluminium-
backed plates with Kieselgel GF 254 (0.2mm). Permanganate, ninhydrin and 
ultraviolet light (254nm) were used in identification. Flash chromatography was 
performed on BDH flash silica, particle size 40-63im. 
Where alumina chromatography is indicated, analytical TLC was carried out on 
Merck aluminium-backed plates with neutral F 254 alumina. Flash chromatography on 
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alumina was carried out using Acros neutral activated alumina, particle size 50-
200tm, deactivated to Brockmann grade III with water (water 6% w/w). 
Chiral SFC 
Method A: a Daicel Chiralpak column was eluted with CO 2 and methanol (95:5), 
3mllmin, at 3 5'C. Sample was detected by UV absorption at 254nm. 
Method B: a Daicel Chiralpak column was eluted with CO 2 and methanol (98:2), 
2mllmin, at 35°C. Sample was detected by UV absorption at 254nm. 
Solid phase reactions 
When naming resin bound compounds, the resin has been considered to be the 
functional class name, and the compound anchored to the resin has been described 
using prefixes. 
Most solid phase reactions were carried out in 3, 10 or 25m1 plastic isolute SPE 
filtration columns with top caps, luer tips and 20tm porosity frits purchased from 
Jones Chromatography. To ensure thorough mixing of reagents, capped isolute 
columns were rotated on a blood rotator. 
Where larger volumes of solvent (> 1 5m1) or inert atmospheres were used, reactions 
were carried out in glass round bottomed flasks and shaken on a New Brunswick 
Scientific Gyrotory® water bath shaker. 
Gel Phase ' 3C NMR spectroscopy 
Samples were prepared by filling an NMR tube with dried resin to a depth of .5cm 
(depending on the ability of the resin to swell). CD 2C12 was then added dropwise to 
the resin until it had swollen completely and a small amount ( - I mm) of CD2C12 
could be seen at the bottom of the NMR tube. 
Where gel phase NMR results are reported, full assignment of the resin-bound atoms 
has not been possible for two reasons. Firstly, quaternary carbons are usually too 
weak and broad to be observed clearly. Secondly, the broad aromatic and benzylic 
signals from the polymer backbone obscure many other signals. It is assumed that for 
atoms which have not been assigned, their corresponding signals are either too weak 
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to be observed or are obscured by the polymer backbone signals. 
General procedure: determination of free OH groups on resin. 9 
2 samples of resin in DCM were spotted onto a silica TLC plate: first 
hydroxymethylpolystyrene (positive control), followed by the resin to be studied. 
Both of the resin samples were spotted with a few drops of solution A followed by 2 
drops of solution B. The TLC plate was heated vigorously for 15 s, causing an 
orange colour to develop on both samples, that gradually faded to colourlessness. 2 
drops of solution C were then added: the positive control turned deep purple, and the 
samples studied varied between colourless and bright pink. 
Solution A: 0.03M p-toluenesulfonyl chloride in toluene. 
Solution B: 0.075M 4-p-nitrobenzylpyridine in toluene. 
Solution C: 10% v/v piperidine in chloroform. 
General procedure: TBAF cleavage of silyl resins 
TBAF (1M in THF, Seq.) was added to a stirring suspension of resin in DMF (5 ml). 
After heating at 80°C for 16h, filtration and concentration of the DMF solution gave 
crude product. TBAF was removed by passing the material through a short column 
of silica (ethyl acetate/hexane 1:1). 
Washing protocol 
The filtered polystyrene resin was washed according to the following procedure: 
THF (x 2), DMF (x 2), DMF/methanol 1:1 (x 2), DMF (x 2), THF (x 2), DCM (x 4). 
Plastic rather than glass pipettes were used to agitate resin as this avoids loss of the 
resin which sticks to glass. For washing the resin was transferred to an isolute tube 
and washed on a VacMaster 10 wash station. 
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Silyl linker synthesis 
4-methoxyphenyltrimethylsilane 76 
To a solution of 4-bromoanisole (0.50 g, 2.7 mmol) in THF under N 2 was added 
"butyllithium (2.06 ml of a 1.43M solution in hexane, 2.9 mmol) at -78°C with 
stirring. After two hours trimethylsilyl chloride (0.37 ml, 2.9 mmol) was added and 
cooling was removed. Stirring was continued overnight. Concentration under 
reduced pressure followed by chromatography on alumina (hexane) afforded 0.30 g 
(63%) of the desired product. 
Vmax  (liquid film) (cm) 3055 (alkyl CH), 1595 (Ar CC), 1102 (Si-0); 8 H (200 MHz, 
CDC13) 0.02 (9H, s, Si(CH3) 3), 3.52 (3H, s, OCH3), 6.65 (2 H, d, J=8Hz, Ar CH), 
7.21 (2 H, d, J=8Hz, Ar CH); O, (62.5MHz,CDC1 3) — 1.1 (SiCH3), 54.9 (OCH), 113.3 
(ArCH), 131.2 (Ar C), 134.6 (ArCH), 160.1 (Ar Q. 
Chloro-(4-methoxyphenyl) diisopropylsilane 77 
0 
Butyllithium (2.00 ml, 1.46M in hexanes, 2.9 mmol) was added dropwise to a 
solution of 4-bromoanisole (0.50 g, 2.8 mmol) in THF (2.50 ml) under argon at 
—78°C. After stirring for lh at —78°C, TLC (ethyl acetate/hexane 1:5) showed 
disappearance of starting material and a new spot at R f 0.26. 
Diisopropyldichlorosilane (0.53 ml, 0.0029 mol) was added and the mixture stirred 
for lh at —78°C. Cooling was then removed and the mixture left stirring overnight. 
Concentration of the sample and chromatography on alumina (ethyl acetate/hexane 
1:5) yielded 0.28 g (39%) of 77 as colourless low-melting crystals. 
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Rf (ethyl acetate/hexane 1:5) 0.31; Vmax  (film)/cm' 3402 (OH), 2945 & 2887 (alkyl 
CH), 1601 & 1512 (Ar CC), 1217 (Si-C), 1042 & 1007 (Si-C), 885 (Si-C), 850 (P-
disubstituted Ar-H), 794 & 688 (Si-O); 8 H (200 MHz, CDCL 3) 0.89 (61-1, d, J=7.2, Pr 
CH3), 0.97 (614, d, J=6.7, 'Pr cH3), 1.13 (214, m, 'Pr CH), 1.81 (0.88H, b, OH), 3.75 
(314, s, OcH3), 6.88 (2H, d, J=8.3, o-ArO), 7.46 (2H, d, J=8.3, o-ArSi); ö (63 MHz, 
CDC13) 12.3 ('Pr GH 3), 16.8 ('Pr GH3), 17.0 ('Pr CH), 54.8 (OGH 3), 113.3 (o-ArO), 
126.0 (i-ArSi), 135.4 (o-ArSi), 160.5 (i-ArO); m/z (APCi) 262 (M+Na), 239 (MW), 
221 (M-OH). 
Benzy1oxy-(4-methoxyphenyl) diisopropylsilane 78 
0" S1 
Butyllithium (1.50 ml, 1.47M in hexanes, 2.1 mmol) was added dropwise to a 
solution of 4-bromoanisole (0.36 g, 1.9 mmol) in THF (5.00 ml) under argon at 
—78°C. The solution was left stirring at —78°C for lh following which TLC (ethyl 
acetate/hexane 1:3) revealed disappearance of starting material. 
Diisopropyldichlorosilane (0.39 g, 2.1 mmol) was added and the solution was 
allowed to warm to RT. After stirring for 3h, it was injected into a solution of 
imidazole (0.13 g, 1.9 mmol) and benzyl alcohol (0.21 g, 1.9 mmol) in DCM (5 ml) 
under argon, and left stirring at RT for 60h. Inorganic byproducts of the reaction 
were removed by concentration of the solution, redissolving in hexane and filtration. 
Finally, removal of hexane by concentration under reduced pressure gave 0.24 g 
(38%) of 78, a colourless oil. 
vm (film)/cm' 2944 & 2865 (alkyl CH), 1595, 1564 & 1503 (Ar C=C), 1278 (Si-C), 
1068 (Si-O), 919 (Si-O), 882 (p-di substituted Ar-H), 812 (Si-C), 731 & 695 
(monosubstituted Ar-H); 8H  (200 MHz, CDC13) 0.95 (3H, d, J 9.0, 'Pr CH3), 1.08 
(3H, d, J 9.0, 'Pr H3), 1.20 (21-1, m, 'Pr CH), 3.70 (31-1, s, OH3), 4.80 (21-1, s, 
CH2Ph), 6.83 (2H, dd, J 6.6, 2.0, o-ArO), 7.26 (5H, m, Ph-If), 7.42 (21-1, dd, J 6.6, 
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2.0, o-ArSi); 8 c (63 MHz, CDC1 3) 12.1 ('Pr GB 3), 17.2 (Pr GH3), 17.4 ('Pr CH), 54.8 
(0GB3), 65.2 (CH2Ph), 113.3 (o-ArO), 124.7 (i-ArSi), 125.7, 126.7 & 128.1 (Ph GB), 
136.0 (o-ArSi), 141.2 (Ph C), 160.5 (i-ArO); m/z (El) 328 (Mt), 255 (M-'Pr), 91 
(PhCH2); found (El) M 328.18514, C2QH2802Si requires 328.18586. 
General procedure for the attempted ortholithiation of 78 
Butyllithium (1.5 eq.) was added dropwise under argon to a stirring solution of 
benzyloxy-(4-methoxyphenyl) diisopropylsilane 78 (1 eq.) and TMEDA (2 eq.) in 
THF at 0°C. The solution was stirred (2-6 h) following which the electrophile (1.5 
eq.) was added. The solution was left stirring overnight. The reaction mixture was 
then concentrated in vacuo, redissolved in hexane and filtered. Concentration of the 
resulting filtrate supplied the product. 
Electrophile 78 (g) Time before adding (h) Result 
DMF 0.100 4 Starting material 
(CB3)3 SiC1 0.050 2 Starting material 
Triphosgene 0.050 2 Starting material 
CO2 0.050 7 Starting material 
D20 0.050 7 79 
Benzyloxy-(4-methoxy-3-deuteriophenyl) diisopropylsilane 79 
0 -1 
Butyllithium (0.329 ml of a 1.39M solution in hexane, 0.23 mmol) was added 
dropwise under argon to a stirring solution of benzyloxy-(4-methoxyphenyl) 
diisopropylsi lane 78 (0.050 g, 0.15 mmol) and TMEDA (0.092 ml, 0.3 mmol) in 
THF (3 ml) at 0°C. The solution was stirred for six hours following which D 20 
(0.006 g, 3.0 x10 mol) was added. The solution was left stirring overnight. The 
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reaction mixture was then concentrated in vacuo, redissolved in hexane and filtered. 
Concentration of the resulting filtrate afforded 0.047 g (94%) of the deuterated 
product. 
oH (200 MHz, CDC1 3) 7.53, 7.51 (2H, m, Ar H ortho Si), 7.39 (5H, m, Ar CH), 6.93 
(1H, d, J=5Hz, o-OCH3 Ar-H), 4.87 (2H, s, benzylic CH 2), 3.84 (3H, s, OCH 3) 1.31 
(2H, sept, J=2.5Hz, 'Pr CH), 1.06 (12H, d, J=2.5Hz, 'Pr CH3); O (62.5MHz,CDC1 3) 
12.1 ('Pr CH 3), 17.2 ('Pr CH 3), 54.8 (OCH 3), 65.2 (CH2Ph), 113.4 (o-ArO), 124.6 (i-
ArSi), 125.7, 126.7 & 128.1 (Ph CH), 136.0 (o-ArSi), 141.2 (Ph C), 160.5 (i-ArO); 
mlz (El) 329 (Mt). 
(4-Bromophenyl)diisopropylsilyloxymethyl polystyrene 83 
J\ cXBr 
A solution of 4-dibromobenzene (3.71 g, 0.0157 mol) in THF (90 ml) was cooled to 
-78°C and °butyllithium (10.6 ml of a 1.63M solution, 17.3 mmol) was added 
dropwise with stirring. The solution was stirred at -78°C for 80 mm. 
Diisopropyldichlorosilane (3.11 ml, 17.3 mol) was added and cooling removed. The 
solution was immediately cannulated into a mixture of hydroxymethylpolystyrene 
(2.00 g, 1.74 mmol), imidazole (0.355 g, 5.22 mmol) and THF (30 ml). The reaction 
mixture was shaken at RT for 15 h. Washing according to protocol and drying under 
vacuum gave resin 83. 
vmax (dichloromethane)/cm' 1088 (Si-O), 810 (Si-Q. S  (63 MHz, CD2C12) 12.3 
(CH(CH3)2), 17.4 (CH(CH3)2), 40.6 (benzylic CH 2 of resin), 128.2 (Ar CH of resin), 
147.6 (Ar C of resin). Found Br 2.88% (loading = 0.36mmolg') 
Free OH test: no colour detected. 
Capping test: signal detected in ' 9F NMR. 
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Capping of 83 with trifluoroacetic anhydride 
To a suspension of 83 (0.200 g, 0.174 mmol) in dry DCM (1 ml), were added 
pyridine (0.16 ml, 2.1 mmol) and trifluoroacetic anhydride (0.16 ml, 1.0 mmol). 
After shaking overnight the resin was filtered, washed according to the standard 
protocol and dried under vacuum. 
6F (235 MHz, CD2C12) —77.86 (br s); ö (63 MHz, CD 2CL2) 12.2 (CH(CH 3) 2) 1  17.4 
(CH(CH3)2), 40.6 (benzylic CH 2 of resin), 70.6 (CF 3), 128.2 (Ar CH of resin), 147.6 
(Ar C of resin). 
Attempts to optimise (4-Bromophenyl)diisopropylsilyloxymethyl polystyrene 83 
formation. General procedure. 
A solution of 4-dibromobenzene in THF (20 ml) was cooled to —78°C and 
°butyllithium was added dropwise with stifling. The solution was stirred at —78°C for 
2 h. Diisopropyldichlorosilane was added and cooling removed. The solution was 
stirred at RT and then cannulated into a mixture of resin (0.200 g, 0.174 mmol), 
imidazole (0.0355 g, 0.522 mmol), DMAP (0.0063 g, 5.2x10 5 mol) and THF (3 ml). 
The reaction mixture was shaken at rt. Washing according to protocol and drying 
under vacuum gave the product resin. 
Rxn Amount Amount Time Time after Resin Free 
of BuLi* of after resin addn OH test 
'Pr2 SiC12 Pr2 SiC12 
addition 
SB17F 1.1 1.1 3h 16h 83 pale 
pink 
SB18F 1.1 2.2 2h 120h hydroxymethyl- bright 
polystyrene pink 
SB19F 3.3 3.3 2h 16h hydroxymethyl- pale 
polystyrene pink 




Attempt to form chioroformate on (4-Bromophenyl)diisopropylsilyloxymethyl 
polystyrene 83 
To a mixture of 83 (0.100 g, 8.70x10 5 mol) and triphosgene (0.232 g, 
0.348 mmol) under argon was added THF (3 ml) followed quickly by triethylamine 
(0.048 ml, 0.348 mmol). The mixture was shaken at RT for 16 h, then the THF 
solution was removed and the resin washed with 2x10 ml THE THF (3 ml) was then 
added to the resin followed by phenethylamine (0.109 ml, 0.870 mmol). After 
shaking for 44 h the resin was washed according to the standard protocol and dried. 
IR of the resin was identical to that of the starting material. 
Attempted synthesis of (4-Carboxyphenyl)diisopropylsilyloxymethyl 
polystyrene: typical example 
A suspension of 83 (0.350 g, 0.305 mmol) in THF (8 ml) under argon was cooled to 
—78°C and °butyllithium (0.791 ml of a 1.54M solution, 1.22 mmol) was added 
dropwise. The reaction mixture was left standing at —78°C for 1 h, following which a 
solution of triphosgene (0.813 g, 2.74 mmol) in THF (3 ml) was added with stirring. 
Cooling was removed and the mixture was shaken for 16 h. After washing (2x THF, 
2x DMF, 2x THF, 4x DCM), 3 ml of a 1:1 mixture of pyridine and water was added 
to the resin and the mixture shaken for 45 minutes. The resin was washed according 
to the standard protocol and suspended in 3 ml of 1:1 DMF/H 20 and the mixture was 
acidified to pH 4. After shaking for 1 h, the resin was washed again according to the 
standard protocol and dried under vacuum to give S1342F. 
Vmax  (dichloromethane)/cm' 1700 (w)(C0), 1088 (Si-O), 810 (Si-C). 
5B42F (0.100 g, 8.70x10 5  mol) was subjected to the standard cleavage conditions. 
No benzoic acid was detected by TLC or 'H NIMR. 
Attempted synthesis of (4Chlorocarbonylphenyl)diisopropylSilylOXyIflethY1 
polystyrene: typical example 
A suspension of 83 (0.200 g, 0.174 mmol) in THF (8 ml) under argon was cooled to 
—78°C and butyllithium (0.47 ml of a 1.57M solution, 0.700 mmol) was added 
dropwise. The reaction mixture was left standing at —78°C for 1 h, following which a 
110 
Experimental 
solution of triphosgene (0.465 g, 1.57 mmol) in THF (3 ml) was added with stirring. 
Cooling was removed and the mixture was shaken for 24 h. The resin was filtered, 
washed (2x THF, 2x DMF, 2x THF, 4x DCM) and dried under vacuum to give 
SB52F. 
Vrnax  (dichloromethane)/cm' 1771 (C=O), 1175 (Si-0). 
SB52F (0.050 g, 4.35x10 5 mol) was subjected to the standard cleavage conditions. 
No benzoyl chloride was detected by TLC or 'H NMR. 
Attempted reaction of N-(2-phenylethyl)benzamide and (4-
Carboxyphenyl)diisopropylsilyloxymethyl polystyrene 
Resin supposed to be (4-chlorocarbonylphenyl)diisopropylsilyloxymethyl 
polystyrene (above) (0.150 g, 0.130 mmol), DMAP (0.0048 g, 3.9x10 5 mol), 
phenethylamine (0.066 ml, 0.580 mmol) and DCM (4 ml) were rotated for 16 h. 
Filtration, washing according to the standard protocol and drying under vacuum 
afforded the product resin. 
Vmax  (dichloromethane)/cm' 1718 (C=O), 1082 (Si-0). 
SB54F (0.091 g, 7.92x10 5  mol) was subjected to the standard cleavage conditions. 
No SB46F was detected by TLC or 'H NMR. 
N-(2-phenylethyl)benzamide 
Benzoylchloride (0.25 ml, 2.2 mmol) was added dropwise to a solution of 
phenethylamine (0.30 ml, 2.4 mol) and triethylamine (0.50 ml, 3.6 mmol) in 
chloroform (10 ml). After stirring for 1 h, the reaction mixture was poured into 
chloroform (100 ml), washed with 3x HCl (70 ml, 0.2N) and H 20(100 ml), dried 
(Mg504) and concentrated in vacuo to give 0.50 g (92%) of the desired compound. 
Mp 112-113°C, lit 18 ' 114°C; 	(250 MHz, CDC13) 2.92 (2H, t, J 7.0, NHCH 2CH2), 
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3.69 (2H, dt, J 5.9, 7.0, NHCH2CH2), 6.38 (1H, br s, NH), 7.20-7.50 (8H, m, Ar-H), 
7.68-7.72 (2H, m, Ar-H); & (63 MHz, CDC1 3) 35.5 (N}TICH 2 CH2), 41.0 
(NHCH2CH2), 126.4, 126.7, 128.4, 128.5, 128.6 & 131.2 (Ar CH), 134.4 & 138.8 
(Ar C), 167.4 (C=O); m/z (El) 225 (M), 134 (M-C 6H5CH2), 105 (C6H5CO), 91 
(C6H5CH2), 77 (CH 5). 






83 (0.500 g, 0.49 mmol) was swelled in THF (6 ml) under argon. After cooling to - 
78°C, butyl1ithium (1.30 ml, 2.0 mmol) was added and the reaction stirred at —78°C 
for 1 h. DMF (0.378 ml, 4.9 mmol) was added and cooling removed. After shaking 
for 16h the resin was filtered and washed according to the standard protocol to give 
resin SB65C. 
vmax (DCM)/cm' 1701 (C0), 1080 (Si-0), 810 (Si-C). 
Attempted synthesis of (4-Chlorocarbonylphenyl)diisopropylsilyloxymethyl 
polystyrene via oxidation 
Novabiochem formyl resin (0.050 g, 1.7x10 5 mol) was swelled in the minimum 
volume of DCM (approx. 0.5 ml) under argon. Sulfuryl chloride (1 ml, 4.5 mmol) 
was added dropwise and the mixture shaken overnight. The resin was then filtered, 
washed according to the standard protocol and dried under vacuum. JR revealed no 
shift in the carbonyl stretch but the Si-0 stretch at 1080cm' was not present. 
vmax (DCM)/cm 1701 (C0). 
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4-Bromobenzoyl chloride 182 
Br 1 
Thionyl chloride (18.0 ml, 0.358 mol) was added dropwise to 4-bromobenzoic acid 
(10.3 g, 0.051 mol) to give a cloudy suspension, which on heating to 600  became 
clear. After stirring under reflux at 60 °C overnight, excess thionyl chloride was 
removed in vacuo, yielding 11.2 g (99%) of needle-like crystals. IR was obtained, 
and the product was used directly without further purification. 
Vmax  (dichloromethane)/cm' 3400 (acid OH), 1771 (acid chloride C=O), 1730 (acid 
C=O), 1568, 1504 (Ar C=C), 703 (C-CI), 641 (C-Br). 
Methyl (4-bromobenzoyl) glycinate 84 
Br 0 
Glycine methyl ester hydrochloride (5.54 g, 0.044 mol) was added with stirring to a 
solution of sodium bicarbonate (4.00 g, 0.048 mol) in water (160 ml). Gas was 
liberated. SB1A (11.2 g, 0.051 mol) was added as a solid and stirred for 5mm 
following which a colourless precipitate formed. Dioxane (50 ml) was added to aid 
dissolution, and the reaction was stirred overnight at RT. The resultant solution was 
extracted with ethyl acetate (3 x 100 ml). The organic portions were combined and 
washed with saturated sodium bicarbonate solution (150 ml), hydrochloric acid (150 
ml, 2M) and brine (150 ml). Drying (MgSO4) and concentration under reduced 
pressure gave an amorphous white solid, which was recrystallised from boiling ethyl 
acetate/hexane (1:1) to give 9.99 g (83%) of 84 as white crystals. 
Rf (ethyl acetate/hexane 1:1) 0.49; Mp 115.9-118.4°C; v(nujol)/cm' 3050 (amide 
NH), 1750 (ester C=O), 1646 (amide I), 1592 (Ar C=C), 1552 (amide II), 764 (p- 
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disubstituted Ar-H); 8 H (200 MHz, CDC13) 3.80 (3H, s, COOCH3), 4.23 (2H, d, J 5.8. 
CH2NH), 6.70 (1H, b, NH), 7.54 (2H, d, J 8.3 Ar-H), 7.66 (2H, d, J 8.3 Ar-H); & (63 
MHz, CDC13) 41.6 (Cl-I2), 52.3 (CH3), 126.4 (i-ArBr), 128.6 & 131.65 (Ar-H), 132.22 
(i-ArCO), 166.4 (CONH), 170.4 (COOCH 3); Found (FAB) MH 271.99214, 
C 10H 11N0379Br requires 27 1.99224. 
General procedure for the attempted lithiation of 84 
84 (0.685 g, 2.52 mmol) and any other additives were dissolved in THF under argon 
and cooled to —78 °C. "Butyllithium (2eq.) was added dropwise with stirring and the 
reaction mixture turned red. Stirring was continued for 15 mm, following which 
electrophile was added. Stirring was continued at —78°C and then at RT. TLC (ethyl 
acetate/hexane 1:1) showed decomposition in all cases. 
Electrophile Amount Additive Amount Time after Time after 
(eq) (eci) BuLi addition electrophile 
addition 
Pr2SiC12 1.1 None - 15 min io min @ -78°C, 
16h@RT 
'Pr2 SiC12 1.1 None - 15 min 64h @ RT 
Pr2SiCl2 1.1 TMEDA 2 15 min 30 min @ -78°C, 
16h@RT 
Me3 SiC1 2.4 KH 1.2 10 min 5 min @ RT 
Allyl 4-bromobenzoate 85 
Br 
Ally! alcohol (2.89 g, 0.050 mol), 4-bromobenzoic acid (1.00 g, 5 mmol) and 4-
toluenesulfonic acid (1.13 g, 6 mmol) were refluxed at 85°C for three hours. 
TLC (ethyl acetate/hexane 1:4) revealed disappearance of starting material. Excess 
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allyl alcohol was removed in vacuo, and the resulting residue was dissolved in ethyl 
acetate (100 ml), washed with saturated sodium bicarbonate solution (100 ml), dried 
(MgSO4) and concentrated in vacuo to give a brown oil. This was purified by column 
chromatography (ethyl acetate/hexane 1:2) giving 0.86 g (67%) of 85 as a colourless 
oil. 
Rf (ethyl acetate/hexane 1:4) 0.76; 8 H (200 MHz, CDC13) 4.75 (2H, ddd, J 5.5, 1.5, 
1. 1, COCH2) 5.24 (1H, ddt, J 13.9, 1.5, 1. 1, CH=CH2 cis to H), 5.31 (1H, ddt, J 17.2, 
11. 5, 1.5, CH=CH2 trans to H), 5.95 (1H, ddt, J 17.2, 13.9, 5.5, CH=CH2), 7.49 (2H, 
d, J 8.8, Ar-H), 7.83 (2H, d, J 9, Ar-I/); 8 c (63 MHz, CDC1 3) 165.4 (COO), 
131 .9(CH=CH 2), 131 .6(Ar-H), 131 .0(Ar-H), 129.0(i-ArBr), 128.0(i-ArCO), 
118.4(CH=CH 2), 65.6(COOCH 2); m1z242 ("Br M+), 240 (' 913r M+), 185, (81BrM-
CH2C(H)=CH 2) 183 (7913r M-CH2C(H)CH2), 157 (81 Br, C6H4Br) 155 (7913r, C6H4Br); 
Found (El) M'239.97866, C, 0H9027913r requires 239.97860. 
Attempted lithiation of 85 
A solution of 85 (0.697 g, 2.52 mmol) in THF (2 ml) under argon was cooled to - 
78°C and nbutyllithium (1.30 ml of a 1.94M solution in hexanes, 2.52 mmol) was 
added with stirring. A dark red/orange precipitate formed. Stirring was continued for 
15 min at —78°C following which diisopropyldichlorosilane (0.500 ml, 2.77 mmol) 
was added. After 20 min at —78°C cooling was removed and the reaction left stirring 
for 16 h. It was then dissolved in hexane, filtered and concentrated in vacuo. TLC 
(ethyl acetate/hexane 1:4) revealed spots for starting material, 4-bromobenzoic acid 
and another faster-running spot. Since 85 had proved to be unstable on silica the 
reaction mixture was distilled (35°C, 0.7mbar) and the distillate and residue 
examined in 'H NMR but both contained only mixtures of 85 and 4-bromobenzoic 
acid. 
Dehydroamino acid synthesis 
Effect of Erlenmeyer conditions on hydroxymethylpolystyrene 
Hydroxymethylpolystyrene (0.026 g, 6.89x10 6 mol), acetic anhydride (0.50 ml, 5.3 
mmol), sodium acetate (0.002 g, 2. 1x10 5 mol) and benzaldehyde (0.0022 g, 2. 1x10 5 
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mol) were heated for 16 h at 120°C. The resin was then filtered and washed 
according to the usual protocol. An attempt was made to obtain an JR of the resin but 
the resin beads were blackened and unswellable, so further analysis attempts were 
abandoned. 
General procedure for the synthesis of aldimines 
Aniline (1 ml, 0.011 mol), the aldehyde (0.011 mol) and toluene (20 ml) were heated 
with azeotropic removal of water for 16 h. The solution was then concentrated and 
the resultant dark brown solid was recrystallised to give the desired product. 





Benzaldehyde (2.28 g, 0.0215 mol) was added to aniline (2.00 g, 0.02 l5mmol) with 
vigorous stirring. After a few seconds heat was evolved, a gas was given off and 
solid formed. The mixture was stirred for a further 15 minutes and then added to 
95% ethanol. After standing at room temperature for 10 minutes and at 0°C for 30 
minutes the mixture was filtered and the resulting yellow crystals were washed with 
cold ethanol and dried to give 3.41 g (88%) of 89. 
Mp 49-49°C, lit 183 50-51°C; vmax (nujo1)/cm' 1629 (C=N), 1592, 1595, 1500 (Ar 
C=C), 765, 693 (monosubstituted Ar-H); 8 H (250 MHz, CDC13) 7.37 (8H, m, Ar-H), 
7.93 (2H, m, Ar-H), 8.48 (1H, s, N=CH); ö (63 MHz, CDC1 3) 120.7, 125.8, 128.6, 
128.8, 128.9 & 131.2 (Ar CH), 136.0 & 151.9 (Ar C), 160.2 (C=N); m/z (El) 181 






The general procedure outlined above was followed using 4-hydroxybenzaldehyde to 
give 0.75 g (35%) of the title compound after recrystallisation in boiling ethyl 
acetate/ethanol. 
Mp 196.9-200.4°C, lit 184 189.5-191°C; v max (fi1m)/cm' 2590 (H-bonded OH), 1602 
(Ar C=C), 1574 (imine C=N), 1514 (Ar C=C), 840 (p-disubstituted Ar-H), 759 & 
690 (monosubstituted Ar-H); 5 H (360 MHz, CDC13) 6.87 (2H, d, J 8.4, o-ArCN), 7.16 
(3H, m, Ph-H), 7.36 (2H, m, Ph-H), 7.76 (2H, d, J 8.4, o-ArO), 8.42 (1H, b, imine 
CH), 10.16 (0.8H, b, OH); & (63 MHz, DMSO) 115.8, 121.0 & 125.4 (Ar CH), 
127.6 (Ar C), 129.2 & 130.8 (Ar CH), 152.1 (Ar C), 160.1 (C=N), 160.8 (Ar C); m/z 





The general procedure outlined above was followed using 4-chlorobenzaldehyde to 
yield 0.50 g (21%) of the title compound after reciystallisation in ethyl acetate. 
Mp 51-53 0C, lit"' 63-64°C; v max (film)/cm' 1622 (imine C=N), 1590 (Ar C=C), 875 
(C-Q, 829 (p-disubstituted Ar-H), 761 & 696 (monosubstituted Ar-H); 6 H (200 
MHz, CDC13) 7.22 (2H, d, J 8.4, o-ArC1), 7.38 (5H, m, Ph-H), 7.84 (2h, d, J 8.4, o- 
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ArCN), 8.42 (11-1, s, imine Cl]); 6 (63 MHz, CDC1 3) 120.7, 126.1, 128.9, 129.1 & 
129.3 (,Ax CH), 134.5, 137.2 & 151.4 (Ar C), 158.7 (NCH); m/z (El) 217 (37C1-M), 
215 (35Cl-M), 104 (Ph-N=CH), 77 (Ph); Found (El) 215.05023, C 13H 10N35C1 requires 
215 .050 18. 
General procedure for the synthesis of ketimines 
Amine (leq.), ketone (leq.), toluene and catalyst were heated with azeotropic 
removal of water. In each case the reaction was continued until TLC showed no 
improvement in the conversion to imine. 
In all cases except 105, the pure product was obtained by hexane/acetonitrile 
extraction in which the reaction mixture was filtered, concentrated in vacuo and 
dissolved in hexane (approximately 100 ml per gram of product). The hexane was 
then washed three times with acetonitrile (20 ml per gram of product) and 
concentrated under reduced pressure to give the imine. 105 was obtained by 
filtration, concentration of the toluene solution and trituration with MTBE. In all 
cases the imines were characterised and used without further purification since they 
are all unstable to silica. 
All ketimines except 107 and 108 were synthesised in this way. 
N-(phenyl)phenylmethylideneamine 103 
N ° 
According to the procedure outlined above, aniline (6.38 ml, 0.068 mol), 
acetophenone (8.00 ml, 0.068 mol) titanium tetrachloride (0.10 ml of a 1M solution 
in DCM, 0.1 mmol) and toluene (80 ml) were heated for 44 h. Purification as above 
yielded 4.75 g (3 5%) of waxy yellow crystals. 
Mp 33-36°C, lit 186 40-41°C; oH (400MHz, CDC1 3) 2.20 (31-1, s, CH3), 6.74-6.80 (211, 
118 
Experimental 
m, Ar-H), 7.11-7.20(111, m, Ar-H), 7.30-7.39 (2H, m, Ar-H), 7.41-7.48 (3H, m, Ar- 




According to the procedure outlined above, 4-chloroaniline (8.25 g, 0.064 mol), 4-
bromoacetophenone (12.87 g, 0.064 mol) titanium tetrachloride (0.20 ml of a 1M 
solution in DCM, 0.2 mmol) and toluene (100 ml) were heated for 88 h. Purification 
as above yielded 5.61 g (29%) of a yellow oil. 
6H (400 MHz, CDC1 3) 2.18 (1.27h, s, NCCH3), 
2.20*  (1.2811, s, NCCH3), 6.67-6.89 
(2H, m, Ar-H), 7.13-7.60 (611, m, Ar-H), 7.78-7.89 (2H, m, Ar-H). 
N-(4-chlorophenyl)-1-(4-methylphenyl)ethylideneamine 105 
N hl 
According to the procedure outlined above, 4-chloroaniline (10.00 g, 0.078 mol), 4-
methylacetophenone (10.52 ml, 0.078 mol) titanium tetrachloride (0.20 ml of a 1M 
solution in DCM, 0.2 mmol) and toluene (100 ml) were heated for 16 h. Purification 
as above yielded 7.08 g (29%) of a yellow oil. 
6. (400 MHz, CDC1 3) 2.27 (311, s, C6H4CH3), 2.34 (311, s, N=CCH3), 6.77-7.18 (6H, 
m, Ar-H), 7.73-7.77 (2 H, m, Ar-H); O (63 MHz, CDC1 3) 18.9 (C6H4 CH3), 21.0 
(N=CCH3), 122.0, 125.5, 128.2 & 128.5, (Ar CH) 138.0, 141.0 & 149.9 (Ar C), 
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167.2 (C=N); m/z (El) 245 (37C1 M), 243 ("Cl Mt), 230 (37C1 M-CH 3), 228 ("Cl M-
CH3), 129 (37C1C6H4N), 127 (35C1C6H4N); Found (El) ( 35C1 M) 243.08 156, 
C 15H 14NC1 requires 243.08 148. 
N-(phenyl)-1-(4-chlorophenyl)propylideneamine 106 
C 
According to the procedure outlined above, aniline (3.13 g, 0.034 mol), 4-
chloropropiophenone (6.00 g, 0.035 mol), pTSA (0.001 g, 7.6x10 6 mol) and toluene 
(35 ml) were heated for 48 h. Purification as above yielded 2.01 g (25%) of orange 
solid. 
Mp 4953°C, v a (nujol)/cm 1 2725 (alkyl CH), 1634 (C=N), 1591 (Ar C=C), 770 & 
696 (monosubstituted Ar-H), 743 (C-Cl); 5 H (250 MHz, CDC1 3) 1.22' (1.1H, t, J 7. 1, 
CH2CH3), 1.67 (1.9H, t, J 7.7, CH 2CH), 2.62 (1.47H, q, J 7.7, CH2CH3), 2.97' 
(0.52H, q, J 7.2, CH2CH3), 6.79 (2H, d, J 8.7, C 6H4), 7.38 (5H, m, C6H5), 7.87 (2H, d, 
J 8.4, C6H4); O (63 MHz, CDC13) 8.0*  (CH2 CH3), 12.7 CH2 CH3), 23.2 CH2CH3), 
31.6' CH2CH3), 114.9 (Ar C), 118.4, 123.0, 128.5, 128.7 & 128.9 (Ar CH), 136.2, 
136.3' & 151.1 (Ar C), 169.4 (C=N); m/z (FAB) 244 (MH), 214 (M-CH2CH3), 132 





To a flame-dried flask under argon containing activated 3A molecular sieves were 
added 2-butanone (2 ml, 0.022 mol), aniline (2.12 ml, 0.023 mol) and toluene (70 
ml). The mixture was stirred gently for 16 hours. Decanting off the molecular sieves 
and concentrating the toluene solution gave the crude product, which was distilled at 
reduced pressure to yield 1.65 g (50%) of 107 as a yellow oil. 
Rf (ethyl acetate/hexane 1:1) 0.95; Bp 24°C (2.5 mmHg), lit 176 100°C (30nmiHg); 
vmax (fi1m)/cm' 3053 (aryl H stretch), 2983 (alkyl CH), 1661 (imine C=N), 1602, 
1499 & 1490 (Ar C=C), 1450 (alkyl CH deformations), 737 & 703 (monosubstituted 
Ar-H); 8H(360 MHz, CDC13) 1.04*  (0.81H, t, J 7.7, CH3CH2), 1.21 (2.19H, t, J 7.3, 
CH3CH2), 1.76 (2.19H, s, CH3C=N), 2.13* (0.58H, q, J 7.7, CH3CH2), 2.16*  (0.81H, 
s, CH3CN), 2.43 (1.52H, q, J 7.3, CH 3CH2), 6.69 (2H, m, Ar-H), 7.07 (1H, m, Ar-
II), 7.28 (2H, m, Ar-If); O (63 MHz, CDC1 3) 10.4 (CH3CH2), 11.5* (CH3CH2),  19.0* 
(CH3C=N), 25.2 (CH3C=N), 27.1*  (CH3 CH204.4 (CH3CH2), 114 . 9* , 118.3*, 119.3, 






4-bromobenzophenone (2.00 g, 7.65 mmol), heptamethyldisilazane (1.34 g, 7.65 
mmol) and zinc chloride (0.052 g, 0.38 mmol) were heated at 70°C in a sealed vessel 
for 72 h. The resultant brown oil/gum was dissolved in DCM, filtered and 
concentrated to give 1.92 g of a brown solid which 'H NMR revealed to be a 1.09:1 
mixture of ketone and imine, giving 0.94 g (45%) of the desired compound. The 
crude mixture was used without further purification. 
vm. 	2582 (alkyl CH), 1661 (C=O), 1647 (C=N), 1586 & 1500 (Ar CC), 
841 & 827 (p-disubstituted Ar-H), 778 & 737 (monosubstituted Ar-H), 694 (C-Br); 
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According to the procedure outlined above, aniline (15.18 ml, 0.17 mol), 2,4-
dimethylpentan-3-one (25.03 ml, 0.18 mol), pTSA (0.060 g, 0.3 mmol) and toluene 
(70 ml) were heated for 19 h. Purification as above yielded 3.62 g (11%) of a dark 
orange oil. 
Vmax  (film)/cm' 2963-2871 (alkyl CH), 1652 (C=N), 771 (monosubstituted Ar-H); oH 
(360 MHz, CDC13) 1.06 (6H, d, J 6.8, CH(CH3)2), 1.24 (6H, d, J 6.8, CH(CH3) 2), 
2.82 (2H, sept, J6.8, CH(CH3)2), 6.68 (2H, m, m-ArN), 7.03 (1H, m,p-ArN), 7.30 
(2H, m, o-ArN); O (63 MHz, CDC1 3) 20.2 (CH(CH 3)2), 22.9 (CH(CH 3)2), 30.1 
(CH(CH3)2), 30.4 (CH(CH 3) 2), 119.4, 122.8 & 129.2 (Ar CH), 151.9 (Ar C), 184.2 
(C=N); m/z (FAB) 190 (MW), 146 (M-'Pr), 77 (C 6H5) Found (FAB) MH 190.15934, 
C 13H20N requires 190.15958. 
General procedure: synthesis of oxazolones 
Coupling agent was added to a suspension of hippuric acid in DCM. When the 
reaction mixture turned clear after approx. 1 h, imine was added and the mixture 




The general procedure was followed using hippuric acid (0.100 g, 0.558 mmol), 
EDCI (0.420 g, 2.19 mmol), 89 (0.084 g, 4.64 mmol) and DCM (5 ml). On 
completion the reaction mixture was poured into DCM (50 ml) and washed with sat. 
NaHCO 3 (20 ml) and water (20 ml), dried (MgSO 4) and concentrated in vacuo to 
give 0.078 g (67%) of 92 as a yellow solid. 
Mp 163165°C, lit72 165°C Vmax (film)/Cm' 1800 (CO), 1660 (C=N), 1590 (C=C), 
880 (alkene CH), 770, 720 (monosubstituted Ar-H); 5H (250 MHz, CDC13) 7.18 (1H, 
s, C=C(H)Ph), 7.48 (7H, m, Ar-H), 8.12 (3H, m, Ar-H); o (63 MHz, CDC1 3) 125.5 
(CCH), 128.3, 128.8, 128.9, 131.1, 131.7 & 132.3 (Ar CH), 133.2 (C=CH), 133.4 
(Ar C), 163.4 (C=N), 167.5 (C=O); m/z (El) 250 (MH), 249 (Mt), 105 
(Ph(H)C=C(N)H), 77 (Ph). Found (FAB) M 249.07898, C 16H 1 1 NO2 requires 
249.07898. 
Synthesis of 92 via benzaldehyde 
EDCI (0.357g, 1.86 mmol) was added to a suspension of hippuric acid (0.200g, 1.11 
mmol) in DCM (5m!). When the reaction mixture turned clear after approx. 1 h, 
benzaldehyde (0. 100g, 9.3 1x10mol) was added and the mixture heated at 53°C for 
24 hours. Column chromatography (ethyl acetate/hexane 1:9) yielded 0.045g (19%) 
of the desired product as a yellow powder. 




The general procedure was followed using hippuric acid (0.130 g, 0.72 mmol), EDCI 
(1.56 g, 1.32 mmol), 90 (0.800 g, 0.65 mmol) and DCM (10 ml). On completion the 
reaction mixture was poured into DCM (40 ml) which was washed with 2x KHSO 4 
solution (25 ml, 0.2M) and dried (MgSO4). Concentration of the DCM in vacuo gave 
a bright yellow amorphous solid which was further purified by flash column 
chromatography (ethyl acetate/hexane 1:4) yielding 0.105 g (55%) of a yellow 
powder. 
Mp 206-207, lit"' 221°C; oH (200 MHz, CDC13) 5.24 (1H, s, C=CH), 5.60 (1H, br 5, 
OR), 6.89 (2H, d, J 8.5, C6H4OH) , 7.18 (2H, d, J 8.5, C 6H40H), 7.40-7.60 (3H, m, 
C6H5), 8.11 (2H, d, J 8.2, C6115); O (63 MHz, CDC13) 115.2 (Ar CH), 124.8 & 125.1 
(Ar C), 126.9 & 128.2 (Ar CH), 129.6 (Ar C), 130.7 (Ar CH), 132.2 (C=CH), 134.1 
(Ar CH), 159.9 (C=CH), 161.3 (C=N), 166.3 (C=O); m/z (FAB) 265 (M), 105 
(C6H5CO), 77 (C6H); Found (FAB) (M) 265.07469, C, 6H, 1 NO3 requires 265.07389. 
4((Z)-4-Chlorobenzylidene)-2-phenyloxazol-5(411)-one 94 
CI 
The general procedure was followed using hippuric acid (0.456 g, 2.55 mmol), EDCI 
(0.889 g, 4.64 mmol), 91 (0.500 g, 2.32 mmol) and DCM (10 ml). On completion the 
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reaction mixture was poured into DCM (20 ml) which was washed with 2x KHSO 4 
solution (10 ml, 0.3M) and dried (MgSO4). Concentration in vacuo gave a yellow 
solid, which was further purified by flash column chromatography (ethyl 
acetate/hexane 1:10) yielding 0.244 g (3 7%) of a yellow solid. 
Mp 210-21 1°C, lit"' 197-198°C; 5 H (250 MHz, CDC13) 7.18 (1H, s, CCH), 7.41-
7.63 (5H, m, C6H5), 8.08-8.19 (4H, m, C 6H4C1); 8 (63 MHz, CDC1 3) 125.3 (C=CH), 
128.3, 128.9, 129.1 & 131.9 (Ar CH), 132.0 (Ar C), 133.4 (Ar CH), 137.2 (Ar C), 
149.5 (CO), 151.0 (C=CH), 164.0 (C=N); m/z (FAB) 286(37C1 MH), 284 (35 C1 
MH), 105 (C6H5CO), 77 (C6H); Found (FAB) (35C1 MH) 284.04790, C, 6H 11NO2C1 
requires 284.04784. 
4-(1 -Phenyl)ethylidene-2-phenyloxazol-5(411)-one 110 
The general procedure was followed using hippuric acid (3.74 g, 0.0209 mol), DCC 
(7.84 g, 0.0380 mol), 103 (3.70 g, 0.0190 mol), and DCM (50 ml). On completion 
the reaction mixture was filtered over Celite®, washing with DCM (100 ml). The 
DCM solution was washed with 4x KHSO4 solution (100 ml, 0.3M) and dried 
(MgSO4). Concentration of the DCM in vacuo gave a dark orange oil. Flash column 
chromatography (ethyl acetate/heptane 1:20) gave 1.12 g of Z isomer and 2.18 g of a 
2.1:1 mixture of Z and E isomers so that in all, 3.30 g (67%) of a 3.7:1 mixture of Z 
and E isomers was obtained. 
Z isomer 
Mp 98-101°C, lit" 104°C; Vmax (nUjo1)/cm 1783 (C=O), 1758 (C=N), 777 & 701 
(monosubstituted Ar-H); 8 H (250 MHz, CDC1 3) 2.79 (3H, s, CH3), 7.49 (6H, m, Ar-
I-f), 7.87 (2H, m, Ar-If), 8.05 (2H, m, Ar-If); O (63 MHz, CDC1 3) 18.2 (CH3), 125.6 
(Ar C), 127.8 (Ar CH), 127.9 (Ar CH), 128.6 (Ar CH), 128.8 (Ar CH), 131.0 (Ar C), 
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132.5 (Ar cl-I), 138.7 (C=C(CH 3)Ph), 149.1 (CCCO 2CH3), 160.2 (CO), 166.6 
(C=N); m/z (El) 263 (M), 105 (PhCO), 77 (Ph); Found (El) M 263.09393, 
C 17H 13NO2 requires 263.09463; Found C 77.35% H 4.32% N 5.27%, C 17H 13NO2 
requires C 77.55%, H 4.98%, N 5.32%. Crystal structure was obtained (see 
appendix). 
2.1:1 mixture ofZand E isomers 
8H (250 MHz, CDC13) 
2.68*  (0.97H, s, CH3), 2.81 (2.03H, s, CH3), 7.41-7.62 (7H, m, 
Ar-If), 7.83-8.15 (3H, m, Ar-If). 
4-(1-Phenyl)ethylidene-2-phenyloxazol-5(411)-one 110 for hydrolysis - typical 
procedure 
As above, the general procedure was followed using hippuric acid (7.49 g, 0.0420 
mol), DCC (15.7 g, 0.0760 mol), 103 (7.42 g, 0.038 mol) and DCM (100 ml). On 
completion the reaction mixture was washed according to the procedure, 
concentrated in vacuo and used without further purification. 
4-(1-(4-Bromophenyl)ethylidene)-2-phenyloxazol-5(411)-one 111 
The general procedure was followed using hippuric acid (3.57 g, 0.0200 mol), DCC 
(7.49 g, 0.0362 mol), 104 (5.60 g, 0.0180 mol), and DCM (80 ml). On completion, 
the reaction mixture was filtered over celite and the celite washed with DCM (100 
ml). The DCM solution was washed with 2x KHSO4 solution (100 ml, 0.3M) and 
dried (MgSO4). Concentration of the DCM in vacuo gave a dark orange oil which 
was used without further purification. 
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4-(1-(4-Methylphenyl)ethylidene) 2-phenyloxazol-5(4H)-one 112 
The general procedure was followed using hippuric acid (4.85 g, 0.0270 mol), DCC 
(10.16 g, 0.0490 mol), 105 (6.60 g, 0.0250 mol), and DCM (100 ml). On completion 
the reaction mixture was filtered over celite and the celite washed with DCM (100 
ml). The DCM solution was washed with 2x KHSO4 solution (100 ml, 0.3M) and 
dried (MgSO4). Concentration of the DCM in vacuo gave a brown oil which was 
used without further purification. 
4-(1-(4-Chlorophenyl)propylidene) 2-phenyloxazol-5(411)-one 113 
The general procedure was followed using hippuric acid (0.687 g, 3.84 mmol), EDCI 
(1.34 g, 6.97 mmol), 106 (0.850 g, 3.49 mmol), and DCM (70 ml). Concentration of 
the reaction mixture in vacuo gave a yellow oil. Flash column chromatography on 
alumina (ethyl acetate/hexane 1:10) afforded 0.567 g (52%) of pale yellow crystals. 
Mp 71-76°C; v ma,, (nujol)/cm' 2850 (alkyl CH), 1793 (C=O), 1762 (C=N), 1639 
(C=C), 1589&1500 (Ar C=C), 828 (p-disubstituted Ar-H), 778 (monosubstituted Ar-
H), 722 & 700 (C-Cl); 8 H (250 MHz, CDC1 3) 1.14(0.73H, t, J 7.6, CH 2CH3), 1.21 
(2.27H, t, J 7.5, CH2CH3), 3.11(0.44H, q, J 7.6, CH2CH3), 3.31 (1.56H, q, J 7.5, 
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CH2CH3), 7.42-7.56 (5H, m, C6H5) , 7.79 (2H, d, J 8.4, C6H4), 8.08 (2H, d, J 8.4, 
C6H4); & (63 MHz, CDC13) 12.6'( CH2 CH3), 13.5 (CH2 CH3), 24.3 (CH2CH3), 29.0* 
(CH2CH3)
1 
 125.6 (N-C=C), 125.7* (N-C=C), 127.8, 128.3, 128.4', 128.7*,  129.2' & 
129.6'(Ar CH), 130.9 (N-C=C), 131.2,131.4 - & 132.7 (Ar CH), 134.2' (Ar C), 
135.2' (Ar CH), 135.6 (Ar C), 135.7 (Ar CH), 154.0 (Ar C), 155.8' (Ar C), 160.7 
(C=N), 161.1' (C=N), 164.2' (C0), 165.9 (C=O) ; m/z (FAB) 314 (37C1 MH), 313 
(37C1 Mi), 312 (35C1 MH), 311 (35C1 M), 105 (C6H5CO), 77 (CA) ; Found (FAB) 
(35Cl MH) 3 12.07820, C 18H 15NO2C1 requires 312.07914. 
Attempted synthesis of 4-(Diisopropylidene) 2-phenyloxazol-5(4H)-one 114 
The general procedure was followed using hippuric acid (0.520 g, 2.91 mmol), EDCI 
(1.01 g, 5.28 mmol), 109 (0.500 g, 2.64 mmol), and DCM (50 ml). After heating for 
72 h only starting material was identified by TLC, and distillation under reduced 
pressure yielded 0.423 g (85% recovery) of 109. 
4-(1-(4-Bromophenyl)benzylidene) 2-phenyloxazol-5(4H)-one 115 
YN O  
The general procedure was followed using hippuric acid (0.317 g, 1.77 mol), EDCI 
(0.618 g, 3.22 mol), 108 (0.900 g of crude mixture, estimated 1.61 mmol), and DCM 
(30 ml). Concentration of the reaction mixture in vacuo gave a yellow oil. Flash 
column chromatography (ethyl acetate/hexane 1:5) gave 0.486 g (75%) of bright 
yellow crystals. 
Mp 64-65°C; Vmax (flUO 1)/Cfli ' 2850 (alkyl CH), 1798 (C=O), 1634 (C=N), 1590 
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(C=C), 1578 & 1506 (Ar C=C), 865 (p-disubstituted Ar-H), 755 & 721 
(monosubstituted Ar-H), 699 (C-Br); 5H (250 MHz, CDC1 3) 7.22 (2H, d, J 8.4, 
C6H4Br), 7.45 (10H, m, C6H5), 8.11 (2H, d, J 8.4, C 6H4Br); O (63 MHz, CDC1 3) 
126.0 (N-C=C), 128.0 (N-C=C), 128.9, 129.3, 130.4, 130.9 w , 131.9 - 132.0, 132. 1, 
132.6* & 133.1 (Ar CH), 136.7, 137.6, 149.2 & 163.0 (Ar C), 165.9 (CN), 196.1 
(CO); m/z (FAB) 406 ("Br MH), 404 (79Br MH); Found (79Br MH) 404.08272, 
C22H 15NO2Br requires 404.02863. 
4-(1 -methyl)propylidene-2-phenyloxazol-5(4ll)-Ofle 116 
The general procedure was followed using hippuric acid (1.26 g, 7.05 mmol), EDCI 
(2.46 g, 1.28 mmol), 107 (0.942 g, 6.40 mmol), and DCM (100 ml). Concentration of 
the reaction mixture in vacuo gave a yellow oil. Flash column chromatography (ethyl 
acetate/hexane 1:4) afforded 1.06 g (77%) of a yellow gum. 
V max (film)ICm' 1792 (C=O), 1665 (C=N), 1596, 1571 & 1494 (Ar C=C), 1376 (C-
0), 777 & 701 (monosubstituted Ar-H); OH (250 MHz, CDC1 3) 1.21 (1.5H, t, J 7.5, 
CH2CH3)1 1.23* (1.5H, t, J 7.6, CH2CH3) , 2.37 (1.5H, s, C=CCH3), 2.43 (1.5H, s, 
C=CCH3), 2.79*  (1H, q, J 7.6, CH2CH3), 2.90 (1H, q, J 7.5, CH2CH3), 7.53 (3H, m, 
Ar-H), 8.08 (2H, m, Ar-H); 8 (63 MHz, CDC13) 12.1*  (CH2 CH3), 12.2 (CH 2 CH3), 
17.1* (C=CCH3), 20.0 (C=CCH3), 25.9* (CH2CH3), 28.9 (CH 2CH3), 125.9 k & 126.0 
(Ar C), 127.4',127.5, 128.6,132.1* & 132.2 (Ar CH), 158.6*  (N-C=C), 159.0 (N-
C=C), 159.2* (N-CC), 159.4 (N-CC), 164.9 (C=0), 165.6 (C=N); m/z (FAB) 216 
(MW), 215 (Md), 105 (C6H5CO), 77 (CA); Found (FAB) (M) 216.10246, 
C 13H 13NO2 requires 216.10246. 
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General procedure: methanolysis of oxazolones 
The oxazolone was added to a stirring solution of sodium methoxide in methanol, 
turning the solution yellow. The reaction mixture was stirred until the yellow colour 
disappeared and TLC (ethyl acetate/hexane 1:4) confirmed that the reaction had gone 
to completion (typically 10 min to 1 h). 
In the earlier reactions the methanol solution was acidified to pH 5 before 
concentrating in vacuo. The crude material obtained was dissolved in DCM, washed 
with water, dried (MgSO 4) and concentrated in vacuo to give a product which was 
further purified by flash column chromatography. In the later reactions the methanol 
solution was simply concentrated and the product purified by flash column 
chromatography. 
Methyl (E/Z)-2-benzamido-3-phenylbut-2-enoate 96— typical procedure 
HI 
The general procedure was followed using pure Z isomer of 110 (0.827 g, 3.14 
mmol), sodium methoxide (0.017 g, 0.314 mmol) and methanol (20 ml). The 
reaction mixture was concentrated, washed as described and purified by flash 
column chromatography (ethyl acetate/heptane 1:4) giving 0.463 g (50%) of product. 
'H NMR shows that this is a 7:1 mixture of isomers. Recrystallisation from boiling 
hexane/ethyl acetate supplied a small amount of pure Z isomer. 
Mp 138-139°C, lit 87 147-149°C; 8H  (200 MHz, CDC13) 2.39 (31-1, s, CCCH3), 3.92 
(311, s, COOCH3), 7.08-7.63 (Ar-H). Crystal structure was obtained (see appendix). 
The general procedure was followed using the 2.5:1 Z:E mixture obtained from 110 
(1.00 g, 3.80 mmol), sodium methoxide (0.020 g, 0.38 mmol) and methanol (25 ml). 
The reaction mixture was concentrated, washed as described and purified by flash 
column chromatography (ethyl acetate/heptane 1:4 followed by ethyl acetate/heptane 




v.. (nujol)/cm- ' 1713 (ester C0), 1641 (amide C=O), 1514 (Ar C=C), 777 & 700 
(monosubstituted Ar-H) H  (250 MHz, CDC13) 1.76 (1H, b, NH), 2.22' (1.37H, s, 
C=CCH3), 2.39 (1.62H, s, C=CCH3) 3.50' (1.37H, s, OCH3), 3.90 (1.62H, s, OCH3), 
7.16-7.61 (10H, m, Ar-I-I); 8 (63 MHz, CDC1 3) 20.4 (CCCH3), 52.1 (COUCH3), 
123.6 (Ar C), 126.9, 127.3, 128.2, 128.5, 128.8 & 131.8 (Ar CH), 132.9 (Ar C), 
137.2 (C=CCH3), 139.5 (C=CCH3), 165.5 (COUCH3), 165.6 (CONH); m/z (FAB) 
296 (MH), 295 (M), 264 (M-OCH 3) 1  190 (M-C6H5CO), 105 (C6H5CO), 77 (C6H5); 
Methyl (E/Z)_2-benzamido-3-(4-chlorophenyl)pent-2-eflOate 99 
Ck 
r N 	ON-,, 
The general procedure was followed using 113 (0.300 g, 0.962 mmol), sodium 
methoxide (0.0104 g, 0.192 mmol) and methanol (8 ml). Concentration of the 
methanol solution and chromatography on alumina (ethyl acetate/hexane 1:50) gave 
0.150 g (45%) of the desired compound as a white solid. 
Mp 114-115°C; V(flujo1)/cm' 3250 (NH), 2850 (alkyl CH), 1723 (ester C=0), 
1643 (amide I), 1600 & 1579 (Ar C=C), 1510 (amide II), 829 (p-disubstituted Ar-H), 
770 (monosubstituted Ar-H), 720 (C-CI), 695 (monosubstituted Ar-H); 6 H (250 
MHz, CDC13) 0.99' (0.69H, t, J 7.6, CH 2CH3), 1.04 (2.31H, t, J 7.4, CHCH3), 2.58' 
(0.45H, q, J 7.6, CH2CH3), 2.66 (1.52H, q, J 7.6, CH2CH3), 3.50' (0.67H, s, OCH3), 
3.88 (2.23H, s, OCH3), 7.13-7.62 (9H, m, Ar-H); O (63 MHz, CDC1 3) 12.0' 
(CH2 CH3), 13.2 (CH2 CFI3), 27.6 (CH2CH3), 28.2' (CH2CH3), 52.4' (OCH3), 52.7 
(OCH3), 124.4, 127.5, 127.8', 128.7, 129.2', 129.4, 129.6, 129.9, 132.5 & 132.6' (Ar 
CH), 133.4 (N-C=C), 133.7 (N-C=C), 134.0,134.6% 136.9,138.1% 141.6 & 145.3' 
(Ar C), 165.8 (COUCH 3), 165.9 (CONH), 166.1' (CONH); m/z (FAB) 346 (37C1 
MH), 345 (37C1 M), 344 (35C1 MH), 343 (35C1 Mt), 314 (37C1 MH-OCH3), 313 (37C1 
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M-OCH3), 312 ("Cl MH-OCH 3), 311 (35Cl M-OCH3), 240 (37C1 M-C6H5CO), 238 
(35C1 M-C6H5CO), 105 (C 6H5CO), 77 (C6H5); Found (FAB) ( 35C1 MH) 344.10560, 
C, 9H, 9NO3 requires 344.10535. 
Methyl (E/Z)-2-benamido-3-methyl-pent-2-enoate 100 
Cf 
 çço 
The general procedure was followed using 116 (0.301 g, 1.40 mmol), sodium 
methoxide (0.0151 g, 0.280 mmol) and methanol (8 ml). Concentration of the 
methanol solution and chromatography (ethyl acetate/hexane 4:1) afforded 0.245 g 
(71%) of the title compound, a white solid. 
Mp 122-123°C, lit .. 158°C; vmax (film)/cm' 2923 (alkyl CH), 1723 (ester C=O), 1635 
(amide I), 1601 & 1579 (Ar C=C), 1518 (amide II), 767 & 702 (monosubstituted Ar-
H); 8H(250 MHz, CDC1 3) 1.06 (1.55H, t, J 7.6, CH2CH3), 1.13*  (1.45H, t, J 7.6, 
CH2CH3), 1.88*  (1.63H, s, CCCH3), 2.16 (1.37H, s, CCCH3), 2.25 (1.1H, q, J 7.6, 
CH2CH3), 2.56*  (0.9H, q, J 7.6, CH2CH3), 3.73 & 3•74* (3H, s, two signals not 
resolved, OCH3), 7.47 (4H, m, Ar-H), 7.86 (2H, m, Ar-H); ö, (63 MHz, CDC1 3) 11.4 
(CH2CH3), 12.6*  (CH2 CH3), 18.4 (C=CCH3), 19.7*  (C=CCH3),  27.5*  (CH2CH3), 28.4 
(CH2CH3), 51.7 (OCH3)
1 
 120.6 (NC=C), 120.8 (NC=C), 127.1, 128.4 & 131.6 (Ar 
CH), 133.7 & 133.8* (Ar 6), 150.3*  (COOCH 3), 150.6 (COOCH3), 165.8*  (CONH), 
166.4 (CONH); m/z (FAB) 248 (MW), 216 (M-OCH 3), 188 (M-COOCH 3), 142 (M-
COUCH3 , C6H5CO), 105 (C6H5CO), 77 (C6H); Found (FAB) (MW) 248.12870, 
C 14H 18NO3 requires 248.12867. 
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Methyl (E/Z)-2-benzamido-3-(4-bromophenyl)but-2-enoate 101 
Br 
cicb o 
The general procedure was followed using 115 (0.358 g, 0.886 mmol), sodium 
methoxide (0.019 g, 0.355 mmol) and methanol (150 ml). The reaction was 
monitored by TLC (ethyl acetate/heptane 1:4) and as the reaction progressed, a fast 
running spot appeared and increased in intensity. On complete disappearance of 
starting material, the reaction mixture was concentrated and purified by 
chromatography (ethyl acetate/heptane 1:4) to give 0.205 g (57%) of the desired 
product and 0.098 g of the higher running product, which was identified as 4-
bromobenzophenone by 'H NMR. 
Mp 152-153°C; v x (nujo1)/cm' 1732 (ester C=O), 1640 (amide I), 1598 (Ar C=C), 
1581 (alkene C=C), 1511 (amide II), 825, (p-disubstitutedAr-H), 765 & 720 
(monosubstituted Ar-H), 694 (C-Br); 6H(250 MHz, CDC13) 
3•55* 
 (1.5H, s, 
COOCH3), 3.62 (1.511, s, COOCH3), 7.02-7.71 (Ar-H); O (63 MHz, CDC1 3) 52.1 
(COOCH3), 52.2 (COOCH3), 122.3*  (C=C(Ar)2), 125.6 (C=C(Ar)2), 125.7 
(CC(Ar) 2), 127.2 (Ar CH), 127.9 (C=C(Ar) 2), 128.1, 128.3 (Ar CH), 128.6*  (Ar C), 
128.7, 128.9, 129.1, 129.7, 130.7, 131.3, 131.5, 131.9 & 132.2 (Ar CH), 132.3, 
134.5*, 135.4,137.1% 137.6,138.1 * & 138.7 (Ar C), 165.0*  (COOCH3), 165.2 
(COOCH3), 165.9* (CONH), 166.0 (CONH); m/z (FAB) 438 ("Br MH), 436 ("Br 
MH), 406 ("Br M-OCH 3), 404 (79Br M-OCH3058 (MH-Br), 325 (MH-Br, OCH 3) 
General procedure: hydrolysis of oxazolones 
A solution of the oxazolone in THF was added to a solution of NaOH in water. The 
mixture was stirred until TLC (ethyl acetate/hexane 1:4) confirmed that the reaction 
had gone to completion. THF was then removed in vacuo and the resultant solution 
washed with 2x DCM. After acidifying to pH 4.5 the water solution was extracted 




2Benzamido-3-phenyl-but-2-eflOiC acid typical procedure 
[iI 
The general procedure was followed with 110 (4.50 g of crude material, 0.0 17 1 mol 
based on 100% yield of oxazolone), sodium hydroxide (0.0.684 g, 0.0171 mol), 
water (67 ml) and THF (100 ml). The reaction was worked up as in the procedure to 
yield 2.59 g (53%) of the title compound, a white powder. 
Mp 187-188°C, lit 190 198°C; 8 H (400 MHz, DMSO) 2.158 (0.62H, s, CCCH3), 2.40 
(2.38 H, s, C=CCH3), 7.29-7.67 (8H, m, Ar-H), 7.707.76* (0.42H, m, Ar-H), 8.01- 
8.06 (1.58 H, m, Ar-H); O (63 MHz, DMSO) 20.9 (C=CCH 3), 124.7 (CCCH 3), 
127.6, 127.8, 128.2, 128.3 & 131.5 (ArCH), 133.8 & 141.1 (Ar C), 142.6 (CCCH-
), 166.3 (COOCH 3), 166.9 (CONH); m/z (FAB) 282 (MH), 264 (M-OH), 105 




The general procedure was followed with 111(7.04 g of crude material, 0.018 mol 
based on 100% yield of oxazolone), sodium hydroxide (0.72 g, 0.018 mol), water 
(160 ml) and THF (150 ml). The reaction was worked up as in the procedure to yield 
134 
Experimental 
1.416 g (22%) of the title compound, a white powder. 
2-Benzamido-3-(4-methylphenyl)but-2-enoic acid 
The general procedure was followed with 112 (8.32 g of crude material, 0.025 mol 
based on 100% yield of oxazolone), sodium hydroxide (1.00 g, 0.025 mol), water 
(160 ml) and THF (150 ml). The reaction was worked up as in the procedure to yield 
6.840 g (92%) of the title compound as a white solid. 
General procedure: esterification of amino acids 
Thionyl chloride was added dropwise to a solution of the acid in methanol. The 
reaction was then heated at reflux until TLC (ethyl acetate/hexane 1:1) confirmed 
disappearance of amino acid. The methanol solution was then concentrated in vacuo 
and the residue redissolved in DCM. After washing once with water and drying 
(MgSO4) the DCM was concentrated in vacuo to give the desired product. 
Methyl (E/Z)-2-benzamido-3-phenylbut-2-enoate 96 - typical procedure 
HI 
The general procedure was followed using SB87D (4.40 g, 0.0156 mol), thionyl 
chloride (3.72 g, 0.313 mol) and methanol (100 ml). 2.15 g (46.5%) of the title 
compound was obtained. 
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Mp 131-133, lit" 147-149°C; v(flUjOl)/Cm' 1714 (ester C=O), 1640 (amide I), 
1514 (Ar C=C), 767 & 720 (monosubstituted Ar-H); 8 H (400 MHz, CDC13) 2.18* 
(1.08H, s, C=CCH3), 2.38 (1.92H, s, C=CCH3), 3.5 1*  (1.08H, s, COOCH3), 3.90 
(1.92H, s, COOCH3), 7.03-8.11 (10H, m, Ar-H); & (63 MHz, CDC1 3) 21.8 
(C=CCH3), 52.1 (COOCH3), 123.6 (Ar C), 127.0, 127.6, 128.2, 128.5, 128.8 & 131.8 
(Ar CH), 132.9 (Ar C), 137.1 (CCCH3), 139.5 (C=CCH3), 165.3 (COOCH3), 165.5 
(CONH); m/z (El) 295 (Mi), 264 (M-OCH 3) 1  190 (M-C6H5CO), 105 (C6H5CO), 77 
(CA); Found (El) (M) 295.12057, C 18H 17NO3 requires 295.12084. 
Methyl (E/Z)-2-benzamido-3-(4-bromophenyl)but-2-enoate 97 
r 
N 	01-1 HI 
The general procedure was followed using SB67Dba (1.40 g, 3.88 mmol), thionyl 
chloride (0.925 g, 7.78 mmol) and methanol (30 ml). 1.15 g (79%) of the desired 
product was isolated. 
Mp 134-137°C; V ax (nujol)/cm' 1723 (ester C=O), 1628 (amide I), 1593 & 1576 (Ar 
C=C), 1517 (amide II), 824 (p-disubstituted Ar-H), 758 & 716 (monosubstituted Ar-
H); 5H (250 MHz, CDC13) 
2.19*  (0.86H, s, CCCH3), 2.35 (2.14H, s, CCCH3), 
3•50* 
(0.86 H, s, COOCH3), 3.85 (2.14 H, s, COOCH3), 7.10-7.89 (9H, m, Ar-H); & (63 
MHz, CDC1 3) 20.4 (C=CCH 3), 52.2 (COOGH3), 122.2 & 123.9 (Ar C), 127.0, 128.6, 
129.1, 131.2 & 132.0 (Ar CH), 132.8 (Ar C), 136.9 (C=CCH3), 138.6 (C=CCH 3), 
165.3 (COOCH3), 165.5 (CONH); m/z (FAB) 376 (8tBr MH), 375 (81 Br M 1 ), 374 
(79Br MH), 373 (Br M*),  344 (81 Br M-OCH3), 342 (79Br M-OCH 3), 270 ("Br M-
C6H5CO), 268 (79Br M-C6H5CO), 105 (C6H5CO), 89 (C6H5C), 77 (C6H5); Found 
(FAB) ("Br M) 375.02907, C 18H 16NO3Br requires 375.02936; Found C 57.49%, H 
4.35%, N 3.89%, C 18H 16NO3Br requires C 57.78%, H 4.31%, N 3.74%. 
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Methyl (E/Z)-2-benzamido-3-(4-methylphenyl)but-2-enoate 98 
The general procedure was followed using SB67Daa (6.80 g, 0.0200 mol), thionyl 
chloride (5.40 g, 0.0460 mol) and methanol (150 ml). 3.61 g (50%) of the desired 
product was isolated. 
Mp 121-122'C, lit 81  12 1-123°C v max (nujol)/cm' 1724 (ester C=O), 1645 (amide I), 
1600 & 1578 (Ar C=C), 1509 (amide II), 819 (p-disubstituted Ar-H), 729 & 691 
(monosubstituted Ar-H); 8 H (250 MHz, CDC13) 
2.20*  (0.86H, s, C=CCH3), 2.31 (2.14 
H, s, C=CCH3), 2.39 (3H, s, C6H4CH3), 
3•49* 
 (0.86H, s, COOCH3), 3.86 (2.14 H, 5 
COOCH3), 7.11-7.90 (9H, m, Ar-H); ö (63 MHz, CDC1 3) 20.4 (C=CCH 3), 21.1 
(C6H4 CH3), 52.1 (COOCH3), 123.4 (Ar C), 127.0, 127.3, 128.5, 129.5 & 131.8 (Ar 
CH), 132.0 (Ar C), 133.0 (Ar C), 136.7 (CCCH 3), 138.1 (C=CCH3), 165.3 
(COOCH3), 165.6 (CONH); m/z (FAB) 310 (MW), 309 (M), 278 (M-2xCH 3), 204 
(M-C6H5CO), 105 (C6H5CO), 77(C6H5) ; Found (FAB) (MW) 310.14475, C 19H20NO3 
requires 310.14432. 
Isomerisation 
Attempted isomerisation of 4-(1 -phenyl)ethylidene-2-phenyloxazol-5(411)-one 
110 in HBr/ acetic acid: general procedure 
110 (0.100 g, 0.38 mmol, 3.65:1 Z:E isomers) was dissolved in a solution of HBr in 
acetic acid (30% w/w HBr in acetic acid, 5.0 ml) at 0°C and stirred for 16h. The 
reaction mixture was then poured onto ice (approx. 30 ml) whichwas extracted with 
3x DCM (15 ml). The DCM portions were combined and washed with 3x H 20 (40 
ml), dried (Na2SO4) and concentrated in vacuo yielding a yellow gum which was 
examined in 'H NMR. 




The reaction vessel was stirred at 5°C with the flask open to the atmosphere. 0.080g 
(80% recovery) of material was obtained. 'H NMR indicated a 2:1 mixture ofZand 
E isomers. 
5H(400 MHz, CDC13) 2.65*  (1.00H, s, CCCH3), 2.79 (2.00H, s, C=CCH3), 7.40-
7.61 (6H, m, Ar-H), 7.82-7.89 (2H, m, Ar-H), 8.02-8.13 (2H, m, Ar-If). 
Set two 
The reaction vessel was stirred at 5°C with the flask sealed. 0.076g (76% recovery) 
of material was obtained. 'H NMR indicated a 2:1 mixture of Z and E isomers. 
6H(400 MHz, CDC13) 2.65 (1.00H, s, C=CCH3), 2.79 (2.00H, s, C=CCH3), 7.40-
7.61 (6H, m, Ar-H), 7.82-7.89 (2H, m, Ar-If), 8.02-8.13 (2H, m, Ar-H). 
Set three 
The reaction vessel was stirred at 20°C with the flask sealed. 0.1OOg (100% 
recovery) of material was obtained. 'H NMR indicated a 1.8:1 mixture of Z and E 
isomers. 
8H (400 MHz, CDC13) 
2.65*  (0.84H, s, C=CCH3), 2.81 (2.16H, s, C=CCH3), 7.38-
7.61 (6H, m, Ar-If), 7.83-7.89 (2H, m, Ar-H), 8.04-8.12 (2H, m, Ar-I). 
Isomerisation of methyl (E/Z)-2-benzamido-3-phenylbut-2-enoate 96 in 
triethylamine 
Triethylamine (0.00728g, 8.45x10 5mol) was added to a solution of 96 (0.050g, 0.169 
mmol, 4:1 Z:E mixture) in DCM (5m1). After stirring at rt for 16h, the reaction 
mixture was poured into DCM (lOOml), washed with 0.3N KHSO 4 (50m1) and water 
(50m1), dried over MgSO4 and concentrated to give 0.100 (100%) of 96. 'H NMR 
confirmed a 4:1 mixture of Z and E isomers. 
0H (200 MHz, CDC1 3) 1.85 (1H, b, NH), 2.16*  (0.6H, s, CCCH3), 2.30 (2.4H, 5, 
C=CCH3), 3.40*  (0.6H, s, OCH3), 3.84 (2.4H, s, COOCH3), 7.10-7.90(1OH, m, Ar- 
H). 
Isomerisation of 2-benzamido-3-phenyl-but-2-enoic acid in sodium hydroxide 
Two solutions were prepared, each containing 110 (0.500 g, 1.9 mmol, 5:1 mixture 
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of Z and E isomers), NaOH (0.076 g, 1.9 mmol), H20(7.4 ml) and THF (17 ml). The 
reactions were stirred at RT for lh and 16h respectively, then worked up. THF was 
removed by concentration in vacuo and the remaining solution was poured into H 20 
(20 ml). After washing with 3x DCM (30 ml) the water was acidified to pH 4 and 
extracted with 2x DCM (30 ml). The DCM extractions were combined, dried 
(MgSO4), and concentrated in vacuo to give 0.408 g (76% recovery) of SB87D in the 
case of the 1 h hydrolysis, and 0.370 g (69% recovery) of SB87D in the 16h 
hydrolysis. The isomer ratio for the 1 h hydrolysis was 4.9:1 Z.E. For the 16 h 
hydrolysis, the ratio had increased to 7.2:1 Z.-E. The 7.2:1 mixture was submitted to 
the same reaction conditions for a further 16h but no change in the isomer ratio was 
observed. 
1 h hydrolysis: 8 H (400 MHz, CDC13) 
2.16*  (0.51H, s, C=CCH3), 2.40 (2.49H, s, 
C=CCH3), 7.28-7.60 (6H, m, Ar-H), 7.74 (1.66H, d, J 7.7, Ar-H), 8.03 (0.34Hz, d, J 
7.8, Ar-H). 
16 h hydrolysis: 5H  (400 MHz, CDC13) 
2.18*  (0.37H, s, CCCH3), 2.42 (2.63H, s, 
CCCH3), 7.27-7.60 (6H, in, Ar-H), 7.73 (1.75H, d, J 7.7, Ar-H), 8.03 (0.25Hz, d, J 
7.8, Ar-H). 
Asymmetric hydrogenation of dehydroamino esters 
General Procedure: hydrogenation of amino esters 
Substrate, degassed methanol and catalyst were added to a 50 ml Parr hydrogenation 
vessel. The vessel was purged, first with N 2 for 5 minutes, then with 3 cycles of 
pressurising with H2 (90 psi) and releasing. After purging, the vessel was pressurised 
to the initial reaction pressure and the reaction mixture left to stir. Where samples 
were taken for TLC, this was done by injecting through the sampling port, so that 
although the vessel had to be depressurised and then repressurised, the reaction 
mixture was not exposed to the air. Where extra catalyst was added the vessel was 
depressurised and purged with N 21  catalyst was added and the vessel purged and 
repressurised. 
For reactions using Pd/C, product was recovered simply by filtering the methanol 
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solution and concentrating under reduced pressure. 
For the reactions using DuPHOS-Rh and BPE-Rh the methanol solution was 
concentrated in vacuo and the resulting crude mixture was passed through a short 
column of silica using ethyl acetate as eluant. Evaporation of solvent gave the pure 
product. 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118 via palladium catalysed 
hydrogenation 
N 	011-1 
Following the general procedure 96(0.10 g, 0.34 mmol, 1.6:1 Z/E), methanol (20 ml) 
and 10% Pd on activated charcoal (0.010 g, 9.5x10 6 mol of Pd) were hydrogenated 
at 120 psi. After 3 h TLC showed no product formed. More PdJC was added (0.015 
g, 1.9x10 5  mol) and the mixture hydrogenated at 120 psi for a further 72 h. Workup 
yielded 0.10 g (100%) of product. 
R (mm) method A 5.30 (19.3%), 6.19 (30.7%), 8.19 (19.7%), 9.85 (30.4%); 8H 
(400MHz, CDC13) 1.41* (1.32H, d, J=7.8), 1.44 (1.67H, d, J=7.2), 1.68 (1H, br s), 
3.62 (1.72H, s), 3.76*  (1.28H, s), 5.00 (1H, m), 6.31 (0.58H, d, J=8.4), 6.62*  (0.42H, 
d, J=8.4), 7.17-7.79 (1 OH, m). 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118: Rh-(RR)-MeDuPHOS 
hydrogenation 
Following the general procedure 96 (0.10 g, 0.34 mmol, 3.6:1 mixture of Z and E 
isomers), methanol (5 ml) and {Rh (cyclooctadiene)[(R,R)-MeDuPHOS]}BF 4 
(0.0010 g, 1.66x10 6 mol) were hydrogenated at 90 psi for 18 h. TLC showed 
complete conversion of starting material. Purification according to the procedure 
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gave 0.10 g (100%) of a white solid. 
R1 (mm) method A 5.37 (7.5%), 6.19(88.4%), 8.31 (3.8%), 10.05 (0.3% 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118: Rh-(RR)-MeBPE 
hydrogenation 
Following the general procedure 96 (0.10 g, 0.34 mmol, 3.6:1 mixture of Z and E 
isomers), methanol (10 ml) and {Rh (cyclooctadiene) [(R,R)-MeBPE] } CFSO 
(0.0010 g, 1.80x10 6 mol) were hydrogenated at 90 psi for 44 h. TLC showed starting 
material still present. The mixture was hydrogenated at 120 psi for a further 24 h. 
Purification according to the procedure gave 0.10 g (100%) of a white solid. 
R (mm) method A 5.19 (5.4%), 6.00 (93.0%), 7.83 (1.3%), 9.41 (0.4%). 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118: Rh-(SS)-EtDuPHOS 
hydrogenation 
Following the general procedure 96 (0.10 g, 0.34 mmol, 3.6:1 mixture of Z and E 
isomers), methanol (10 ml) and {Rh (cyc1ooctadiene)[(S,S)-EtDuPHOS]}BF 4 
(0.0016 g, 2.4x10 6 mol) were hydrogenated at 90 psi for 44 h. TLC showed starting 
material present. The mixture was hydrogenated at 120 psi for a further 24 h. 
Purification according to the procedure gave 0.093 g (93%) of a white solid. 
R (mm) method A 5.26 (1.1%), 6.11(1.6%), 7.95 (1.0%), 9.42 (96.3%). 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118: Rh-(SS)-EtBPE 
Following the general procedure 96(0.10 g, 0.34 mmol, 3.6:1 mixture ofZ and E 
isomers), methanol (10 ml) and (Rh (cyclooctadiene)[(S,S)-EtBPE]}BF 4 (0.00 15 g, 
2.4x10 6  mol) were hydrogenated at 100 psi for 44 h. TLC showed starting material 
still present. The mixture was hydrogenated at 120 psi for a further 24 h. Purification 
according to the general procedure gave 0.10 g (100%) of a white solid. 
R (mm) method A 5.26 (2.1%), 6.14 (1.1%), 7.96 (3.9%), 9.38 (92.9%). 
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Synthesis of methyl 2-benzamido-3-phenylbutyrate 118, 16h at 150 psi 
Following the general procedure 96 (0.10 g, 0.34 mmol, 3.6:1 mixture of Z and E 
isomers), methanol (10 ml) and {Rh (cyclooctadiene)[(S,S)-EtDuPHOS]}BF 4 
(0.0022 g, 3.3x10 mol) were hydrogenated at 150 psi for 22 h 10 mm. Samples 
were taken at lh intervals in the last 7 h of the experiment. R (mm) method B, t=16h 
10 min 6.11(0.4%), 7.11(0.6%), 10.66 (0.5%), 12.97 (48.8%), 16.3 (starting 
material) (49.8%). Later samples showed no decrease in the proportion of starting 
material in the reaction. 
Synthesis of methyl 2-benzamido-3-phenylbutyrate 118 to completion at 150 psi 
Following the general procedure 96(0.10 g, 0.34 mmol, 3.6:1 mixture ofZ and E 
isomers), methanol (10 ml) and {Rh (cyclooctadiene)[(S,5)-EtDuPHOS]BF 4 
(0.0022 g, 3.3x10 6  mol) were hydrogenated at 150 psi for 184h. Purification 
according to the general procedure gave 0.1OOg (100%) of a white solid. 
R (mm) method B, 6.01 (6.0%), 7.00 (1.3%), 10.50 (7.1%), 12.71 (85.7%). 
Synthesis of ethyl 2-benzamido-3-phenylbutyrate 118 to completion at 180 psi 
Following the general procedure 96(0.10 g, 0.34 mmol, 3.6:1 mixture ofZ and E 
isomers), methanol (10 ml) and {Rh (cyclooctadiene)[(S,S)-EtDuPHOS]BF 4 
(0.0022 g, 3.4x10 6  mol) were hydrogenated for 192 h at 180 psi. Workup and 
purification gave 0.089 g (89%) of a white solid. 
R (mm) method A 6.14 (6.0%),7.16 (1.1%),10.72 (7.3%),12.90 (85.7%); Vmax 
(nujol)/cm' 1737 (C=O), 1634 (CN); oH (250MHz, CDC13) 1.38*  (0.39H, d, J=7.8), 
1.42 (2.61H, d, J=7.2),1.61 * (0.13H, m), 1.82 (0.87H, m), 3.53 (2.61H, s), 3.70* 
(0.3911, s), 4.95 (0.87H, dd, J=6.9, 8.7), 4.98* (0.13H, m), 6.50 k (0.16H, d, J=8.4), 
6.88 (0.83H, d, J=8.4), 7.14-7.51 (8H, m), 7.617.64* (0.27H, m), 7.70-7.74 (1.73H, 
m); O  (63 MHz, CDC13) 16.9 (CHCH3)1 
17.5* (CHCH3),  42.0*  (CHCH3), 42.7 
(CHCH3), 51.9 (OCH 3), 52.1' (OCH 3), 57.4' (CHCO2CH3), 58.0 (CHCO2CH3), 
126.8, 126.9, 127.1, 127.3, 127.5, 128.3, 128.4, 128.6 & 131.7 (ArCH), 133.5', 
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133.6, 140.5* & 140.8 (Ar C), 167.2 (CO2CH3), 167.4* (CO 2CH3), 171.9 (CONH), 
172.0* (CONH); m/z (FAB) 298 (MW), 238 (M-CO 2CH3) 1  193 (M-C6H5CO), 105 
(C6H5CO), 89 (CAC),  77 (Ph); Found (FAB) (MW) 298.14433, C 18H 19NO3 requires 
298.14432. 
Methyl 2-benzamido-3-(4-chlorophenyl)pentaflOate 119 
ZT - 
I 	HH 0 
Following the procedure 99 (0.10 g, 0.29 mmol, 3.3:1 mixture of Z and E isomers), 
methanol (10 ml) and 10% Pd on activated charcoal (0.010 g, 9.5xl0 6 mol of Pd) 
were hydrogenated at 120 psi for 93 h. TLC (ethyl acetate/hexane 1:4) revealed 
disappearance of starting material. Purification according to the general procedure 
gave 0.090 g (90%) of a colourless glass. 
R1  (mm) method B 15.74 (9.9%),17.38 (9.4%),18.92 (40.3%),21.27 (40.2%). 
Vmax  (nuj 01)/cm' 2967 (alkyl CH), 1735 (ester C=0), 1663 (amide I), 1581 (amide II); 
oH (400MHz, CDC13) 0.86 (2.4H, t, J=7.3, CH3CH2), 0.92* (0.6H, t, J=7.3, CH3CH2), 
1.91 (1.6H, m, CH3CH2), 2.01* (0.4H, m, CH3CH2), 3.01 (0.8H, dt, J=10.6, 6.0, 
CHCH2CH3), 3.24* (0.2H, dt, J=8.6, 5.0, CHCH 2CH3), 3.59 (2.4H, s, OCH3), 
3•74* 
(0.6H, s, OCH3), 5.06 (0.8H, dd, J=8.5, 6.5, CHCO2CH3), 5.18* (0.2H, dd, J=8.6,4.8, 
CHCO2CH3), 6.60 (0.8H, d, J=8.5, NH), 6.30*  (0.2H, d, J=8.0, NH), 7.14-7.16 (2H, 
m, Ar-H), 7.18-7.39 (2H, m, Ar-H), 7.40-7.56 (3H, m, Ar-H); 8 c (63 MHz, CDC13) 
12.1 (CH 3CH2), 14.0k (CH3CH2), 22.6*  (CH3 CH2), 24.4 (CH3CH2), 499* 
(CHCH2CH3), 51.1 (CHCH2CH3), 
55•9* 
(CHCO2CH3), 57.0 (CHCO 2CH3), 126.9, 
127.2, 128.0, 128.3, 128.5 & 131.7 (Ar CH), 128.6, 133.8 & 139.1* (Ar C), 166.6 
(COCA), 167.0* (COCA), 171.68 (CONH), 172.0*  (CONH); m/z (El) 345 (M), 
311 (M-CH3), 280 (M-2x CH3), 252 (M-CH3 CO2CH3); Found (El) (M) 345.11228, 
C 19H20N0335C1 requires 345.113 17. 
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Following the general procedure 100 (0.100 g, 0.40 mmol, 1.1:1 mixture of Z and E 
isomers), methanol (10 ml) and 10% Pd on activated charcoal (0.010 g, 9.5x10 6 mol 
of Pd) were hydrogenated at 120 psi for 93 h. Purification according to the general 
procedure gave 0.100 g (100%) of a white solid. A separation method could not be 
found for the four isomers but 'H NMR integrations indicate a 1:1 mixture of 
diastereoisomers. 
Mp 61-63°C, lit mp' 9 ' 89°C; V max (nujol)/cm' 2928 (alkyl CH), 1735 (ester C=O), 
1662 (amide I), 1517 (amide II); oH (250MHz, CDC10 0.90-1.03 (6H, m, 
CH3CH2CHCH3), 1.24 (1H, m, CH3CH2), 1.50*  (1H, m, CH3CH2), 2.02 (1H, m, 
CH3CH2CHCH3), 3.78 (3H, s, OCH3), 4.81 (0.5H, dd, J=5.0, 8.5, CHCO2CH3), 4.92* 
(0.5H, dd, J=4.0, 8.5, CHCO2CH3), 6.60 (0.5H, d, J=8.4, NH), 6.67* (0.5H, d, J=8.0, 
NH), 7.40-7.56 (3H, m, Ar-H), 7.78-7.86 (2H, m, Ar-H); & (63 MHz, CDC1 3) 12.0 
& 12.2 (CH 3CH2), 15.2 & 15.9 (CH3CH), 25.7 & 26.7 (CH3 CH2), 38.6 & 38.7 
(CH3 CH), 52.6 & 52.8 (OCH3), 56.1 & 57.2 (CHCO2CH3), 127.45, 129.0 & 132.1 
(Ar CH), 134.5 & 134.6 (Ar C), 167.5 & 167.8 (COPh), 173.1 & 173.3 (CO2CH3); 
m/z (FAB) 250 (MW), 190 (M-0O 2CH3), 105 (PhCO); Found (FAB) (MW) 
250.14448, C 14H20NO3 requires 250.14432. 
(2S, 3R) and (2S, 35) Methyl 2-benzamido-3-methylpentanoate 120 
Following the general procedure 100 (0.072 g, 0.29 mmol, 1.1:1 mixture of Z and E 
isomers), methanol (10 ml) and {Rh (cyclooctadiene)[(S,S)-EtDuPHOS)}BF 4 
(0.0019 g, 2.8x10 6  mol) were hydrogenated at 120 psi for 16 h. Purification 
according to the general procedure gave 0.072 g (100%) of a white solid which was 
identified as 121, rather than the desired methyl 2-benzamido-3-(4-bromophenyl)-3-
phenyipropanoate. OH (400MHz, CDC13) 0.80 (6H, m, CH3CH2CHCH3), 1.21 (1H, m, 
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CH3CH2), 1.49*  (1H, m, CH3CH2), 2.05 (1H, m, CH 3CH2CHCH3), 3.78 (3H, s, 
OCH3), 4.81 (0.5H, dd, J=, CHCO 2CH3), 4.92' (0.5H, dd, J=, CHCO 2CH3), 6.60 
(0.5H, d, J=, NH), 6.69' (0.5H, d, J=, NH), 7.41-7.57 (3H, m, Ar-H), 7.78-7.84 (2H, 
m, Ar-H); ö (63 MHz, CDC1 3) 12.1 & 12.2 (CH 3CH2), 15.2 & 15.9 (CH3CH), 25.8 
& 26.7 (CH3 CH2), 38.6 & 38.7 (CH 3 CH), 52.6 & 52.8 (OCH 3), 56.1 & 57.2 
(CHCO2CH3), 127.48, 129.0 & 132.2 (Ar CH), 134.5 & 134.6 (Ar C), 167.5 & 167.8 
(COPh), 173.1 & 173.4 (CO 2CH3). 
Methyl 2-benzamido-3,3-diphenylpropenoate 121 
9 0 
f NCO2Me 
Following the procedure 101 (0.100 g, 0.23 mmol), methanol (10 ml) and 10% Pd on 
activated charcoal (0.010 g, 9.5x10 6 mol of Pd) were hydrogenated at 120 psi for 
16h. Purification according to the procedure gave 0.082 g (100%) of a white solid. 
Mp 186-187°C; V x (nujo1)/cm' 2870 (alkyl CH), 1733 (ester C=O), 1639 (amide I), 
1630 (Ar C=C) 1508 (amide II), 740 & 699 (monosubstituted Ar-H); oH (250MHz, 
CDC13) 3.58 (3H, s, COOCH3), 7.15-7.69 (15H, m, Ar-H); O (63 MHz, CDC1 3) 29.6 
(COOCH3), 125.4 (N-C=C), 127.2, 128.0, 128.6, 128.8, 129.1, 129.8 & 132.1 (Ar 
CH), 132.4 (N-C=C), 135.9, 138.1 & 139.1 (Ar C), 165.0 (COOCH3), 166.2 
(CONH); Found (FAB) (MW) 358.14424, C 23H20NO3 requires 358.14432. 
Isomerisation of methyl (Z)-2-benzamido-3-phenylbut-2-enoate 96 in methanol 
A solution of 96 (0.0041 g, 1.39x10 5  mol, 96.4% Z isomer) in -methanol (10 ml) was 
stirred at RT for 96 h. Concentration in vacuo yielded 0.004 g of 96 (100% 
recovery). 'H NMR confirmed that the amount of E isomer in the sample had 
increased from 3.6% to 16.2%. 
0H (200 MHz, CDC1 3) 2.20' (0.49H, s, CCCH3), 2.32 (2.51H, s, C=CCH3), 3.48' 
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(0.49H, s, COOCH3), 3.88 (2.51H, s, COOCH3), 7.21-7.47 (8H, m, Ar-H), 7.57 
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Crystal data and structure refinement for 4-(1-phenyl)ethylidene-2-
phenyloxazol-5(4H)-one 110 
A. Crystal data 
Empirical formula C 17H 13NO2 
Formula weight 263.28 
Wavelength 0.71073 A 
Temperature 220(2) K 
Crystal system Monoclinic 
Space group P21/n 
Unit cell dimensions a = 18.6532(19) A 
b=7.5024(9)A 
c = 19.084(2) A 
Volume 266 1.3(5) A3 
Number of reflections for cell 48 (15<0<16°) 
Z 8 
Density (calculated) 1.314 Mg/M3 
Absorption coefficient 0.087 mm- ' 
F(000) 1104 
CL = 90° 
= 94.809(13)° 
90° 
B. Data collection 
Crystal description 	 Colourless tablet 
Crystal size 	 0.51x0.38x0.19 mm 
0 range for data collection 	 2.92 to 24.95 0 










C. Solution and refinement 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data/restraints/parameters 
Goodness-of-fit on F 2 
direct (SHELXS-97 (Sheldrick, 1990)) 
Full-matrix least-squares on F 2 
SHELXL-97 
geometric 
riding/rotating group (Me) 
4652/0/364 
0.967 
Conventional R [F>4a(F)] 	 RI = 0.0493 [2726 data] 
Weighted R (F 2 and all data) 	 wR2= 0.1101 
Extinction coefficient 	 0.0084(7) 
Final maximum ö/a 	 0.012 
Weighting scheme 
Calc w = 1/[\s2(F02)+(0.0495P)2+0.0000P] where P = (170 2+2Fc2)/3 
Largest diff. Peak and hole 	 0.163 and —0.179 e.k3 
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Table 1 Atomic coordinates (x10 4) and equivalent isotropic displacemtn parameters 
(A2 x 10) for 4-(1-phenyl)ethylidene-2-phenyloxazol-5(411)-one 110. U(eq) is 
defined as one third of the trace of the orthogonalised Uij tensor. 
x 	y 	z 	U(eq) 
0(1 A) 9098(1) 1320(2) 361(1) 38(1) 
C(2A) 9292(l) 1872(3) -285(1) 33(1) 
C(21A) 8738(l) 1774(3) -872(1) 32(1) 
C(22A) 8914(1) 2267(3) -1538(1) 41(1) 
C(23A) 8403(l) 2196(4) -2103(1) 50(1) 
C(24A) 7714(l) 1609(4) -2000(1) 54(1) 
C(25A) 7537(1) 1118(4) -1344(1) 51(1) 
C(26A) 8045(l) 1213(4) -772(1) 42(1) 
N(3A) 9935(l) 2456(3) -302(1) 34(1) 
C(4A) 10245 (l) 2392(3) 398(1) 34(1) 
C(41A) 10918(1) 2944(3) 636(1) 36(1) 
C(42A) 11446(1) 3667(3) 177(1) 36(1) 
C(43A) 12182(1) 3631(4) 405(1) 48(1) 
C(44A) 12688(l) 4365(4) 5(2) 56(1) 
C(45A) 12486(1) 5173(4) -624(2) 55(1) 
C(46A) 11769(1) 5210(3) -865(1) 48(1) 
C(47A) 11257(1) 4447(3) -475(1) 40(1) 
C(48A) 11144(1) 2840(4) 1413(1) 47(1) 
C(5A) 9700(l) 1643(4) 830(1) 41(1) 
0(5A) 9684(l) 1294(3) 1442(1) 60(1) 
0(1 B) 4400(1) 2320(2) 263(1) 42(1) 
C(2B) 5078(l) 2427(3) 13(1) 36(1) 
C(2113) 5116(1) 3200(3) -680(1) 36(1) 
C(2213) 5778(l) 3258(3) -961(1) 43(1) 
C(2313) 5834(2) 3986(4) -1615(1) 52(1) 
C(24B) 5234 (2) 4657(4) -2000(1) 54(1) 
C(25B) 4577 (2) 4601(4) -1720(1) 52(1) 
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C(26B) 4512(1) 3883(3) -1063(1) 45(1) 
N(3B) 5599 (l) 1839(3) 430(1) 36(1) 
C(4B) 5295 (l) 1270(3) 1040(1) 35(1) 
C(41B) 5665 (l) 720(3) 1637(1) 38(1) 
C(42B) 6462(l) 600(3) 1680(1) 35(1) 
C(43B) 6865 (l) 1283(3) 2270(1) 45(1) 
C(44B) 7605 (l) 1248(4) 2311(l) 50(1) 
C(45B) 7960(l) 485(4) 1786(1) 48(1) 
C(46B) 7568(l) -246(4) 1208(1) 43(1) 
C(47B) 6827(1) -175(3) 1153(1) 38(1) 
C(48B) 5297(l) 269(4) 2283(1) 53(1) 
C(5B) 4509(l) 1560(3) 929(1) 40(1) 
0(5B) 4011(l) 1304(2) 1275(1) 54(1) 
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Table 2 Bond lengths (A) and angles(') for 4-(1-phenyl)ethylidene-2-phenyloxazol-
5(4H)-one 110 
O(1A)-C(2A) 	 1.378(2) 
O(1A)-C(5A) 1.398(3) 
C(2A)-N(3A) 1.279(3) 
C(2A)-C(2 1A) 1.462(3) 





















C(2B)-C(2 1 B) 1.451(3) 











C(4 1B)-C(42B) 1.483(3) 












C(22A)-C(2 1 A)-C(26A) 120.1(2) 
C(22A)-C(21A)-C(2A) 118.8(2) 
C(26A)-C(2 1 A)-C(2A) 121.1(2) 

























C(2B)-O( 1 B)-C(5B) 105.58(18) 
N(3B)-C(2B)-O(1B) 115.5(2) 












C(4 1B)-C(4B)-C(5B) 126.8(2) 
N(3B)-C(4B)-C(5B) 107.5(2) 
C(4B)-C(4 1 B)-C(42B) 120.4(2) 
C(4B)-C(4 1 B)-C(48B) 121.7(2) 
















Table 3 Anisotropic displacement parameters (A 2x 1 0) 4-(l -phenyl)ethylidene-2-
phenyloxazol-5(411)-one 110. The anisotropic displacement factor takes the form: - 
2 7E 2 [h2a* 2U1 1+ ... + 2hka*b* U121 
Ull 	U22 	U33 	U23 	U13 	U12 
0(1) 32(1) 48(1) 35(1) 3(1) 5(1) 1(1) 
C(2) 34(1) 34(2) 30(1) 0(1) 6(1) 4(1) 
 29(1) 30(1) 36(1) -2(1) 0(1) 4(1) 
 36(1) 50(2) 39(2) 1(1) 4(1) -3(1) 
 50(2) 61(2) 38(2) 5(1) -2(1) 2(2) 
 45(2) 64(2) 49(2) -3(2) -12(1) 6(2) 
 33(2) 60(2) 60(2) -4(2) 0(1) 0(1) 
 35(1) 48(2) 44(2) 0(1) 6(1) 1(1) 
N(3) 29(1) 39(1) 34(1) -3(1) 1(1) -1(1) 
C(4) 33(1) 38(2) 32(1) -2(1) 1(1) 5(1) 
C(41 37(1) 31(2) 39(1) -6(1) -1(1) 6(1) 
 32(1) 30(1) 44(2) -10(1) -2(1) 2(1) 
 37(2) 49(2) 57(2) -7(2) -7(1) -1(1) 
 29(2) 59(2) 80(2) -11(2) -3(2) -4(1) 
 41(2) 47(2) 78(2) -4(2) 16(2) -2(1) 
 44(2) 43(2) 56(2) 0(1) 7(1) 0(1) 
 34(1) 39(2) 48(2) -3(1) 0(1) 0(1) 
 49(2) 48(2) 43(2) -7(1) -9(1) 4(1) 
C(S) 36(1) 51(2) 35(2) -2(1) -1(1) 5(1) 
0(5) 51(1) 95(2) 35(1) 10(1) 3(1) -2(1) 
0(1) 30(1) 46(1) 50(1) -3(1) 1(1) 2(1) 
C(2) 29(1) 33(2) 47(1) -10(1) 1(1) -1(1) 
 39(1) 29(1) 39(1) -9(1) -3(1) -1(1) 
 42(2) 44(2) 43(2) -5(1) -2(1) 4(1) 
 55(2) 55(2) 46(2) -4(2) 5(1) -1(2) 
 73(2) 50(2) 39(2) -2(1) -4(2) -5(2) 
 57(2) 45(2) 49(2) -3(2) -19(2) 0(2) 
 38(2) 40(2) 54(2) -5(1) -6(1) -2(1) 
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N(3) 30(1) 38(1) 38(1) -2(1) 1(1) 1(1) 
C(4) 31(1) 35(2) 41(2) -4(1) 6(1) -3(1) 
 40(2) 34(2) 40(2) -4(1) 9(1) -6(1) 
 36(1) 34(1) 35(1) 5(1) 3(1) -1(1) 
 51(2) 43(2) 40(2) -1(1) 6(1) -1(1) 
 46(2) 51(2) 52(2) -2(2) -8(1) -7(1) 
 33(1) 56(2) 54(2) 16(2) -1(1) -3(1) 
 4 1(2) 49(2) 41(2) 8(1) 7(1) 4(1) 
 37(2) 39(2) 38(1) 2(1) 1(1) -2(1) 
 52(2) 57(2) 52(2) 2(2) 13(1) -4(2) 
C(S) 36(2) 36(2) 49(2) -8(1) 5(1) -2(1) 
0(5) 36(1) 61(1) 68(1) -5(1) 14(1) -6(1) 
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Table 4 Hydrogen coordinates (x10 4  )  and isotropic displacement parameters 
(A 2X 1 0) for 4-( 1 -phenyl)ethylidene-2-phenyloxazol-5(411)-one 110. 
x y z U(eq) 
H(22A) 9384 2652 -1603 50 
H(23A) 8519 2541 -2553 60 
H(24A) 7365 1546 -2385 64 
H(25A) 7069 716 -1282 61 
H(26A) 7921 902 -320 51 
H(43A) 12332 3097 838 58 
H(44A) 13178 4309 165 68 
H(45A) 12833 5698 -889 65 
H(46A) 11626 5758 -1297 57 
H(47A) 10772 4455 -654 48 
H(48A) 10721 2718 1672 71 
H(4813) 11401 3919 15612 71 
H(48C) 11455 1817 1506 71 
H(2213) 6189 2800 -703 52 
H(2313) 6284 4028 -1802 62 
H(2413) 5273 5147 -2449 65 
H(2513) 4168 5059 -1980 62 
H(26B) 4061 3856 -875 53 
H(43B) 6628 1770 2642 54 
H(44B) 7869 1751 2703 60 
H(4513) 8466 458 1818 57 
H(4613) 7808 -793 851 52 
H(47B) 6566 -656 754 46 
H(48D) 5426 1140 2647 80 
H(48E) 5446 -908 2448 80 




X-ray crystal structure for methyl (E/Z)-2-benzamido-3-phenylbut-2-enoate 96 
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Crystal data and structure refinement for methyl (E/Z)-2-benzamido-3-
phenylbut-2-enoate 96 







Unit cell dimensions 
Volume 













c = 16.055(2) A 
4597.1(1 1) A3 





a = 90° 
3= 114.180(2)0 
= 90° 










035 x 0.09 x 0.03 mm 
CCD area detector 
1.53 to 26.39 0 
-17!~ h:!~ 19,-25:!~ k:!~ 17,-20!~1:~ 19 
25804 
9354 [R(int) = 0.0520] 




	 Sadabs (Tmin = 0.700, Tmax =1.000) 
C. Solution and refinement 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters 
Goodness-of-fit on F 2 
direct (S1R97) 






Conventional R [17>4cy(F)] 	 RI = 0.0455 [5200 data] 
Weighted R (F 2 and all data) 	 wR2 = 0.1180 
Extinction coefficient 	 0.00011(16) 
Final maximum delta/sigma 	 0.009 
Weighting scheme 
caic w=1/[\s 2 (F02 )+(0.0584P)2 +0.0000P] where P=(F0 2 +217c2 )/3 
Largest diff. peak and hole 	 0.234 and -0.234 ek 3 
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Table 1 Atomic coordinates (x 10') and equivalent isotropic displacement 
parameters (A2 x 10) for methyl (E/Z)-2-benzamido-3-phenylbut-2-enoate 96. U(eq) 
is defined as one third of the trace of the orthogonalized Uij tensor. 
x 	y 	z 	U(eq) 
C(1 A) 5399(1) 1635(1) 6295(1) 31(1) 
C(2A) 5995(1) 1120(1) 6300(1) 39(1) 
C(3A) 5677(2) 474(1) 6157(2) 48(1) 
C(4A) 4756(2) 334(1) 5996(2) 48(1) 
C(5A) 4152(2) 838(1) 5979(1) 42(1) 
C(6A) 4469(1) 1485(1) 6128(1) 36(1) 
0(7A) 6602(1) 2436(1) 6528(1) 38(1) 
C(7A) 5793(1) 2319(1) 6460(1) 31(1) 
N(8A) 5246(1) 2810(1) 6534(1) 32(1) 
C(9A) 5561(1) 3479(1) 6692(1) 33(1) 
C(1 OA) 5131(1) 3945(1) 6062(1) 38(1) 
C(1 1A) 4402(1) 3749(1) 5154(1) 37(1) 
C(1 2A) 4605(2) 3273(1) 4630(1) 42(1) 
C(13A) 3932(2) 3077(1) 3792(1) 48(1) 
C(14A) 3040(2) 3345(1) 3462(1) 47(1) 
C(1 SA) 2831(2) 3819(1) 3968(1) 46(1) 
C(1 6A) 3505(1) 4025(1) 4803(1) 42(1) 
C(1 7A) 5324(2) 4678(1) 6214(2) 53(1) 
0(1 8A) 6793(1) 4127(1) 7787(1) 51(1) 
C(1 8A) 6328(1) 3624(1) 7596(1) 38(1) 
0(1 9A) 6458(1) 3128(1) 8195(1) 43(1) 
C(20A) 7199(2) 3232(1) 9092(1) 54(1) 
C(1 B) 3155(1) 3291(1) 10410(1) 33(1) 
C(2B) 2964(1) 3742(1) 9706(2) 44(1) 
C(3B) 2933(2) 4417(1) 9866(2) 56(1) 
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C(4B) 3 110(2) 4636(1) 10736(2) 58(1) 
C(5B) 3333(2) 4197(1) 11445(2) 51(1) 
C(6B) 3348(1) 3526(1) 11286(1) 40(1) 
 3458(1) 2359(1) 9657(1) 39(1) 
C(7B) 3176(1) 2568(1) 10219(1) 30(1) 
N(8B) 2893(1) 2158(1) 10718(1) 34(1) 
C(9B) 2874(1) 1457(1) 10601(1) 37(1) 
C(1OB) 3383(2) 1066(1) 11301(1) 47(1) 
C(11B) 4080(2) 1340(1) 12182(1) 42(1) 
C(12B) 4880(2) 1651(1) 12218(2) 55(1) 
C(13B) 5588(2) 1840(1) 13045(2) 54(1) 
C(14B) 5488(2) 1729(1) 13840(2) 47(1) 
C(1 5B) 4686(2) 1427(1) 13811(1) 46(1) 
C(1 6B) 3988(2) 1229(1) 12987(1) 43(1) 
C(1 7B) 3319(2) 323(1) 11294(2) 83(1) 
0(1 8B) 2271(1) 655(1) 9397(1) 57(1) 
C(1 8B) 2226(2) 1198(1) 9689(1) 39(1) 
0(19B) 1569(1) 1638(1) 9219(1) 41(1) 
C(20B) 920(2) 1410(1) 8332(1) 47(1) 
C(1 C) 3866(1) 3450(1) 7760(1) 32(1) 
C(2C) 3596(1) 4015(1) 7224(2) 43(1) 
C(3C) 3942(2) 4628(1) 7586(2) 51(1) 
C(4C) 4585(2) 4681(1) 8480(2) 51(1) 
C(5C) 4886(2) 4120(1) 901 1(2) 53(1) 
C(6C) 4514(2) 3507(1) 8650(1) 44(1) 
 3281(1) 2701(1) 6506(1) 38(1) 
C(7C) 3492(1) 2798(1) 7329(1) 33(1) 
N(8C) 3415(1) 2313(1) 7871(1) 32(1) 
C(9C) 3124(1) 1662(1) 7534(1) 33(1) 
C(IOC) 3594(1) 1126(1) 7979(1) 35(1) 
C(11C) 4478(1) 1190(1) 8818(1) 40(1) 
C(12C) 5230(2) 1561(1) 8822(2) 59(1) 
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C(13C) 6051(2) 1606(2) 9638(3) 86(1) 
C(14C) 6106(2) 1291(2) 10414(2) 94(1) 
C(1 5C) 5377(2) 924(1) 10404(2) 81(1) 
C(1 6C) 4571(2) 866(1) 9614(2) 52(1) 
C(1 7C) 3261(2) 427(1) 7715(1) 45(1) 
O(1 8C) 2043(1) 1222(1) 6095(1) 46(1) 
C(1 8C) 2224(1) 1619(1) 6703(1) 36(1) 
0(19C) 1607(1) 2073(1) 6735(1) 41(1) 
C(20C) 696(1) 2054(1) 5971(2) 58(1) 
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C(9A)-C( 1 OA) 
C(9A)-C( 1 8A) 











C( 1 B)-C(2B) 







































C(9B)-C(1 8B) 1.492(3) 
C(1OB)-C(11B) 1.491(3) 
C(1OB)-C(17B) 1.501(3) 






0(1 8B)-C( 1 8B) 1.203(2) 
C(18B)-0(19B) 1.332(2) 
0(19B)-C(20B) 1.443(2) 











C(9C)-C(1 8C) 1.490(3) 




C(1 1C)-C(12C) 1.388(3) 





















C( 1 OA)-C(9A)-C( 1 8A) 123.62(18) 
N(8A)-C(9A)-C(18A) 116.22(17) 
C(9A)-C(1OA)-C(1 1A) 119.82(18) 
C(9A)-C( 1 OA)-C(1 7A) 123.98(18) 
C(11A)-C(1OA)-C(17A) 116.19(17) 





C(13A)-C(12A)-C(1 1A) 121.0(2) 
C(14A)-C(13A)-C(12A) 120.3(2) 
C(15A)-C(14A)-C(13A) 119.4(2) 
C(14A)-C(1 5A)-C(16A) 120.7(2) 
C(15A)-C(16A)-C(1 1A) 120.7(2) 
0(18A)-C(18A)-0(19A) 122.82(18) 
















C( 1 OB)-C(9B)-C( 1 8B) 123.29(18) 
N(8B)-C(9B)-C(18B) 116.50(17) 
C(9B)-C(1OB)-C(1 1B) 122.02(18) 
C(9B)-C( 1 OB)-C( 1 7B) 124.61(19) 
C(11B)-C(1OB)-C(17B) 113.37(18) 
C(12B)-C(11B)-C(16B) 118.38(19) 
C(12B)-C(1 1B)-C(1OB) 120.3(2) 
C(16B)-C(1 1B)-C(1OB) 12 1.0(2) 





C(14B)-C(1 5B)-C(16B) 120.6(2) 
C(1 1B)-C(16B)-C(15B) 120.5(2) 
0(1 8B)-C( 1 8B)-0( 1 9B) 122.64(18) 
0(1 8B)-C( 1 8B)-C(9B) 125.23(19) 
0(1 9B)-C( 1 8B)-C(9B) 112.12(18) 
C(18B)-0(19B)-C(20B) 114.40(15) 
C(6C)-C(1C)-C(2C) 118.89(19) 












C(1OC)-C(9C)-C(1 8C) 122.72(18) 
N(8C)-C(9C)-C(18C) 115.51(16) 
C(9C)-C( 1 OC)-C( 11 C) 121.06(17) 
C(9C)-C( 1 OC)-C( 1 7C) 123.85(17) 
C(11C)-C(1OC)-C(17C) 115.01(17) 
C(1 2C)-C(1 1C)-C(16C) 118.7(2) 
C(12C)-C(11C)-C(1OC) 121.1(2) 
C(16C)-C(1 1C)-C(10C) 120.2(2) 









0(1 8C)-C( 1 8C)-0( 1 9C) 
	
123.41(17) 
0(1 8C)-C( 1 8C)-C(9C) 
	
126.00(19) 
0(1 9C)-C( 1 8C)-C(9C) 
	
110.53(17) 
C( 1 8C)-0( 1 9C)-C(20C) 
	
114.70(16) 
Symmetry transformations used to generate equivalent atoms: 
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ible 3 Anisotropic displacement parameters (A2 x 10') for methyl (E/Z)-2-
:nzamido-3-phenylbut-2-enoate 96. The anisotropic displacement factor exponent 
es  the form: -2 pi 2 [ h 2 a*2U11+ ... +2 h  a* b* U12 ] 
Ull U22 U33 U23 U13 U12 
C(1 A) 39(1) 30(1) 22(1) 0(1) 11(1) 4(1) 
C(2A) 36(1) 39(1) 39(1) -2(1) 14(1) 6(1) 
C(3A) 52(1) 34(1) 56(1) -5(1) 21(1) 9(1) 
C(4A) 58(2) 31(1) 54(2) -6(1) 23(1) -1(1) 
C(5A) 45(1) 38(1) 46(1) -7(1) 21(1) -4(1) 
C(6A) 39(1) 34(1) 38(1) -2(1) 18(1) 6(1) 
0(7A) 36(1) 38(1) 42(1) 1(1) 18(1) 3(1) 
C(7A) 33(1) 37(1) 23(1) 4(1) 11(1) 7(1) 
N(8A) 34(1) 28(1) 36(1) -1(1) 16(1) 2(1) 
C(9A) 35(1) 30(1) 38(1) -2(1) 19(1) 0(1) 
C(1 OA) 44(1) 31(1) 42(1) -1(1) 21(1) -1(1) 
C(11A) 44(1) 29(1) 38(1) 4(1) 18(1) 1(1) 
C(1 2A) 47(1) 41(1) 38(1) 4(1) 17(1) 8(1) 
C(13A) 64(2) 42(1) 38(1) 1(1) 19(1) 12(1) 
C(14A) 54(1) 37(1) 39(1) 2(1) 8(1) 2(1) 
C(15A) 45(1) 39(1) 47(1) 5(1) 11(1) 8(1) 
C(1 6A) 50(1) 30(1) 46(1) 1(1) 20(1) 7(1) 
C(1 7A) 62(2) 33(1) 54(1) 3(1) 15(1) -4(1) 
0(1 8A) 49(1) 39(1) 56(1) -4(1) 13(1) -7(1) 
C(1 8A) 41(1) 31(1) 46(1) -1(1) 22(1) 3(1) 
0(1 9A) 49(1) 44(1) 33(1) -1(1) 14(1) -3(1) 
C(20A) 62(2) 57(2) 34(1) -3(1) 11(1) -2(1) 
C(1B) 30(1) 27(1) 42(1) -2(1) 15(1) -2(1) 
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C(2B) 46(1) 35(1) 50(1) 5(1) 19(1) 5(1) 
C(3B) 57(2) 34(1) 78(2) 12(1) 29(1) 6(1) 
C(4B) 56(2) 31(1) 95(2) -12(1) 39(2) -4(1) 
C(5B) 52(1) 41(1) 65(2) -21(1) 30(1) -19(1) 
C(6B) 40(1) 35(1) 48(1) -9(1) 19(1) -11(1) 
 53(1) 32(1) 37(1) -2(1) 25(1) 1(1) 
C(7B) 32(1) 29(1) 24(1) 0(1) 7(1) -2(1) 
N(8B) 49(1) 27(1) 29(1) -4(1) 20(1) -4(1) 
C(9B) 50(1) 27(1) 34(1) -1(1) 16(1) -9(1) 
C(1OB) 66(2) 29(1) 38(1) 0(1) 13(1) -11(1) 
C(1 1B) 54(1) 24(1) 38(1) 4(1) 9(1) -6(1) 
C(12B) 76(2) 45(1) 46(1) -6(1) 28(1) -20(1) 
C(1 3B) 53(1) 46(2) 64(2) -8(1) 23(1) -12(1) 
C(14B) 44(1) 44(1) 44(1) -6(1) 7(1) 2(1) 
C(1 5B) 54(1) 44(1) 39(1) 0(1) 17(1) 9(1) 
C(1 6B) 43(1) 36(1) 44(1) -1(1) 13(1) 3(1) 
C(1 7B) 124(2) 33(1) 53(2) 6(1) -3(2) -19(2) 
0(1 8B) 72(1) 30(1) 47(1) -7(1) 4(1) 3(1) 
C(1 8B) 49(1) 31(1) 38(1) 1(1) 17(1) -6(1) 
0(1 9B) 43(1) 34(1) 40(1) -4(1) 11(1) 1(1) 
C(20B) 51(1) 41(1) 38(1) -4(1) 5(1) 0(1) 
C(1 C) 32(1) 31(1) 38(1) 5(1) 19(1) 4(1) 
C(2C) 35(1) 41(1) 48(1) 11(1) 13(1) 2(1) 
C(3 C) 45(1) 34(1) 73(2) 16(1) 24(1) 3(1) 
C(4C) 54(1) 34(1) 71(2) -3(1) 31(1) -7(1) 
C(5C) 63(2) 43(1) 47(1) -3(1) 17(1) -10(1) 
C(6C) 54(1) 35(1) 41(1) 5(1) 17(1) -2(1) 
 41(1) 41(1) 32(1) 4(1) 16(1) 6(1) 
C(7C) 28(1) 36(1) 33(1) 6(1) 12(1) 8(1) 
N(8C) 37(1) 31(1) 29(1) 0(1) 14(1) -1(1) 
C(9C) 37(1) 31(1) 33(1) -3(1) 17(1) -1(1) 
C(IOC) 37(1) 33(1) 36(1) -1(1) 16(1) 1(1) 
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C(11C) 37(1) 28(1) 47(1) -8(1) 9(1) 7(1) 
C(1 2C) 41(1) 48(2) 84(2) -15(1) 20(1) -2(1) 
C(13C) 39(2) 66(2) 133(3) -36(2) 16(2) -6(1) 
C(14C) 61(2) 73(2) 96(3) -26(2) -21(2) 26(2) 
C(1 5C) 86(2) 48(2) 64(2) -10(1) -14(2) 25(2) 
C(1 6C) 56(1) 33(1) 48(1) -3(1) 2(1) 13(1) 
C(1 7C) 51(1) 33(1) 44(1) -1(1) 12(1) -2(1) 
0(1 8C) 51(1) 45(1) 35(1) -8(1) 12(1) 2(1) 
C(1 8C) 40(1) 35(1) 34(1) 4(1) 17(1) 0(1) 
O(1 9C) 34(1) 46(1) 39(1) -5(1) 10(1) 7(1) 
C(20C) 39(1) 62(2) 54(2) -8(1) 0(1) 12(1) 
183 
Appendices 
Table 4 Hydrogen coordinates (x 104  )  and isotropic displacement parameters (A 2 x 
1 0) for methyl (E/Z)-2-benzamido-3 -phenylbut-2-enoate 96. 
x 	y 	z 	U(eq) 
H(2A) 6628 1214 6402 46 
H(3A) 6092 126 6169 57 
H(4A) 4537 -112 5897 57 
H(5A) 3517 740 5865 51 
H(6A) 4050 1831 6116 44 
H(8A) 4676 2715 6484 39 
H(12A) 5216 3082 4852 50 
H(13A) 4084 2755 3441 58 
H(14A) 2574 3205 2890 56 
H(1 5A) 2218 4007 3742 55 
H(1 6A) 3354 4358 5139 51 
H(1 7A) 5531 4779 6865 79 
H(1713) 4749 4927 5861 79 
H(17C) 5819 4804 6016 79 
H(20A) 7785 3342 9035 81 
H(20B) 7288 2827 9455 81 
H(20C) 7025 3598 9395 81 
H(213) 2854 3589 9111 53 
H(313) 2790 4725 9381 67 
H(4B) 3077 5097 10844 69 
H(513) 3477 4355 12045 61 
H(6B) 3490 3222 11776 48 
H(8B) 2715 2327 11127 41 
H(12B) 4949 1738 11668 66 
H(1313) 6142 2046 13058 65 
H(1413) 5969 1860 14407 57 
184 
Appendices 
H(15B) 4611 1353 14362 56 
H(1 6B) 3441 1014 12977 51 
H(1 7D) 2744 181 10780 124 
H(1 7E) 3302 171 11867 124 
H(1 7F) 3868 132 11231 124 
H(20D) 1269 1282 7970 71 
H(20E) 479 1768 8018 71 
H(20F) 569 1027 8404 71 
H(2C) 3169 3979 6601 52 
H(3C) 3737 5015 7218 61 
H(4C) 4821 5104 8730 61 
H(5C) 5345 4153 9621 64 
H(6C) 4709 3122 9022 53 
H(8C) 3547 2401 8447 39 
H(12C) 5191 1781 8285 71 
H(13C) 6571 1857 9649 103 
H(14C) 6659 1331 10962 113 
H(1 5C) 5421 704 10943 97 
H(1 6C) 4067 600 9614 62 
H(1 7G) 2649 433 7190 68 
H(1 7H) 3198 205 8230 68 
H(171) 3717 187 7552 68 
H(20G) 774 2123 5402 88 
H(20H) 295 2405 6042 88 
H(201) 402 1621 5953 88 
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